,approvedSymbol,approvedName,prefName,drugType,drugId,phase,ctIds,id,disease
0,DHFR,dihydrofolate reductase,METHOTREXATE,Small molecule,CHEMBL34259,4.0,"['NCT01758198', 'NCT00654368', 'NCT01404429', 'NCT00934648', 'NCT01308255', 'NCT00195494', 'NCT03449758', 'NCT00565409', 'NCT02644499', 'NCT00504777', 'NCT01185288', 'NCT02374021', 'NCT00896168', 'NCT02433184', 'NCT00424502', 'NCT02748785', 'NCT00209859', 'NCT04177173', 'NCT00808509', 'NCT00422227', 'NCT03492658', 'NCT00259610', 'NCT02557100', 'NCT00502853', 'NCT01382940', 'NCT01162421', 'NCT00848354', 'NCT02831855', 'NCT03589833', 'NCT00244556', 'NCT01500278', 'NCT00764725', 'NCT01172639', 'NCT01000610', 'NCT00462345', 'NCT00576433', 'NCT02187055', 'NCT00420927', 'NCT03737708', 'NCT01399697', 'NCT00396747', 'NCT02451748', 'NCT01163747', 'NCT00252668', 'NCT01746680', 'NCT01120366', 'NCT00695188', 'NCT04157010']",EFO_0005755,rheumatic disease
1,PTGS1,prostaglandin-endoperoxide synthase 1,SUPROFEN,Small molecule,CHEMBL956,4.0,[],EFO_0005755,rheumatic disease
2,JAK1,Janus kinase 1,TOFACITINIB CITRATE,Small molecule,CHEMBL2103743,4.0,[],EFO_0005755,rheumatic disease
3,SCN11A,sodium voltage-gated channel alpha subunit 11,LIDOCAINE,Small molecule,CHEMBL79,4.0,[],EFO_0005755,rheumatic disease
4,TNF,tumor necrosis factor,CERTOLIZUMAB PEGOL,Antibody,CHEMBL1201831,4.0,[],EFO_0005755,rheumatic disease
5,PTGS2,prostaglandin-endoperoxide synthase 2,DEXKETOPROFEN,Small molecule,CHEMBL75435,4.0,[],EFO_0005755,rheumatic disease
6,ADRB2,adrenoceptor beta 2,EPINEPHRINE,Small molecule,CHEMBL679,4.0,['NCT03119038'],EFO_0005755,rheumatic disease
7,PTGS2,prostaglandin-endoperoxide synthase 2,CELECOXIB,Small molecule,CHEMBL118,4.0,['NCT03190603'],EFO_0005755,rheumatic disease
8,JAK3,Janus kinase 3,TOFACITINIB,Small molecule,CHEMBL221959,4.0,"['NCT02092467', 'NCT02187055', 'NCT02321930', 'NCT02831855']",EFO_0005755,rheumatic disease
9,DHFR,dihydrofolate reductase,METHOTREXATE,Small molecule,CHEMBL34259,4.0,"['NCT05353829', 'NCT05626348', 'NCT05827497', 'NCT02714634']",EFO_0005755,rheumatic disease
10,DHFR,dihydrofolate reductase,METHOTREXATE,Small molecule,CHEMBL34259,4.0,"['NCT00716248', 'NCT02275299', 'NCT00291915', 'NCT02764515', 'NCT00523692', 'NCT02878161', 'NCT01548001']",EFO_0005755,rheumatic disease
11,NR3C1,nuclear receptor subfamily 3 group C member 1,METHYLPREDNISOLONE HEMISUCCINATE,Small molecule,CHEMBL1201265,4.0,['NCT03082092'],EFO_0005755,rheumatic disease
12,TNF,tumor necrosis factor,GOLIMUMAB,Antibody,CHEMBL1201833,4.0,['NCT05080218'],EFO_0005755,rheumatic disease
13,SCN7A,sodium voltage-gated channel alpha subunit 7,LIDOCAINE,Small molecule,CHEMBL79,4.0,['NCT04143165'],EFO_0005755,rheumatic disease
14,SCN9A,sodium voltage-gated channel alpha subunit 9,LIDOCAINE,Small molecule,CHEMBL79,4.0,['NCT02102620'],EFO_0005755,rheumatic disease
15,SCN2A,sodium voltage-gated channel alpha subunit 2,LIDOCAINE,Small molecule,CHEMBL79,4.0,['NCT00904605'],EFO_0005755,rheumatic disease
16,SCN9A,sodium voltage-gated channel alpha subunit 9,ROPIVACAINE HYDROCHLORIDE,Small molecule,CHEMBL1889140,4.0,['NCT00620828'],EFO_0005755,rheumatic disease
17,NR3C1,nuclear receptor subfamily 3 group C member 1,METHYLPREDNISOLONE HEMISUCCINATE,Small molecule,CHEMBL1201265,4.0,[],EFO_0005755,rheumatic disease
18,PDE4C,phosphodiesterase 4C,APREMILAST,Small molecule,CHEMBL514800,4.0,['NCT03783026'],EFO_0005755,rheumatic disease
19,PTGS2,prostaglandin-endoperoxide synthase 2,SULFASALAZINE,Small molecule,CHEMBL421,4.0,"['NCT00422227', 'NCT00259610', 'NCT02451748', 'NCT02374021', 'NCT00764725', 'NCT02433184', 'NCT01172639', 'NCT03449758']",EFO_0005755,rheumatic disease
20,ADRB2,adrenoceptor beta 2,EPINEPHRINE,Small molecule,CHEMBL679,4.0,"['NCT02464176', 'NCT03513276']",EFO_0005755,rheumatic disease
21,PTGS1,prostaglandin-endoperoxide synthase 1,ACETAMINOPHEN,Small molecule,CHEMBL112,4.0,"['NCT00246168', 'NCT01382940']",EFO_0005755,rheumatic disease
22,PTGS1,prostaglandin-endoperoxide synthase 1,INDOMETHACIN,Small molecule,CHEMBL6,4.0,[],EFO_0005755,rheumatic disease
23,OPRM1,opioid receptor mu 1,FENTANYL,Small molecule,CHEMBL596,4.0,"['NCT01742897', 'NCT00562627']",EFO_0005755,rheumatic disease
24,SCN8A,sodium voltage-gated channel alpha subunit 8,ROPIVACAINE,Small molecule,CHEMBL1077896,4.0,['NCT03119038'],EFO_0005755,rheumatic disease
25,KCNK3,potassium two pore domain channel subfamily K member 3,SEVOFLURANE,Small molecule,CHEMBL1200694,4.0,['NCT03540030'],EFO_0005755,rheumatic disease
26,TUBB4A,tubulin beta 4A class IVa,COLCHICINE,Small molecule,CHEMBL107,4.0,['NCT02602028'],EFO_0005755,rheumatic disease
27,NDUFB4,NADH:ubiquinone oxidoreductase subunit B4,METFORMIN,Small molecule,CHEMBL1431,4.0,['NCT02741960'],EFO_0005755,rheumatic disease
28,JAK3,Janus kinase 3,UPADACITINIB,Small molecule,CHEMBL3622821,4.0,['NCT05153200'],EFO_0005755,rheumatic disease
29,MT-ND1,mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 1,METFORMIN,Small molecule,CHEMBL1431,4.0,['NCT02741960'],EFO_0005755,rheumatic disease
30,TUBB2B,tubulin beta 2B class IIb,COLCHICINE,Small molecule,CHEMBL107,4.0,['NCT05698680'],EFO_0005755,rheumatic disease
31,PTGS2,prostaglandin-endoperoxide synthase 2,KETOROLAC,Small molecule,CHEMBL469,4.0,"['NCT00562627', 'NCT00901628']",EFO_0005755,rheumatic disease
32,SLC6A4,solute carrier family 6 member 4,DULOXETINE,Small molecule,CHEMBL1175,4.0,['NCT04532684'],EFO_0005755,rheumatic disease
33,PTGS1,prostaglandin-endoperoxide synthase 1,DICLOFENAC,Small molecule,CHEMBL139,4.0,"['NCT02183129', 'NCT00141102', 'NCT00447759', 'NCT00140972']",EFO_0005755,rheumatic disease
34,TNF,tumor necrosis factor,ETANERCEPT,Protein,CHEMBL1201572,4.0,"['NCT04485325', 'NCT03976245']",EFO_0005755,rheumatic disease
35,TRAF3IP2,TRAF3 interacting protein 2,IGURATIMOD,Small molecule,CHEMBL2107455,4.0,['NCT03855007'],EFO_0005755,rheumatic disease
36,PTGS1,prostaglandin-endoperoxide synthase 1,ACETAMINOPHEN,Small molecule,CHEMBL112,4.0,['NCT03994731'],EFO_0005755,rheumatic disease
37,OPRM1,opioid receptor mu 1,TAPENTADOL,Small molecule,CHEMBL1201776,4.0,['NCT01631513'],EFO_0005755,rheumatic disease
38,ADRB1,adrenoceptor beta 1,EPINEPHRINE,Small molecule,CHEMBL679,4.0,"['NCT00562627', 'NCT00901628', 'NCT02462148']",EFO_0005755,rheumatic disease
39,GABRA1,gamma-aminobutyric acid type A receptor subunit alpha1,SEVOFLURANE,Small molecule,CHEMBL1200694,4.0,['NCT03540030'],EFO_0005755,rheumatic disease
40,PTGS1,prostaglandin-endoperoxide synthase 1,SULFASALAZINE,Small molecule,CHEMBL421,4.0,['NCT02466581'],EFO_0005755,rheumatic disease
41,PTGS2,prostaglandin-endoperoxide synthase 2,NABUMETONE,Small molecule,CHEMBL1070,4.0,[],EFO_0005755,rheumatic disease
42,FAAH,fatty acid amide hydrolase,ACETAMINOPHEN,Small molecule,CHEMBL112,4.0,['NCT01105936'],EFO_0005755,rheumatic disease
43,PTGS2,prostaglandin-endoperoxide synthase 2,PARECOXIB,Small molecule,CHEMBL1206690,4.0,[],EFO_0005755,rheumatic disease
44,XDH,xanthine dehydrogenase,FEBUXOSTAT,Small molecule,CHEMBL1164729,4.0,[],EFO_0005755,rheumatic disease
45,SCN3A,sodium voltage-gated channel alpha subunit 3,ROPIVACAINE,Small molecule,CHEMBL1077896,4.0,"['NCT02658149', 'NCT01537146', 'NCT02576249', 'NCT00620828', 'NCT02365181']",EFO_0005755,rheumatic disease
46,DHFR,dihydrofolate reductase,METHOTREXATE,Small molecule,CHEMBL34259,4.0,"['NCT05393050', 'NCT03813771']",EFO_0005755,rheumatic disease
47,SCN7A,sodium voltage-gated channel alpha subunit 7,ROPIVACAINE,Small molecule,CHEMBL1077896,4.0,['NCT04257682'],EFO_0005755,rheumatic disease
48,PTGS2,prostaglandin-endoperoxide synthase 2,BENZYDAMINE,Small molecule,CHEMBL12610,4.0,[],EFO_0005755,rheumatic disease
49,RBX1,ring-box 1,THALIDOMIDE,Small molecule,CHEMBL468,4.0,['NCT05527444'],EFO_0005755,rheumatic disease
50,PTGS2,prostaglandin-endoperoxide synthase 2,ACETAMINOPHEN,Small molecule,CHEMBL112,4.0,[],EFO_0005755,rheumatic disease
51,SCN4A,sodium voltage-gated channel alpha subunit 4,BUPIVACAINE,Small molecule,CHEMBL1098,4.0,['NCT03119038'],EFO_0005755,rheumatic disease
52,TNF,tumor necrosis factor,INFLIXIMAB,Antibody,CHEMBL1201581,4.0,"['NCT01638715', 'NCT01000441', 'NCT01295151', 'NCT00794898', 'NCT00246064', 'NCT00896168', 'NCT00396747', 'NCT02770794', 'NCT00714493', 'NCT01308255']",EFO_0005755,rheumatic disease
53,NR3C1,nuclear receptor subfamily 3 group C member 1,PREDNISOLONE,Small molecule,CHEMBL131,4.0,[],EFO_0005755,rheumatic disease
54,PTGS1,prostaglandin-endoperoxide synthase 1,NAPROXEN,Small molecule,CHEMBL154,4.0,['NCT00643799'],EFO_0005755,rheumatic disease
55,SCN2A,sodium voltage-gated channel alpha subunit 2,LIDOCAINE,Small molecule,CHEMBL79,4.0,['NCT04143165'],EFO_0005755,rheumatic disease
56,PTGS2,prostaglandin-endoperoxide synthase 2,DIFLUNISAL,Small molecule,CHEMBL898,4.0,[],EFO_0005755,rheumatic disease
57,PTGS1,prostaglandin-endoperoxide synthase 1,SULFASALAZINE,Small molecule,CHEMBL421,4.0,['NCT03813771'],EFO_0005755,rheumatic disease
58,PTGS2,prostaglandin-endoperoxide synthase 2,IGURATIMOD,Small molecule,CHEMBL2107455,4.0,['NCT03855007'],EFO_0005755,rheumatic disease
59,SCN10A,sodium voltage-gated channel alpha subunit 10,PRILOCAINE,Small molecule,CHEMBL1194,4.0,['NCT02384915'],EFO_0005755,rheumatic disease
60,TNF,tumor necrosis factor,INFLIXIMAB,Antibody,CHEMBL1201581,4.0,['NCT00432406'],EFO_0005755,rheumatic disease
61,SCN3A,sodium voltage-gated channel alpha subunit 3,LIDOCAINE,Small molecule,CHEMBL79,4.0,['NCT05670236'],EFO_0005755,rheumatic disease
62,ADRA1B,adrenoceptor alpha 1B,EPINEPHRINE,Small molecule,CHEMBL679,4.0,['NCT03119038'],EFO_0005755,rheumatic disease
63,TUBB6,tubulin beta 6 class V,COLCHICINE,Small molecule,CHEMBL107,4.0,['NCT04601883'],EFO_0005755,rheumatic disease
64,TNF,tumor necrosis factor,GOLIMUMAB,Antibody,CHEMBL1201833,4.0,"['NCT01718951', 'NCT01604629']",EFO_0005755,rheumatic disease
65,FLT1,fms related receptor tyrosine kinase 1,NINTEDANIB,Small molecule,CHEMBL502835,4.0,[],EFO_0005755,rheumatic disease
66,VDR,vitamin D receptor,ERGOCALCIFEROL,Small molecule,CHEMBL1536,4.0,['NCT04177758'],EFO_0005755,rheumatic disease
67,TUBB6,tubulin beta 6 class V,COLCHICINE,Small molecule,CHEMBL107,4.0,[],EFO_0005755,rheumatic disease
68,SCN4A,sodium voltage-gated channel alpha subunit 4,BUPIVACAINE HYDROCHLORIDE,Small molecule,CHEMBL1200396,4.0,['NCT02863120'],EFO_0005755,rheumatic disease
69,SCN7A,sodium voltage-gated channel alpha subunit 7,LIDOCAINE,Small molecule,CHEMBL79,4.0,[],EFO_0005755,rheumatic disease
70,SCN11A,sodium voltage-gated channel alpha subunit 11,ROPIVACAINE,Small molecule,CHEMBL1077896,4.0,['NCT05336968'],EFO_0005755,rheumatic disease
71,SCN11A,sodium voltage-gated channel alpha subunit 11,MEPIVACAINE,Small molecule,CHEMBL1087,4.0,['NCT04257682'],EFO_0005755,rheumatic disease
72,NR3C1,nuclear receptor subfamily 3 group C member 1,DEXAMETHASONE PHOSPHORIC ACID,Small molecule,CHEMBL1201302,4.0,[],EFO_0005755,rheumatic disease
73,PTGS2,prostaglandin-endoperoxide synthase 2,ETORICOXIB,Small molecule,CHEMBL416146,4.0,['NCT00140972'],EFO_0005755,rheumatic disease
74,PTGS1,prostaglandin-endoperoxide synthase 1,ACEMETACIN,Small molecule,CHEMBL189171,4.0,[],EFO_0005755,rheumatic disease
75,NDUFV2,NADH:ubiquinone oxidoreductase core subunit V2,METFORMIN,Small molecule,CHEMBL1431,4.0,['NCT02741960'],EFO_0005755,rheumatic disease
76,PTGS2,prostaglandin-endoperoxide synthase 2,CELECOXIB,Small molecule,CHEMBL118,4.0,"['NCT02780323', 'NCT00447759', 'NCT00141102', 'NCT00346216']",EFO_0005755,rheumatic disease
77,PTGS2,prostaglandin-endoperoxide synthase 2,IBUPROFEN,Small molecule,CHEMBL521,4.0,[],EFO_0005755,rheumatic disease
78,TNF,tumor necrosis factor,ADALIMUMAB,Antibody,CHEMBL1201580,4.0,"['NCT04222920', 'NCT04194827', 'NCT04251741', 'NCT05626348']",EFO_0005755,rheumatic disease
79,PTGS1,prostaglandin-endoperoxide synthase 1,DICLOFENAC POTASSIUM,Small molecule,CHEMBL1200804,4.0,['NCT00141102'],EFO_0005755,rheumatic disease
80,SLC22A6,solute carrier family 22 member 6,PROBENECID,Small molecule,CHEMBL897,4.0,[],EFO_0005755,rheumatic disease
81,TNF,tumor necrosis factor,ADALIMUMAB,Antibody,CHEMBL1201580,4.0,"['NCT01382160', 'NCT01021735', 'NCT00649922', 'NCT02374021', 'NCT01295151', 'NCT00480272', 'NCT04255134', 'NCT02092467', 'NCT01000441', 'NCT01270087', 'NCT02187055', 'NCT01185288', 'NCT00837434', 'NCT02451748', 'NCT03737708', 'NCT01500278', 'NCT01609205', 'NCT00234897', 'NCT01162421', 'NCT00234234', 'NCT00420927', 'NCT02056184', 'NCT01119859', 'NCT02557100', 'NCT00808509', 'NCT02198651']",EFO_0005755,rheumatic disease
82,ALOX5,arachidonate 5-lipoxygenase,SULFASALAZINE,Small molecule,CHEMBL421,4.0,['NCT02466581'],EFO_0005755,rheumatic disease
83,SCN2A,sodium voltage-gated channel alpha subunit 2,LIDOCAINE,Small molecule,CHEMBL79,4.0,[],EFO_0005755,rheumatic disease
84,PLAT,"plasminogen activator, tissue type",AMINOCAPROIC ACID,Small molecule,CHEMBL1046,4.0,['NCT01873768'],EFO_0005755,rheumatic disease
85,ATP4A,ATPase H+/K+ transporting subunit alpha,ESOMEPRAZOLE,Small molecule,CHEMBL1201320,4.0,[],EFO_0005755,rheumatic disease
86,JAK2,Janus kinase 2,UPADACITINIB,Small molecule,CHEMBL3622821,4.0,['NCT05153200'],EFO_0005755,rheumatic disease
87,SCN10A,sodium voltage-gated channel alpha subunit 10,ROPIVACAINE,Small molecule,CHEMBL1077896,4.0,['NCT02365727'],EFO_0005755,rheumatic disease
88,SLC6A2,solute carrier family 6 member 2,TAPENTADOL HYDROCHLORIDE,Small molecule,CHEMBL1201777,4.0,['NCT01631513'],EFO_0005755,rheumatic disease
89,PTGS2,prostaglandin-endoperoxide synthase 2,KETOROLAC,Small molecule,CHEMBL469,4.0,['NCT02570503'],EFO_0005755,rheumatic disease
90,NR3C1,nuclear receptor subfamily 3 group C member 1,CORTISONE ACETATE,Small molecule,CHEMBL1650,4.0,[],EFO_0005755,rheumatic disease
91,NR3C1,nuclear receptor subfamily 3 group C member 1,METHYLPREDNISOLONE,Small molecule,CHEMBL650,4.0,"['NCT02576249', 'NCT02292082']",EFO_0005755,rheumatic disease
92,MS4A1,membrane spanning 4-domains A1,RITUXIMAB,Antibody,CHEMBL1201576,4.0,"['NCT00576433', 'NCT00504777', 'NCT01021735', 'NCT00502853', 'NCT02731560', 'NCT01295151', 'NCT00462345', 'NCT01765374', 'NCT01593332', 'NCT01000610', 'NCT01638715', 'NCT01382940', 'NCT00934648', 'NCT01000441', 'NCT00424502']",EFO_0005755,rheumatic disease
93,TRPV1,transient receptor potential cation channel subfamily V member 1,ACETAMINOPHEN,Small molecule,CHEMBL112,4.0,"['NCT01382940', 'NCT00246168']",EFO_0005755,rheumatic disease
94,NR3C1,nuclear receptor subfamily 3 group C member 1,CORTISONE ACETATE,Small molecule,CHEMBL1650,4.0,[],EFO_0005755,rheumatic disease
95,NR3C1,nuclear receptor subfamily 3 group C member 1,PREDNISOLONE,Small molecule,CHEMBL131,4.0,[],EFO_0005755,rheumatic disease
96,ALOX5,arachidonate 5-lipoxygenase,MECLOFENAMIC ACID,Small molecule,CHEMBL509,4.0,[],EFO_0005755,rheumatic disease
97,ADRB3,adrenoceptor beta 3,EPINEPHRINE,Small molecule,CHEMBL679,4.0,['NCT02570503'],EFO_0005755,rheumatic disease
98,PTGS2,prostaglandin-endoperoxide synthase 2,NAPROXEN,Small molecule,CHEMBL154,4.0,[],EFO_0005755,rheumatic disease
99,SCN8A,sodium voltage-gated channel alpha subunit 8,MEPIVACAINE,Small molecule,CHEMBL1087,4.0,['NCT04257682'],EFO_0005755,rheumatic disease
100,VDR,vitamin D receptor,ALFACALCIDOL,Small molecule,CHEMBL1601669,4.0,['NCT00668330'],EFO_0005755,rheumatic disease
101,NR3C1,nuclear receptor subfamily 3 group C member 1,HYDROCORTISONE PROBUTATE,Small molecule,CHEMBL1200953,4.0,[],EFO_0005755,rheumatic disease
102,MS4A1,membrane spanning 4-domains A1,RITUXIMAB,Antibody,CHEMBL1201576,4.0,[],EFO_0005755,rheumatic disease
103,SCN4A,sodium voltage-gated channel alpha subunit 4,ROPIVACAINE HYDROCHLORIDE,Small molecule,CHEMBL1889140,4.0,['NCT00620828'],EFO_0005755,rheumatic disease
104,GABRG1,gamma-aminobutyric acid type A receptor subunit gamma1,REMIMAZOLAM,Small molecule,CHEMBL4297526,4.0,['NCT05760534'],EFO_0005755,rheumatic disease
105,PTGS2,prostaglandin-endoperoxide synthase 2,ETORICOXIB,Small molecule,CHEMBL416146,4.0,['NCT00142558'],EFO_0005755,rheumatic disease
106,SCN11A,sodium voltage-gated channel alpha subunit 11,LIDOCAINE,Small molecule,CHEMBL79,4.0,['NCT01045694'],EFO_0005755,rheumatic disease
107,SCN4A,sodium voltage-gated channel alpha subunit 4,BUPIVACAINE,Small molecule,CHEMBL1098,4.0,"['NCT00562627', 'NCT02863120', 'NCT02462148']",EFO_0005755,rheumatic disease
108,PTGS1,prostaglandin-endoperoxide synthase 1,DICLOFENAC,Small molecule,CHEMBL139,4.0,"['NCT02528201', 'NCT00715091']",EFO_0005755,rheumatic disease
109,TYK2,tyrosine kinase 2,TOFACITINIB,Small molecule,CHEMBL221959,4.0,['NCT05803135'],EFO_0005755,rheumatic disease
110,NR3C1,nuclear receptor subfamily 3 group C member 1,PREDNISONE,Small molecule,CHEMBL635,4.0,[],EFO_0005755,rheumatic disease
111,NR3C1,nuclear receptor subfamily 3 group C member 1,TRIAMCINOLONE ACETONIDE,Small molecule,CHEMBL1504,4.0,[],EFO_0005755,rheumatic disease
112,NR3C1,nuclear receptor subfamily 3 group C member 1,PREDNISONE,Small molecule,CHEMBL635,4.0,[],EFO_0005755,rheumatic disease
113,TNF,tumor necrosis factor,CERTOLIZUMAB PEGOL,Antibody,CHEMBL1201831,4.0,"['NCT01255761', 'NCT01147341', 'NCT01443364', 'NCT02451748', 'NCT01500278', 'NCT01295151', 'NCT00993668', 'NCT00580840']",EFO_0005755,rheumatic disease
114,TNF,tumor necrosis factor,GOLIMUMAB,Antibody,CHEMBL1201833,4.0,"['NCT01602302', 'NCT03100253']",EFO_0005755,rheumatic disease
115,FDPS,farnesyl diphosphate synthase,PAMIDRONIC ACID,Small molecule,CHEMBL834,4.0,['NCT02313727'],EFO_0005755,rheumatic disease
116,NR3C1,nuclear receptor subfamily 3 group C member 1,DEXAMETHASONE SODIUM PHOSPHATE,Small molecule,CHEMBL2021430,4.0,[],EFO_0005755,rheumatic disease
117,PTGS1,prostaglandin-endoperoxide synthase 1,DICLOFENAC,Small molecule,CHEMBL139,4.0,[],EFO_0005755,rheumatic disease
118,SCN2A,sodium voltage-gated channel alpha subunit 2,ROPIVACAINE,Small molecule,CHEMBL1077896,4.0,['NCT04155983'],EFO_0005755,rheumatic disease
119,SCN11A,sodium voltage-gated channel alpha subunit 11,ROPIVACAINE,Small molecule,CHEMBL1077896,4.0,['NCT03219983'],EFO_0005755,rheumatic disease
120,ADRA2A,adrenoceptor alpha 2A,CLONIDINE,Small molecule,CHEMBL134,4.0,['NCT02570503'],EFO_0005755,rheumatic disease
121,PTGS2,prostaglandin-endoperoxide synthase 2,CELECOXIB,Small molecule,CHEMBL118,4.0,['NCT00904605'],EFO_0005755,rheumatic disease
122,PTGS2,prostaglandin-endoperoxide synthase 2,IBUPROFEN,Small molecule,CHEMBL521,4.0,"['NCT00630929', 'NCT01860833', 'NCT01066676', 'NCT00620867']",EFO_0005755,rheumatic disease
123,ADRA1D,adrenoceptor alpha 1D,EPINEPHRINE,Small molecule,CHEMBL679,4.0,"['NCT02697955', 'NCT02658149']",EFO_0005755,rheumatic disease
124,ADRA1D,adrenoceptor alpha 1D,EPINEPHRINE,Small molecule,CHEMBL679,4.0,['NCT03119038'],EFO_0005755,rheumatic disease
125,NR3C1,nuclear receptor subfamily 3 group C member 1,PREDNISONE,Small molecule,CHEMBL635,4.0,['NCT01210677'],EFO_0005755,rheumatic disease
126,SCN8A,sodium voltage-gated channel alpha subunit 8,LIDOCAINE,Small molecule,CHEMBL79,4.0,['NCT00904605'],EFO_0005755,rheumatic disease
127,ADRA2C,adrenoceptor alpha 2C,EPINEPHRINE,Small molecule,CHEMBL679,4.0,"['NCT02365727', 'NCT02765815']",EFO_0005755,rheumatic disease
128,SCN8A,sodium voltage-gated channel alpha subunit 8,LIDOCAINE,Small molecule,CHEMBL79,4.0,['NCT02176304'],EFO_0005755,rheumatic disease
129,TLR7,toll like receptor 7,HYDROXYCHLOROQUINE,Small molecule,CHEMBL1535,4.0,['NCT03813771'],EFO_0005755,rheumatic disease
130,TNF,tumor necrosis factor,ETANERCEPT,Protein,CHEMBL1201572,4.0,"['NCT00726804', 'NCT00910273']",EFO_0005755,rheumatic disease
131,TUBB2A,tubulin beta 2A class IIa,COLCHICINE,Small molecule,CHEMBL107,4.0,[],EFO_0005755,rheumatic disease
132,PTGS1,prostaglandin-endoperoxide synthase 1,KETOROLAC,Small molecule,CHEMBL469,4.0,[],EFO_0005755,rheumatic disease
133,SLC6A2,solute carrier family 6 member 2,DULOXETINE,Small molecule,CHEMBL1175,4.0,['NCT01558700'],EFO_0005755,rheumatic disease
134,NR3C1,nuclear receptor subfamily 3 group C member 1,BETAMETHASONE,Small molecule,CHEMBL632,4.0,['NCT02612272'],EFO_0005755,rheumatic disease
135,IL6R,interleukin 6 receptor,TOCILIZUMAB,Antibody,CHEMBL1237022,4.0,[],EFO_0005755,rheumatic disease
136,CACNA2D1,calcium voltage-gated channel auxiliary subunit alpha2delta 1,GABAPENTIN,Small molecule,CHEMBL940,4.0,"['NCT03540030', 'NCT02155257']",EFO_0005755,rheumatic disease
137,ALOX12,"arachidonate 12-lipoxygenase, 12S type",BENOXAPROFEN,Small molecule,CHEMBL340978,4.0,[],EFO_0005755,rheumatic disease
138,SCN9A,sodium voltage-gated channel alpha subunit 9,LIDOCAINE HYDROCHLORIDE,Small molecule,CHEMBL1200409,4.0,['NCT05670236'],EFO_0005755,rheumatic disease
139,PTGS1,prostaglandin-endoperoxide synthase 1,INDOMETHACIN,Small molecule,CHEMBL6,4.0,['NCT03473665'],EFO_0005755,rheumatic disease
140,NDUFC2,NADH:ubiquinone oxidoreductase subunit C2,METFORMIN,Small molecule,CHEMBL1431,4.0,['NCT02741960'],EFO_0005755,rheumatic disease
141,SCN3A,sodium voltage-gated channel alpha subunit 3,ROPIVACAINE,Small molecule,CHEMBL1077896,4.0,['NCT02365727'],EFO_0005755,rheumatic disease
142,PTGS2,prostaglandin-endoperoxide synthase 2,KETOROLAC,Small molecule,CHEMBL469,4.0,"['NCT02658149', 'NCT03540030']",EFO_0005755,rheumatic disease
143,NR3C1,nuclear receptor subfamily 3 group C member 1,DEXAMETHASONE PHOSPHORIC ACID,Small molecule,CHEMBL1201302,4.0,[],EFO_0005755,rheumatic disease
144,TNF,tumor necrosis factor,ETANERCEPT,Protein,CHEMBL1201572,4.0,['NCT05164198'],EFO_0005755,rheumatic disease
145,FAAH,fatty acid amide hydrolase,ACETAMINOPHEN,Small molecule,CHEMBL112,4.0,['NCT03994731'],EFO_0005755,rheumatic disease
146,PTGS2,prostaglandin-endoperoxide synthase 2,APAZONE,Small molecule,CHEMBL1565476,4.0,[],EFO_0005755,rheumatic disease
147,SCN1A,sodium voltage-gated channel alpha subunit 1,MEPIVACAINE,Small molecule,CHEMBL1087,4.0,['NCT04257682'],EFO_0005755,rheumatic disease
148,FDPS,farnesyl diphosphate synthase,ZOLEDRONIC ACID,Small molecule,CHEMBL924,4.0,['NCT01218035'],EFO_0005755,rheumatic disease
149,PTGS1,prostaglandin-endoperoxide synthase 1,NAPROXEN,Small molecule,CHEMBL154,4.0,[],EFO_0005755,rheumatic disease
150,GABRQ,gamma-aminobutyric acid type A receptor subunit theta,SEVOFLURANE,Small molecule,CHEMBL1200694,4.0,['NCT03540030'],EFO_0005755,rheumatic disease
151,TUBB,tubulin beta class I,COLCHICINE,Small molecule,CHEMBL107,4.0,[],EFO_0005755,rheumatic disease
152,IL1B,interleukin 1 beta,CANAKINUMAB,Antibody,CHEMBL1201834,4.0,[],EFO_0005755,rheumatic disease
153,HTR3A,5-hydroxytryptamine receptor 3A,RAMOSETRON,Small molecule,CHEMBL1643895,4.0,['NCT01102491'],EFO_0005755,rheumatic disease
154,TLR7,toll like receptor 7,HYDROXYCHLOROQUINE,Small molecule,CHEMBL1535,4.0,['NCT05841758'],EFO_0005755,rheumatic disease
155,PTGS1,prostaglandin-endoperoxide synthase 1,KETOPROFEN,Small molecule,CHEMBL571,4.0,[],EFO_0005755,rheumatic disease
156,HRH2,histamine receptor H2,FAMOTIDINE,Small molecule,CHEMBL902,4.0,[],EFO_0005755,rheumatic disease
157,PTGS1,prostaglandin-endoperoxide synthase 1,OXYPHENBUTAZONE,Small molecule,CHEMBL3989676,4.0,[],EFO_0005755,rheumatic disease
158,TLR9,toll like receptor 9,HYDROXYCHLOROQUINE,Small molecule,CHEMBL1535,4.0,"['NCT02714634', 'NCT05626348']",EFO_0005755,rheumatic disease
159,PTGS2,prostaglandin-endoperoxide synthase 2,KETOROLAC,Small molecule,CHEMBL469,4.0,[],EFO_0005755,rheumatic disease
160,ADRA2C,adrenoceptor alpha 2C,CLONIDINE,Small molecule,CHEMBL134,4.0,['NCT02365727'],EFO_0005755,rheumatic disease
161,NDUFA9,NADH:ubiquinone oxidoreductase subunit A9,METFORMIN,Small molecule,CHEMBL1431,4.0,['NCT02741960'],EFO_0005755,rheumatic disease
162,OPRM1,opioid receptor mu 1,TRAMADOL,Small molecule,CHEMBL1237044,4.0,"['NCT01728246', 'NCT00635349', 'NCT01019265', 'NCT01063842']",EFO_0005755,rheumatic disease
163,SCN5A,sodium voltage-gated channel alpha subunit 5,LIDOCAINE,Small molecule,CHEMBL79,4.0,['NCT03540030'],EFO_0005755,rheumatic disease
164,PTGS1,prostaglandin-endoperoxide synthase 1,TOLMETIN,Small molecule,CHEMBL1020,4.0,[],EFO_0005755,rheumatic disease
165,TYK2,tyrosine kinase 2,TOFACITINIB,Small molecule,CHEMBL221959,4.0,[],EFO_0005755,rheumatic disease
166,NR3C1,nuclear receptor subfamily 3 group C member 1,DEXAMETHASONE SODIUM PHOSPHATE,Small molecule,CHEMBL2021430,4.0,[],EFO_0005755,rheumatic disease
167,SCN2A,sodium voltage-gated channel alpha subunit 2,LIDOCAINE,Small molecule,CHEMBL79,4.0,['NCT03540030'],EFO_0005755,rheumatic disease
168,TNF,tumor necrosis factor,ETANERCEPT,Protein,CHEMBL1201572,4.0,['NCT01287715'],EFO_0005755,rheumatic disease
169,SCN1A,sodium voltage-gated channel alpha subunit 1,ROPIVACAINE,Small molecule,CHEMBL1077896,4.0,"['NCT03801265', 'NCT03513276']",EFO_0005755,rheumatic disease
170,NR3C1,nuclear receptor subfamily 3 group C member 1,PREDNISOLONE,Small molecule,CHEMBL131,4.0,[],EFO_0005755,rheumatic disease
171,HMGCR,3-hydroxy-3-methylglutaryl-CoA reductase,SIMVASTATIN,Small molecule,CHEMBL1064,4.0,['NCT04177173'],EFO_0005755,rheumatic disease
172,JAK1,Janus kinase 1,UPADACITINIB,Small molecule,CHEMBL3622821,4.0,['NCT05080218'],EFO_0005755,rheumatic disease
173,PTGS2,prostaglandin-endoperoxide synthase 2,SUPROFEN,Small molecule,CHEMBL956,4.0,[],EFO_0005755,rheumatic disease
174,PTGS2,prostaglandin-endoperoxide synthase 2,INDOMETHACIN,Small molecule,CHEMBL6,4.0,[],EFO_0005755,rheumatic disease
175,SCN10A,sodium voltage-gated channel alpha subunit 10,LIDOCAINE HYDROCHLORIDE,Small molecule,CHEMBL1200409,4.0,['NCT05670236'],EFO_0005755,rheumatic disease
176,SCN8A,sodium voltage-gated channel alpha subunit 8,LIDOCAINE,Small molecule,CHEMBL79,4.0,['NCT03540030'],EFO_0005755,rheumatic disease
177,ADRB2,adrenoceptor beta 2,EPINEPHRINE,Small molecule,CHEMBL679,4.0,"['NCT02697955', 'NCT02658149']",EFO_0005755,rheumatic disease
178,SCN8A,sodium voltage-gated channel alpha subunit 8,LIDOCAINE,Small molecule,CHEMBL79,4.0,['NCT05670236'],EFO_0005755,rheumatic disease
179,TLR9,toll like receptor 9,HYDROXYCHLOROQUINE,Small molecule,CHEMBL1535,4.0,['NCT04077957'],EFO_0005755,rheumatic disease
180,SCN5A,sodium voltage-gated channel alpha subunit 5,LIDOCAINE,Small molecule,CHEMBL79,4.0,['NCT01045694'],EFO_0005755,rheumatic disease
181,SCN5A,sodium voltage-gated channel alpha subunit 5,ROPIVACAINE,Small molecule,CHEMBL1077896,4.0,['NCT03219983'],EFO_0005755,rheumatic disease
182,TUBB3,tubulin beta 3 class III,COLCHICINE,Small molecule,CHEMBL107,4.0,[],EFO_0005755,rheumatic disease
183,SCN7A,sodium voltage-gated channel alpha subunit 7,LIDOCAINE,Small molecule,CHEMBL79,4.0,[],EFO_0005755,rheumatic disease
184,IL1R1,interleukin 1 receptor type 1,ANAKINRA,Protein,CHEMBL1201570,4.0,[],EFO_0005755,rheumatic disease
185,PTGS2,prostaglandin-endoperoxide synthase 2,NABUMETONE,Small molecule,CHEMBL1070,4.0,['NCT02049606'],EFO_0005755,rheumatic disease
186,SCN8A,sodium voltage-gated channel alpha subunit 8,ROPIVACAINE,Small molecule,CHEMBL1077896,4.0,['NCT02299271'],EFO_0005755,rheumatic disease
187,TNF,tumor necrosis factor,ETANERCEPT,Protein,CHEMBL1201572,4.0,['NCT03813771'],EFO_0005755,rheumatic disease
188,NR3C1,nuclear receptor subfamily 3 group C member 1,METHYLPREDNISOLONE HEMISUCCINATE,Small molecule,CHEMBL1201265,4.0,[],EFO_0005755,rheumatic disease
189,PLG,plasminogen,TRANEXAMIC ACID,Small molecule,CHEMBL877,4.0,"['NCT03109652', 'NCT02865174', 'NCT02152917', 'NCT02453802']",EFO_0005755,rheumatic disease
190,IL6R,interleukin 6 receptor,TOCILIZUMAB,Antibody,CHEMBL1237022,4.0,"['NCT01491815', 'NCT02466581']",EFO_0005755,rheumatic disease
191,PTGS2,prostaglandin-endoperoxide synthase 2,FENOPROFEN CALCIUM,Small molecule,CHEMBL2103736,4.0,[],EFO_0005755,rheumatic disease
192,SLC6A2,solute carrier family 6 member 2,TAPENTADOL,Small molecule,CHEMBL1201776,4.0,['NCT01631513'],EFO_0005755,rheumatic disease
193,NDUFV3,NADH:ubiquinone oxidoreductase subunit V3,METFORMIN,Small molecule,CHEMBL1431,4.0,['NCT02741960'],EFO_0005755,rheumatic disease
194,GABRP,gamma-aminobutyric acid type A receptor subunit pi,PROPOFOL,Small molecule,CHEMBL526,4.0,"['NCT02292082', 'NCT03540030', 'NCT02784626']",EFO_0005755,rheumatic disease
195,TNF,tumor necrosis factor,ETANERCEPT,Protein,CHEMBL1201572,4.0,[],EFO_0005755,rheumatic disease
196,GABRP,gamma-aminobutyric acid type A receptor subunit pi,DESFLURANE,Small molecule,CHEMBL1200733,4.0,['NCT03540030'],EFO_0005755,rheumatic disease
197,SLC22A12,solute carrier family 22 member 12,SULFINPYRAZONE,Small molecule,CHEMBL832,4.0,[],EFO_0005755,rheumatic disease
198,IL1R1,interleukin 1 receptor type 1,ANAKINRA,Protein,CHEMBL1201570,4.0,"['NCT00111410', 'NCT00121043']",EFO_0005755,rheumatic disease
199,DHFR,dihydrofolate reductase,METHOTREXATE,Small molecule,CHEMBL34259,4.0,['NCT00443430'],EFO_0005755,rheumatic disease
200,TLR9,toll like receptor 9,HYDROXYCHLOROQUINE,Small molecule,CHEMBL1535,4.0,"['NCT02374021', 'NCT03449758', 'NCT00422227', 'NCT02644499', 'NCT02433184', 'NCT00764725', 'NCT02451748', 'NCT00259610']",EFO_0005755,rheumatic disease
201,PTGS2,prostaglandin-endoperoxide synthase 2,CELECOXIB,Small molecule,CHEMBL118,4.0,[],EFO_0005755,rheumatic disease
202,SCN4A,sodium voltage-gated channel alpha subunit 4,LIDOCAINE,Small molecule,CHEMBL79,4.0,['NCT04143165'],EFO_0005755,rheumatic disease
203,IMPDH2,inosine monophosphate dehydrogenase 2,MYCOPHENOLIC ACID,Small molecule,CHEMBL866,4.0,['NCT01112215'],EFO_0005755,rheumatic disease
204,PTGS1,prostaglandin-endoperoxide synthase 1,KETOROLAC,Small molecule,CHEMBL469,4.0,['NCT05336968'],EFO_0005755,rheumatic disease
205,PTGS2,prostaglandin-endoperoxide synthase 2,DICLOFENAC,Small molecule,CHEMBL139,4.0,"['NCT02528201', 'NCT00715091']",EFO_0005755,rheumatic disease
206,ADRB1,adrenoceptor beta 1,EPINEPHRINE,Small molecule,CHEMBL679,4.0,"['NCT03513276', 'NCT02464176']",EFO_0005755,rheumatic disease
207,SCN11A,sodium voltage-gated channel alpha subunit 11,LIDOCAINE,Small molecule,CHEMBL79,4.0,['NCT03540030'],EFO_0005755,rheumatic disease
208,GABRB2,gamma-aminobutyric acid type A receptor subunit beta2,PROPOFOL,Small molecule,CHEMBL526,4.0,"['NCT02292082', 'NCT03540030', 'NCT02784626']",EFO_0005755,rheumatic disease
209,SCN8A,sodium voltage-gated channel alpha subunit 8,LIDOCAINE,Small molecule,CHEMBL79,4.0,['NCT01045694'],EFO_0005755,rheumatic disease
210,NR3C1,nuclear receptor subfamily 3 group C member 1,PREDNISONE,Small molecule,CHEMBL635,4.0,[],EFO_0005755,rheumatic disease
211,SCN3A,sodium voltage-gated channel alpha subunit 3,LIDOCAINE,Small molecule,CHEMBL79,4.0,['NCT02176304'],EFO_0005755,rheumatic disease
212,SCN4A,sodium voltage-gated channel alpha subunit 4,LIDOCAINE,Small molecule,CHEMBL79,4.0,['NCT05670236'],EFO_0005755,rheumatic disease
213,ADRA2C,adrenoceptor alpha 2C,DEXMEDETOMIDINE,Small molecule,CHEMBL778,4.0,"['NCT02784626', 'NCT05065775']",EFO_0005755,rheumatic disease
214,NR3C1,nuclear receptor subfamily 3 group C member 1,PREDNISOLONE,Small molecule,CHEMBL131,4.0,['NCT00908089'],EFO_0005755,rheumatic disease
215,TUBB4B,tubulin beta 4B class IVb,COLCHICINE,Small molecule,CHEMBL107,4.0,['NCT05698680'],EFO_0005755,rheumatic disease
216,TUBB3,tubulin beta 3 class III,COLCHICINE,Small molecule,CHEMBL107,4.0,['NCT02602028'],EFO_0005755,rheumatic disease
217,NR3C1,nuclear receptor subfamily 3 group C member 1,BETAMETHASONE PHOSPHORIC ACID,Small molecule,CHEMBL1201207,4.0,['NCT05058209'],EFO_0005755,rheumatic disease
218,MIF,macrophage migration inhibitory factor,IGURATIMOD,Small molecule,CHEMBL2107455,4.0,['NCT05803135'],EFO_0005755,rheumatic disease
219,DHFR,dihydrofolate reductase,METHOTREXATE,Small molecule,CHEMBL34259,4.0,[],EFO_0005755,rheumatic disease
220,SCN8A,sodium voltage-gated channel alpha subunit 8,ROPIVACAINE,Small molecule,CHEMBL1077896,4.0,"['NCT02863120', 'NCT00901628', 'NCT00562627']",EFO_0005755,rheumatic disease
221,SCN9A,sodium voltage-gated channel alpha subunit 9,LIDOCAINE,Small molecule,CHEMBL79,4.0,['NCT01045694'],EFO_0005755,rheumatic disease
222,NR3C1,nuclear receptor subfamily 3 group C member 1,PREDNISONE,Small molecule,CHEMBL635,4.0,[],EFO_0005755,rheumatic disease
223,PTGS2,prostaglandin-endoperoxide synthase 2,SULFASALAZINE,Small molecule,CHEMBL421,4.0,['NCT01659242'],EFO_0005755,rheumatic disease
224,SCN4A,sodium voltage-gated channel alpha subunit 4,BUPIVACAINE,Small molecule,CHEMBL1098,4.0,['NCT03219983'],EFO_0005755,rheumatic disease
225,NR3C1,nuclear receptor subfamily 3 group C member 1,PREDNISONE,Small molecule,CHEMBL635,4.0,[],EFO_0005755,rheumatic disease
226,ALOX5,arachidonate 5-lipoxygenase,SULFASALAZINE,Small molecule,CHEMBL421,4.0,['NCT03739853'],EFO_0005755,rheumatic disease
227,PTGS2,prostaglandin-endoperoxide synthase 2,DICLOFENAC,Small molecule,CHEMBL139,4.0,"['NCT00447759', 'NCT00141102']",EFO_0005755,rheumatic disease
228,SCN5A,sodium voltage-gated channel alpha subunit 5,LIDOCAINE,Small molecule,CHEMBL79,4.0,['NCT02102620'],EFO_0005755,rheumatic disease
229,TUBB4B,tubulin beta 4B class IVb,COLCHICINE,Small molecule,CHEMBL107,4.0,[],EFO_0005755,rheumatic disease
230,PTGS2,prostaglandin-endoperoxide synthase 2,DICLOFENAC,Small molecule,CHEMBL139,4.0,[],EFO_0005755,rheumatic disease
231,NR3C1,nuclear receptor subfamily 3 group C member 1,PREDNICARBATE,Small molecule,CHEMBL1200386,4.0,[],EFO_0005755,rheumatic disease
232,IL1B,interleukin 1 beta,CANAKINUMAB,Antibody,CHEMBL1201834,4.0,['NCT05080218'],EFO_0005755,rheumatic disease
233,CRBN,cereblon,THALIDOMIDE,Small molecule,CHEMBL468,4.0,['NCT03122431'],EFO_0005755,rheumatic disease
234,ATP4A,ATPase H+/K+ transporting subunit alpha,ESOMEPRAZOLE MAGNESIUM,Small molecule,CHEMBL2146133,4.0,[],EFO_0005755,rheumatic disease
235,SCN3A,sodium voltage-gated channel alpha subunit 3,ROPIVACAINE,Small molecule,CHEMBL1077896,4.0,['NCT04155983'],EFO_0005755,rheumatic disease
236,TUBB4B,tubulin beta 4B class IVb,COLCHICINE,Small molecule,CHEMBL107,4.0,['NCT02602028'],EFO_0005755,rheumatic disease
237,SLC6A2,solute carrier family 6 member 2,TAPENTADOL,Small molecule,CHEMBL1201776,4.0,['NCT01631513'],EFO_0005755,rheumatic disease
238,PTGS1,prostaglandin-endoperoxide synthase 1,IBUPROFEN,Small molecule,CHEMBL521,4.0,"['NCT01066676', 'NCT01860833', 'NCT00620867', 'NCT00630929']",EFO_0005755,rheumatic disease
239,OPRM1,opioid receptor mu 1,TRAMADOL HYDROCHLORIDE,Small molecule,CHEMBL1237065,4.0,"['NCT00635349', 'NCT01063842']",EFO_0005755,rheumatic disease
240,SCN11A,sodium voltage-gated channel alpha subunit 11,LIDOCAINE,Small molecule,CHEMBL79,4.0,['NCT05670236'],EFO_0005755,rheumatic disease
241,SLC22A12,solute carrier family 22 member 12,BENZBROMARONE,Small molecule,CHEMBL388590,4.0,[],EFO_0005755,rheumatic disease
242,PTGS1,prostaglandin-endoperoxide synthase 1,MECLOFENAMATE SODIUM,Small molecule,CHEMBL1562610,4.0,[],EFO_0005755,rheumatic disease
243,OPRM1,opioid receptor mu 1,CODEINE,Small molecule,CHEMBL485,4.0,"['NCT00324038', 'NCT02501564']",EFO_0005755,rheumatic disease
244,SCN2A,sodium voltage-gated channel alpha subunit 2,LIDOCAINE,Small molecule,CHEMBL79,4.0,['NCT05670236'],EFO_0005755,rheumatic disease
245,SCN3A,sodium voltage-gated channel alpha subunit 3,ROPIVACAINE,Small molecule,CHEMBL1077896,4.0,['NCT02299271'],EFO_0005755,rheumatic disease
246,ALOX5,arachidonate 5-lipoxygenase,SULFASALAZINE,Small molecule,CHEMBL421,4.0,['NCT00637780'],EFO_0005755,rheumatic disease
247,RBX1,ring-box 1,THALIDOMIDE,Small molecule,CHEMBL468,4.0,['NCT03122431'],EFO_0005755,rheumatic disease
248,NR3C1,nuclear receptor subfamily 3 group C member 1,TRIAMCINOLONE ACETONIDE,Small molecule,CHEMBL1504,4.0,['NCT01230424'],EFO_0005755,rheumatic disease
249,PTGS2,prostaglandin-endoperoxide synthase 2,DEXIBUPROFEN,Small molecule,CHEMBL175,4.0,['NCT01066676'],EFO_0005755,rheumatic disease
250,PTGS1,prostaglandin-endoperoxide synthase 1,ACETAMINOPHEN,Small molecule,CHEMBL112,4.0,"['NCT00635349', 'NCT01699815', 'NCT01728246', 'NCT00324038', 'NCT02839876', 'NCT01063842', 'NCT03540030']",EFO_0005755,rheumatic disease
251,PTGS2,prostaglandin-endoperoxide synthase 2,DICLOFENAC SODIUM,Small molecule,CHEMBL1034,4.0,[],EFO_0005755,rheumatic disease
252,PTGS1,prostaglandin-endoperoxide synthase 1,SULFASALAZINE,Small molecule,CHEMBL421,4.0,['NCT02714634'],EFO_0005755,rheumatic disease
253,PTGS2,prostaglandin-endoperoxide synthase 2,DICLOFENAC,Small molecule,CHEMBL139,4.0,['NCT00174317'],EFO_0005755,rheumatic disease
254,DHFR,dihydrofolate reductase,METHOTREXATE,Small molecule,CHEMBL34259,4.0,['NCT01895764'],EFO_0005755,rheumatic disease
255,PTGS2,prostaglandin-endoperoxide synthase 2,MELOXICAM,Small molecule,CHEMBL599,4.0,[],EFO_0005755,rheumatic disease
256,CD80,CD80 molecule,ABATACEPT,Protein,CHEMBL1201823,4.0,"['NCT01758198', 'NCT02557100', 'NCT03492658', 'NCT04255134', 'NCT01000441', 'NCT01295151', 'NCT01557374', 'NCT01638715', 'NCT01846975', 'NCT03737708']",EFO_0005755,rheumatic disease
257,NR3C1,nuclear receptor subfamily 3 group C member 1,METHYLPREDNISOLONE,Small molecule,CHEMBL650,4.0,['NCT03994731'],EFO_0005755,rheumatic disease
258,PTGS2,prostaglandin-endoperoxide synthase 2,SULFASALAZINE,Small molecule,CHEMBL421,4.0,['NCT03813771'],EFO_0005755,rheumatic disease
259,NR3C1,nuclear receptor subfamily 3 group C member 1,DEXAMETHASONE PHOSPHORIC ACID,Small molecule,CHEMBL1201302,4.0,[],EFO_0005755,rheumatic disease
260,PTGS2,prostaglandin-endoperoxide synthase 2,SULFASALAZINE,Small molecule,CHEMBL421,4.0,['NCT02714634'],EFO_0005755,rheumatic disease
261,MC2R,melanocortin 2 receptor,CORTICOTROPIN,Protein,CHEMBL1201610,4.0,"['NCT02779153', 'NCT01926054']",EFO_0005755,rheumatic disease
262,PPARG,peroxisome proliferator activated receptor gamma,PIOGLITAZONE,Small molecule,CHEMBL595,4.0,['NCT01322308'],EFO_0005755,rheumatic disease
263,ADRA2B,adrenoceptor alpha 2B,EPINEPHRINE,Small molecule,CHEMBL679,4.0,"['NCT02697955', 'NCT02658149']",EFO_0005755,rheumatic disease
264,DHODH,dihydroorotate dehydrogenase (quinone),LEFLUNOMIDE,Small molecule,CHEMBL960,4.0,['NCT01659242'],EFO_0005755,rheumatic disease
265,PTGS1,prostaglandin-endoperoxide synthase 1,SULFASALAZINE,Small molecule,CHEMBL421,4.0,['NCT03797872'],EFO_0005755,rheumatic disease
266,GABRA2,gamma-aminobutyric acid type A receptor subunit alpha2,MIDAZOLAM,Small molecule,CHEMBL655,4.0,['NCT02292082'],EFO_0005755,rheumatic disease
267,TNF,tumor necrosis factor,ADALIMUMAB,Antibody,CHEMBL1201580,4.0,"['NCT05502731', 'NCT05153200']",EFO_0005755,rheumatic disease
268,CHRND,cholinergic receptor nicotinic delta subunit,VECURONIUM,Small molecule,CHEMBL1201219,4.0,['NCT03540030'],EFO_0005755,rheumatic disease
269,SLC6A2,solute carrier family 6 member 2,METHYLPHENIDATE,Small molecule,CHEMBL796,4.0,['NCT00361387'],EFO_0005755,rheumatic disease
270,PTGS2,prostaglandin-endoperoxide synthase 2,DICLOFENAC POTASSIUM,Small molecule,CHEMBL1200804,4.0,['NCT00141102'],EFO_0005755,rheumatic disease
271,FGFR3,fibroblast growth factor receptor 3,NINTEDANIB,Small molecule,CHEMBL502835,4.0,[],EFO_0005755,rheumatic disease
272,NR3C1,nuclear receptor subfamily 3 group C member 1,METHYLPREDNISOLONE SODIUM SUCCINATE,Small molecule,CHEMBL1201081,4.0,['NCT03082092'],EFO_0005755,rheumatic disease
273,SCN1A,sodium voltage-gated channel alpha subunit 1,LIDOCAINE,Small molecule,CHEMBL79,4.0,[],EFO_0005755,rheumatic disease
274,SCN10A,sodium voltage-gated channel alpha subunit 10,ROPIVACAINE,Small molecule,CHEMBL1077896,4.0,['NCT04155983'],EFO_0005755,rheumatic disease
275,PTGS1,prostaglandin-endoperoxide synthase 1,OXAPROZIN,Small molecule,CHEMBL1071,4.0,[],EFO_0005755,rheumatic disease
276,MC2R,melanocortin 2 receptor,CORTICOTROPIN,Protein,CHEMBL1201610,4.0,['NCT03082573'],EFO_0005755,rheumatic disease
277,TUBB2A,tubulin beta 2A class IIa,COLCHICINE,Small molecule,CHEMBL107,4.0,"['NCT01451645', 'NCT01994226', 'NCT02060552', 'NCT02500641']",EFO_0005755,rheumatic disease
278,TUBB8,tubulin beta 8 class VIII,COLCHICINE,Small molecule,CHEMBL107,4.0,['NCT04601883'],EFO_0005755,rheumatic disease
279,SCN5A,sodium voltage-gated channel alpha subunit 5,LIDOCAINE,Small molecule,CHEMBL79,4.0,['NCT05670236'],EFO_0005755,rheumatic disease
280,SCN4A,sodium voltage-gated channel alpha subunit 4,LIDOCAINE,Small molecule,CHEMBL79,4.0,[],EFO_0005755,rheumatic disease
281,GLP1R,glucagon like peptide 1 receptor,LIRAGLUTIDE,Protein,CHEMBL4084119,4.0,['NCT02910570'],EFO_0005755,rheumatic disease
282,SCN2A,sodium voltage-gated channel alpha subunit 2,LIDOCAINE,Small molecule,CHEMBL79,4.0,['NCT02102620'],EFO_0005755,rheumatic disease
283,FAAH,fatty acid amide hydrolase,ACETAMINOPHEN,Small molecule,CHEMBL112,4.0,"['NCT03540030', 'NCT01063842', 'NCT00324038', 'NCT01728246', 'NCT00635349', 'NCT01699815', 'NCT02839876']",EFO_0005755,rheumatic disease
284,PTGS2,prostaglandin-endoperoxide synthase 2,ROFECOXIB,Small molecule,CHEMBL122,4.0,[],EFO_0005755,rheumatic disease
285,JAK1,Janus kinase 1,BARICITINIB,Small molecule,CHEMBL2105759,4.0,[],EFO_0005755,rheumatic disease
286,PTGS2,prostaglandin-endoperoxide synthase 2,CELECOXIB,Small molecule,CHEMBL118,4.0,[],EFO_0005755,rheumatic disease
287,NR3C1,nuclear receptor subfamily 3 group C member 1,TRIAMCINOLONE ACETONIDE,Small molecule,CHEMBL1504,4.0,[],EFO_0005755,rheumatic disease
288,PTGS1,prostaglandin-endoperoxide synthase 1,PHENYLBUTAZONE,Small molecule,CHEMBL101,4.0,[],EFO_0005755,rheumatic disease
289,OPRK1,opioid receptor kappa 1,BUPRENORPHINE,Small molecule,CHEMBL511142,4.0,"['NCT01019265', 'NCT00324038']",EFO_0005755,rheumatic disease
290,CRBN,cereblon,THALIDOMIDE,Small molecule,CHEMBL468,4.0,['NCT05527444'],EFO_0005755,rheumatic disease
291,TNF,tumor necrosis factor,INFLIXIMAB,Antibody,CHEMBL1201581,4.0,['NCT05164198'],EFO_0005755,rheumatic disease
292,PTGS1,prostaglandin-endoperoxide synthase 1,NAPROXEN SODIUM,Small molecule,CHEMBL1200806,4.0,[],EFO_0005755,rheumatic disease
293,OPRM1,opioid receptor mu 1,MORPHINE SULFATE,Small molecule,CHEMBL2103744,4.0,['NCT00901628'],EFO_0005755,rheumatic disease
294,IL17A,interleukin 17A,SECUKINUMAB,Antibody,CHEMBL1743068,4.0,[],EFO_0005755,rheumatic disease
295,SCN2A,sodium voltage-gated channel alpha subunit 2,ROPIVACAINE,Small molecule,CHEMBL1077896,4.0,"['NCT02863120', 'NCT00562627', 'NCT00901628']",EFO_0005755,rheumatic disease
296,NR3C1,nuclear receptor subfamily 3 group C member 1,TRIAMCINOLONE HEXACETONIDE,Small molecule,CHEMBL1200878,4.0,"['NCT02835521', 'NCT02829281']",EFO_0005755,rheumatic disease
297,NDUFA5,NADH:ubiquinone oxidoreductase subunit A5,METFORMIN,Small molecule,CHEMBL1431,4.0,['NCT02741960'],EFO_0005755,rheumatic disease
298,TNF,tumor necrosis factor,CERTOLIZUMAB PEGOL,Antibody,CHEMBL1201831,4.0,[],EFO_0005755,rheumatic disease
299,SCN7A,sodium voltage-gated channel alpha subunit 7,LIDOCAINE HYDROCHLORIDE,Small molecule,CHEMBL1200409,4.0,['NCT05670236'],EFO_0005755,rheumatic disease
300,SCN1A,sodium voltage-gated channel alpha subunit 1,LIDOCAINE,Small molecule,CHEMBL79,4.0,['NCT00904605'],EFO_0005755,rheumatic disease
301,PTGS2,prostaglandin-endoperoxide synthase 2,OXAPROZIN,Small molecule,CHEMBL1071,4.0,[],EFO_0005755,rheumatic disease
302,NR3C1,nuclear receptor subfamily 3 group C member 1,CORTISONE ACETATE,Small molecule,CHEMBL1650,4.0,[],EFO_0005755,rheumatic disease
303,PTGS2,prostaglandin-endoperoxide synthase 2,MELOXICAM,Small molecule,CHEMBL599,4.0,"['NCT02183129', 'NCT02183116', 'NCT00635349']",EFO_0005755,rheumatic disease
304,SCN3A,sodium voltage-gated channel alpha subunit 3,ROPIVACAINE,Small molecule,CHEMBL1077896,4.0,"['NCT03513276', 'NCT03801265']",EFO_0005755,rheumatic disease
305,SCN7A,sodium voltage-gated channel alpha subunit 7,ROPIVACAINE,Small molecule,CHEMBL1077896,4.0,['NCT02299271'],EFO_0005755,rheumatic disease
306,GABRG2,gamma-aminobutyric acid type A receptor subunit gamma2,PROPOFOL,Small molecule,CHEMBL526,4.0,"['NCT02292082', 'NCT03540030', 'NCT02784626']",EFO_0005755,rheumatic disease
307,NDUFA4,NDUFA4 mitochondrial complex associated,METFORMIN,Small molecule,CHEMBL1431,4.0,['NCT02741960'],EFO_0005755,rheumatic disease
308,IL6R,interleukin 6 receptor,SARILUMAB,Antibody,CHEMBL2108730,4.0,[],EFO_0005755,rheumatic disease
309,PTGS2,prostaglandin-endoperoxide synthase 2,IGURATIMOD,Small molecule,CHEMBL2107455,4.0,"['NCT01548001', 'NCT01893151', 'NCT02275299']",EFO_0005755,rheumatic disease
310,NDUFA13,NADH:ubiquinone oxidoreductase subunit A13,METFORMIN,Small molecule,CHEMBL1431,4.0,['NCT02741960'],EFO_0005755,rheumatic disease
311,GABRG1,gamma-aminobutyric acid type A receptor subunit gamma1,PROPOFOL,Small molecule,CHEMBL526,4.0,"['NCT02292082', 'NCT02784626', 'NCT03540030']",EFO_0005755,rheumatic disease
312,CD80,CD80 molecule,ABATACEPT,Protein,CHEMBL1201823,4.0,[],EFO_0005755,rheumatic disease
313,NR3C1,nuclear receptor subfamily 3 group C member 1,DEXAMETHASONE,Small molecule,CHEMBL384467,4.0,[],EFO_0005755,rheumatic disease
314,NR3C1,nuclear receptor subfamily 3 group C member 1,HYDROCORTISONE PROBUTATE,Small molecule,CHEMBL1200953,4.0,[],EFO_0005755,rheumatic disease
315,CD80,CD80 molecule,ABATACEPT,Protein,CHEMBL1201823,4.0,['NCT03227419'],EFO_0005755,rheumatic disease
316,PTGS2,prostaglandin-endoperoxide synthase 2,MELOXICAM,Small molecule,CHEMBL599,4.0,[],EFO_0005755,rheumatic disease
317,SCN1A,sodium voltage-gated channel alpha subunit 1,MEPIVACAINE,Small molecule,CHEMBL1087,4.0,['NCT04257682'],EFO_0005755,rheumatic disease
318,NR3C1,nuclear receptor subfamily 3 group C member 1,PREDNISONE,Small molecule,CHEMBL635,4.0,[],EFO_0005755,rheumatic disease
319,HMGCR,3-hydroxy-3-methylglutaryl-CoA reductase,ATORVASTATIN CALCIUM,Small molecule,CHEMBL393220,4.0,['NCT00120887'],EFO_0005755,rheumatic disease
320,JAK3,Janus kinase 3,TOFACITINIB,Small molecule,CHEMBL221959,4.0,[],EFO_0005755,rheumatic disease
321,SCN8A,sodium voltage-gated channel alpha subunit 8,ROPIVACAINE,Small molecule,CHEMBL1077896,4.0,['NCT03219983'],EFO_0005755,rheumatic disease
322,NR3C1,nuclear receptor subfamily 3 group C member 1,TRIAMCINOLONE ACETONIDE,Small molecule,CHEMBL1504,4.0,['NCT05492851'],EFO_0005755,rheumatic disease
323,TNF,tumor necrosis factor,CERTOLIZUMAB PEGOL,Antibody,CHEMBL1201831,4.0,"['NCT03100253', 'NCT02353780']",EFO_0005755,rheumatic disease
324,FLT4,fms related receptor tyrosine kinase 4,NINTEDANIB,Small molecule,CHEMBL502835,4.0,[],EFO_0005755,rheumatic disease
325,PTGS2,prostaglandin-endoperoxide synthase 2,MECLOFENAMATE SODIUM,Small molecule,CHEMBL1562610,4.0,[],EFO_0005755,rheumatic disease
326,CHRNA1,cholinergic receptor nicotinic alpha 1 subunit,VECURONIUM,Small molecule,CHEMBL1201219,4.0,['NCT03540030'],EFO_0005755,rheumatic disease
327,GABRB3,gamma-aminobutyric acid type A receptor subunit beta3,PROPOFOL,Small molecule,CHEMBL526,4.0,"['NCT02292082', 'NCT03540030', 'NCT02784626']",EFO_0005755,rheumatic disease
328,TUBB2A,tubulin beta 2A class IIa,COLCHICINE,Small molecule,CHEMBL107,4.0,['NCT02602028'],EFO_0005755,rheumatic disease
329,PTGS2,prostaglandin-endoperoxide synthase 2,NAPROXEN SODIUM,Small molecule,CHEMBL1200806,4.0,[],EFO_0005755,rheumatic disease
330,ATP4A,ATPase H+/K+ transporting subunit alpha,ESOMEPRAZOLE,Small molecule,CHEMBL1201320,4.0,[],EFO_0005755,rheumatic disease
331,PTGS2,prostaglandin-endoperoxide synthase 2,NAPROXEN,Small molecule,CHEMBL154,4.0,['NCT02355236'],EFO_0005755,rheumatic disease
332,SCN5A,sodium voltage-gated channel alpha subunit 5,PRILOCAINE,Small molecule,CHEMBL1194,4.0,['NCT02384915'],EFO_0005755,rheumatic disease
333,PTGS1,prostaglandin-endoperoxide synthase 1,ACETAMINOPHEN,Small molecule,CHEMBL112,4.0,[],EFO_0005755,rheumatic disease
334,MS4A1,membrane spanning 4-domains A1,RITUXIMAB,Antibody,CHEMBL1201576,4.0,['NCT01117129'],EFO_0005755,rheumatic disease
335,PTGS2,prostaglandin-endoperoxide synthase 2,FENOPROFEN CALCIUM,Small molecule,CHEMBL2103736,4.0,[],EFO_0005755,rheumatic disease
336,JAK2,Janus kinase 2,TOFACITINIB CITRATE,Small molecule,CHEMBL2103743,4.0,[],EFO_0005755,rheumatic disease
337,SCN9A,sodium voltage-gated channel alpha subunit 9,ROPIVACAINE,Small molecule,CHEMBL1077896,4.0,['NCT02365727'],EFO_0005755,rheumatic disease
338,NDUFB1,NADH:ubiquinone oxidoreductase subunit B1,METFORMIN,Small molecule,CHEMBL1431,4.0,['NCT02741960'],EFO_0005755,rheumatic disease
339,ALOX5,arachidonate 5-lipoxygenase,SULFASALAZINE,Small molecule,CHEMBL421,4.0,['NCT03797872'],EFO_0005755,rheumatic disease
340,JAK1,Janus kinase 1,TOFACITINIB,Small molecule,CHEMBL221959,4.0,"['NCT02187055', 'NCT02831855', 'NCT02092467', 'NCT02321930']",EFO_0005755,rheumatic disease
341,NR3C1,nuclear receptor subfamily 3 group C member 1,TRIAMCINOLONE ACETONIDE,Small molecule,CHEMBL1504,4.0,['NCT05336968'],EFO_0005755,rheumatic disease
342,FKBP1A,FKBP prolyl isomerase 1A,TACROLIMUS,Small molecule,CHEMBL269732,4.0,['NCT02837978'],EFO_0005755,rheumatic disease
343,NR3C1,nuclear receptor subfamily 3 group C member 1,DEXAMETHASONE PHOSPHORIC ACID,Small molecule,CHEMBL1201302,4.0,[],EFO_0005755,rheumatic disease
344,CD80,CD80 molecule,ABATACEPT,Protein,CHEMBL1201823,4.0,[],EFO_0005755,rheumatic disease
345,IL6R,interleukin 6 receptor,TOCILIZUMAB,Antibody,CHEMBL1237022,4.0,[],EFO_0005755,rheumatic disease
346,JAK2,Janus kinase 2,BARICITINIB,Small molecule,CHEMBL2105759,4.0,['NCT03915964'],EFO_0005755,rheumatic disease
347,SCN4A,sodium voltage-gated channel alpha subunit 4,LIDOCAINE HYDROCHLORIDE,Small molecule,CHEMBL1200409,4.0,['NCT05670236'],EFO_0005755,rheumatic disease
348,KCNK10,potassium two pore domain channel subfamily K member 10,SEVOFLURANE,Small molecule,CHEMBL1200694,4.0,['NCT03540030'],EFO_0005755,rheumatic disease
349,IL6R,interleukin 6 receptor,SARILUMAB,Antibody,CHEMBL2108730,4.0,['NCT03449758'],EFO_0005755,rheumatic disease
350,TUBB4A,tubulin beta 4A class IVa,COLCHICINE,Small molecule,CHEMBL107,4.0,[],EFO_0005755,rheumatic disease
351,GABRG1,gamma-aminobutyric acid type A receptor subunit gamma1,MIDAZOLAM,Small molecule,CHEMBL655,4.0,['NCT02292082'],EFO_0005755,rheumatic disease
352,SCN3A,sodium voltage-gated channel alpha subunit 3,LIDOCAINE,Small molecule,CHEMBL79,4.0,['NCT03540030'],EFO_0005755,rheumatic disease
353,GABRA4,gamma-aminobutyric acid type A receptor subunit alpha4,DESFLURANE,Small molecule,CHEMBL1200733,4.0,['NCT03540030'],EFO_0005755,rheumatic disease
354,TLR9,toll like receptor 9,HYDROXYCHLOROQUINE,Small molecule,CHEMBL1535,4.0,['NCT02466581'],EFO_0005755,rheumatic disease
355,TLR7,toll like receptor 7,HYDROXYCHLOROQUINE,Small molecule,CHEMBL1535,4.0,['NCT04077957'],EFO_0005755,rheumatic disease
356,DDB1,damage specific DNA binding protein 1,LENALIDOMIDE,Small molecule,CHEMBL848,4.0,['NCT01408199'],EFO_0005755,rheumatic disease
357,SCN8A,sodium voltage-gated channel alpha subunit 8,LIDOCAINE,Small molecule,CHEMBL79,4.0,[],EFO_0005755,rheumatic disease
358,DHODH,dihydroorotate dehydrogenase (quinone),LEFLUNOMIDE,Small molecule,CHEMBL960,4.0,['NCT02024334'],EFO_0005755,rheumatic disease
359,PTGS1,prostaglandin-endoperoxide synthase 1,DEXKETOPROFEN,Small molecule,CHEMBL75435,4.0,[],EFO_0005755,rheumatic disease
360,PTGS2,prostaglandin-endoperoxide synthase 2,TOLMETIN,Small molecule,CHEMBL1020,4.0,[],EFO_0005755,rheumatic disease
361,TRPV1,transient receptor potential cation channel subfamily V member 1,CAPSAICIN,Small molecule,CHEMBL294199,4.0,[],EFO_0005755,rheumatic disease
362,GABRA6,gamma-aminobutyric acid type A receptor subunit alpha6,PROPOFOL,Small molecule,CHEMBL526,4.0,"['NCT02292082', 'NCT02784626', 'NCT03540030']",EFO_0005755,rheumatic disease
363,IL23A,interleukin 23 subunit alpha,GUSELKUMAB,Antibody,CHEMBL2364648,4.0,['NCT04929210'],EFO_0005755,rheumatic disease
364,PTGS2,prostaglandin-endoperoxide synthase 2,IBUPROFEN,Small molecule,CHEMBL521,4.0,[],EFO_0005755,rheumatic disease
365,PTGS2,prostaglandin-endoperoxide synthase 2,KETOROLAC TROMETHAMINE,Small molecule,CHEMBL1201124,4.0,"['NCT03540030', 'NCT02658149']",EFO_0005755,rheumatic disease
366,SCN9A,sodium voltage-gated channel alpha subunit 9,ROPIVACAINE,Small molecule,CHEMBL1077896,4.0,['NCT05336968'],EFO_0005755,rheumatic disease
367,GUCY1B1,guanylate cyclase 1 soluble subunit beta 1,RIOCIGUAT,Small molecule,CHEMBL2107834,4.0,['NCT02625558'],EFO_0005755,rheumatic disease
368,ADRA2A,adrenoceptor alpha 2A,EPINEPHRINE,Small molecule,CHEMBL679,4.0,"['NCT03513276', 'NCT02464176']",EFO_0005755,rheumatic disease
369,PTGS2,prostaglandin-endoperoxide synthase 2,NAPROXEN,Small molecule,CHEMBL154,4.0,['NCT02501564'],EFO_0005755,rheumatic disease
370,TYK2,tyrosine kinase 2,TOFACITINIB,Small molecule,CHEMBL221959,4.0,"['NCT04928066', 'NCT04927000', 'NCT04485325', 'NCT05606107', 'NCT02157012', 'NCT03976245']",EFO_0005755,rheumatic disease
371,FGFR4,fibroblast growth factor receptor 4,NINTEDANIB ESYLATE,Small molecule,CHEMBL3039504,4.0,[],EFO_0005755,rheumatic disease
372,GABRA5,gamma-aminobutyric acid type A receptor subunit alpha5,MIDAZOLAM,Small molecule,CHEMBL655,4.0,['NCT02292082'],EFO_0005755,rheumatic disease
373,ADRB3,adrenoceptor beta 3,EPINEPHRINE,Small molecule,CHEMBL679,4.0,"['NCT02765815', 'NCT02365727']",EFO_0005755,rheumatic disease
374,IL6R,interleukin 6 receptor,TOCILIZUMAB,Antibody,CHEMBL1237022,4.0,"['NCT03215407', 'NCT02087696', 'NCT03781310']",EFO_0005755,rheumatic disease
375,IL17A,interleukin 17A,SECUKINUMAB,Antibody,CHEMBL1743068,4.0,"['NCT05080218', 'NCT03623867']",EFO_0005755,rheumatic disease
376,FGG,fibrinogen gamma chain,"FIBRINOGEN, HUMAN",Unknown,CHEMBL2109072,4.0,['NCT01235715'],EFO_0005755,rheumatic disease
377,TNF,tumor necrosis factor,ETANERCEPT,Protein,CHEMBL1201572,4.0,[],EFO_0005755,rheumatic disease
378,SLC6A3,solute carrier family 6 member 3,MODAFINIL,Small molecule,CHEMBL1373,4.0,['NCT02155257'],EFO_0005755,rheumatic disease
379,NDUFA7,NADH:ubiquinone oxidoreductase subunit A7,METFORMIN,Small molecule,CHEMBL1431,4.0,['NCT02741960'],EFO_0005755,rheumatic disease
380,NDUFA6,NADH:ubiquinone oxidoreductase subunit A6,METFORMIN,Small molecule,CHEMBL1431,4.0,['NCT02741960'],EFO_0005755,rheumatic disease
381,CD86,CD86 molecule,ABATACEPT,Protein,CHEMBL1201823,4.0,['NCT05080218'],EFO_0005755,rheumatic disease
382,SCN7A,sodium voltage-gated channel alpha subunit 7,ROPIVACAINE,Small molecule,CHEMBL1077896,4.0,['NCT02365727'],EFO_0005755,rheumatic disease
383,MC2R,melanocortin 2 receptor,CORTICOTROPIN,Protein,CHEMBL1201610,4.0,['NCT03419650'],EFO_0005755,rheumatic disease
384,PTGS1,prostaglandin-endoperoxide synthase 1,MEFENAMIC ACID,Small molecule,CHEMBL686,4.0,[],EFO_0005755,rheumatic disease
385,ADRA2C,adrenoceptor alpha 2C,EPINEPHRINE,Small molecule,CHEMBL679,4.0,['NCT03119038'],EFO_0005755,rheumatic disease
386,NR3C1,nuclear receptor subfamily 3 group C member 1,DEXAMETHASONE SODIUM PHOSPHATE,Small molecule,CHEMBL2021430,4.0,[],EFO_0005755,rheumatic disease
387,TNF,tumor necrosis factor,INFLIXIMAB,Antibody,CHEMBL1201581,4.0,['NCT01072058'],EFO_0005755,rheumatic disease
388,PTGS1,prostaglandin-endoperoxide synthase 1,TOLMETIN SODIUM,Small molecule,CHEMBL1200613,4.0,[],EFO_0005755,rheumatic disease
389,HMGCR,3-hydroxy-3-methylglutaryl-CoA reductase,ATORVASTATIN CALCIUM,Small molecule,CHEMBL393220,4.0,['NCT00356473'],EFO_0005755,rheumatic disease
390,NR3C1,nuclear receptor subfamily 3 group C member 1,HYDROCORTISONE PROBUTATE,Small molecule,CHEMBL1200953,4.0,[],EFO_0005755,rheumatic disease
391,PDE4D,phosphodiesterase 4D,APREMILAST,Small molecule,CHEMBL514800,4.0,['NCT03747939'],EFO_0005755,rheumatic disease
392,HTR3C,5-hydroxytryptamine receptor 3C,RAMOSETRON,Small molecule,CHEMBL1643895,4.0,['NCT01102491'],EFO_0005755,rheumatic disease
393,SCN7A,sodium voltage-gated channel alpha subunit 7,LIDOCAINE,Small molecule,CHEMBL79,4.0,['NCT03540030'],EFO_0005755,rheumatic disease
394,PTGS2,prostaglandin-endoperoxide synthase 2,ACETAMINOPHEN,Small molecule,CHEMBL112,4.0,['NCT01105936'],EFO_0005755,rheumatic disease
395,PTGS1,prostaglandin-endoperoxide synthase 1,PIROXICAM,Small molecule,CHEMBL527,4.0,[],EFO_0005755,rheumatic disease
396,TYK2,tyrosine kinase 2,TOFACITINIB,Small molecule,CHEMBL221959,4.0,"['NCT02092467', 'NCT02831855', 'NCT02321930', 'NCT02187055']",EFO_0005755,rheumatic disease
397,TLR9,toll like receptor 9,HYDROXYCHLOROQUINE SULFATE,Small molecule,CHEMBL1690,4.0,['NCT00422227'],EFO_0005755,rheumatic disease
398,PDE4D,phosphodiesterase 4D,APREMILAST,Small molecule,CHEMBL514800,4.0,['NCT02558361'],EFO_0005755,rheumatic disease
399,NR3C1,nuclear receptor subfamily 3 group C member 1,TRIAMCINOLONE ACETONIDE,Small molecule,CHEMBL1504,4.0,['NCT05139875'],EFO_0005755,rheumatic disease
400,ESR1,estrogen receptor 1,BAZEDOXIFENE,Small molecule,CHEMBL46740,4.0,['NCT02602704'],EFO_0005755,rheumatic disease
401,PTGS1,prostaglandin-endoperoxide synthase 1,OXAPROZIN,Small molecule,CHEMBL1071,4.0,[],EFO_0005755,rheumatic disease
402,IL1B,interleukin 1 beta,CANAKINUMAB,Antibody,CHEMBL1201834,4.0,[],EFO_0005755,rheumatic disease
403,TYK2,tyrosine kinase 2,TOFACITINIB CITRATE,Small molecule,CHEMBL2103743,4.0,[],EFO_0005755,rheumatic disease
404,JAK3,Janus kinase 3,TOFACITINIB,Small molecule,CHEMBL221959,4.0,['NCT03504072'],EFO_0005755,rheumatic disease
405,GABRA4,gamma-aminobutyric acid type A receptor subunit alpha4,PROPOFOL,Small molecule,CHEMBL526,4.0,"['NCT03540030', 'NCT02784626', 'NCT02292082']",EFO_0005755,rheumatic disease
406,PTGS1,prostaglandin-endoperoxide synthase 1,IBUPROFEN,Small molecule,CHEMBL521,4.0,[],EFO_0005755,rheumatic disease
407,IL12B,interleukin 12B,USTEKINUMAB,Antibody,CHEMBL1201835,4.0,[],EFO_0005755,rheumatic disease
408,SCN2A,sodium voltage-gated channel alpha subunit 2,ROPIVACAINE,Small molecule,CHEMBL1077896,4.0,['NCT02299271'],EFO_0005755,rheumatic disease
409,NR3C1,nuclear receptor subfamily 3 group C member 1,METHYLPREDNISOLONE ACETATE,Small molecule,CHEMBL1364144,4.0,['NCT03694821'],EFO_0005755,rheumatic disease
410,TUBB4A,tubulin beta 4A class IVa,COLCHICINE,Small molecule,CHEMBL107,4.0,['NCT03913442'],EFO_0005755,rheumatic disease
411,NDUFAB1,NADH:ubiquinone oxidoreductase subunit AB1,METFORMIN,Small molecule,CHEMBL1431,4.0,['NCT02741960'],EFO_0005755,rheumatic disease
412,SCN5A,sodium voltage-gated channel alpha subunit 5,LIDOCAINE HYDROCHLORIDE,Small molecule,CHEMBL1200409,4.0,['NCT05670236'],EFO_0005755,rheumatic disease
413,JAK2,Janus kinase 2,TOFACITINIB,Small molecule,CHEMBL221959,4.0,"['NCT04485325', 'NCT05606107', 'NCT03976245', 'NCT04928066', 'NCT02157012', 'NCT04927000']",EFO_0005755,rheumatic disease
414,FDPS,farnesyl diphosphate synthase,ALENDRONIC ACID,Small molecule,CHEMBL870,4.0,['NCT01770106'],EFO_0005755,rheumatic disease
415,PPIA,peptidylprolyl isomerase A,CYCLOSPORINE,Protein,CHEMBL160,4.0,[],EFO_0005755,rheumatic disease
416,PTGS2,prostaglandin-endoperoxide synthase 2,IGURATIMOD,Small molecule,CHEMBL2107455,4.0,"['NCT05626348', 'NCT04928066']",EFO_0005755,rheumatic disease
417,ADRB3,adrenoceptor beta 3,EPINEPHRINE,Small molecule,CHEMBL679,4.0,"['NCT00562627', 'NCT00901628', 'NCT02462148']",EFO_0005755,rheumatic disease
418,TNF,tumor necrosis factor,ADALIMUMAB,Antibody,CHEMBL1201580,4.0,['NCT00291915'],EFO_0005755,rheumatic disease
419,SCN8A,sodium voltage-gated channel alpha subunit 8,LIDOCAINE,Small molecule,CHEMBL79,4.0,[],EFO_0005755,rheumatic disease
420,GABRA1,gamma-aminobutyric acid type A receptor subunit alpha1,DESFLURANE,Small molecule,CHEMBL1200733,4.0,['NCT03540030'],EFO_0005755,rheumatic disease
421,PTGS2,prostaglandin-endoperoxide synthase 2,INDOMETHACIN,Small molecule,CHEMBL6,4.0,['NCT02770950'],EFO_0005755,rheumatic disease
422,SCN4A,sodium voltage-gated channel alpha subunit 4,ROPIVACAINE,Small molecule,CHEMBL1077896,4.0,['NCT04155983'],EFO_0005755,rheumatic disease
423,FDPS,farnesyl diphosphate synthase,IBANDRONIC ACID,Small molecule,CHEMBL997,4.0,['NCT00668330'],EFO_0005755,rheumatic disease
424,SCN4A,sodium voltage-gated channel alpha subunit 4,MEPIVACAINE,Small molecule,CHEMBL1087,4.0,['NCT04257682'],EFO_0005755,rheumatic disease
425,NDUFAF2,NADH:ubiquinone oxidoreductase complex assembly factor 2,METFORMIN,Small molecule,CHEMBL1431,4.0,['NCT02741960'],EFO_0005755,rheumatic disease
426,PTGS2,prostaglandin-endoperoxide synthase 2,NAPROXEN,Small molecule,CHEMBL154,4.0,"['NCT00807846', 'NCT01544114']",EFO_0005755,rheumatic disease
427,PTGS2,prostaglandin-endoperoxide synthase 2,CELECOXIB,Small molecule,CHEMBL118,4.0,[],EFO_0005755,rheumatic disease
428,PDE4B,phosphodiesterase 4B,APREMILAST,Small molecule,CHEMBL514800,4.0,[],EFO_0005755,rheumatic disease
429,NR3C1,nuclear receptor subfamily 3 group C member 1,TRIAMCINOLONE ACETONIDE,Small molecule,CHEMBL1504,4.0,[],EFO_0005755,rheumatic disease
430,FAAH,fatty acid amide hydrolase,ACETAMINOPHEN,Small molecule,CHEMBL112,4.0,[],EFO_0005755,rheumatic disease
431,PTGS1,prostaglandin-endoperoxide synthase 1,DICLOFENAC,Small molecule,CHEMBL139,4.0,['NCT00174317'],EFO_0005755,rheumatic disease
432,NDUFA2,NADH:ubiquinone oxidoreductase subunit A2,METFORMIN,Small molecule,CHEMBL1431,4.0,['NCT02741960'],EFO_0005755,rheumatic disease
433,TUBB3,tubulin beta 3 class III,COLCHICINE,Small molecule,CHEMBL107,4.0,"['NCT02060552', 'NCT02500641', 'NCT01994226', 'NCT01451645']",EFO_0005755,rheumatic disease
434,NR3C1,nuclear receptor subfamily 3 group C member 1,CORTISONE ACETATE,Small molecule,CHEMBL1650,4.0,[],EFO_0005755,rheumatic disease
435,PTGS1,prostaglandin-endoperoxide synthase 1,SULINDAC,Small molecule,CHEMBL15770,4.0,[],EFO_0005755,rheumatic disease
436,NR3C1,nuclear receptor subfamily 3 group C member 1,BETAMETHASONE SODIUM PHOSPHATE,Small molecule,CHEMBL1200762,4.0,['NCT05139875'],EFO_0005755,rheumatic disease
437,PTGS2,prostaglandin-endoperoxide synthase 2,CELECOXIB,Small molecule,CHEMBL118,4.0,['NCT03473665'],EFO_0005755,rheumatic disease
438,ADRA2A,adrenoceptor alpha 2A,EPINEPHRINE,Small molecule,CHEMBL679,4.0,['NCT02570503'],EFO_0005755,rheumatic disease
439,SCN2A,sodium voltage-gated channel alpha subunit 2,LIDOCAINE HYDROCHLORIDE,Small molecule,CHEMBL1200409,4.0,['NCT05670236'],EFO_0005755,rheumatic disease
440,TUBB2A,tubulin beta 2A class IIa,COLCHICINE,Small molecule,CHEMBL107,4.0,['NCT03913442'],EFO_0005755,rheumatic disease
441,PTGS2,prostaglandin-endoperoxide synthase 2,ACECLOFENAC,Small molecule,CHEMBL93645,4.0,[],EFO_0005755,rheumatic disease
442,NDUFS1,NADH:ubiquinone oxidoreductase core subunit S1,METFORMIN,Small molecule,CHEMBL1431,4.0,['NCT02741960'],EFO_0005755,rheumatic disease
443,PTGS1,prostaglandin-endoperoxide synthase 1,FENOPROFEN,Small molecule,CHEMBL1297,4.0,[],EFO_0005755,rheumatic disease
444,IL17A,interleukin 17A,IXEKIZUMAB,Antibody,CHEMBL1743034,4.0,[],EFO_0005755,rheumatic disease
445,GABRA3,gamma-aminobutyric acid type A receptor subunit alpha3,DESFLURANE,Small molecule,CHEMBL1200733,4.0,['NCT03540030'],EFO_0005755,rheumatic disease
446,SCN4A,sodium voltage-gated channel alpha subunit 4,LIDOCAINE,Small molecule,CHEMBL79,4.0,['NCT02176304'],EFO_0005755,rheumatic disease
447,ADRB2,adrenoceptor beta 2,EPINEPHRINE,Small molecule,CHEMBL679,4.0,['NCT02570503'],EFO_0005755,rheumatic disease
448,NR3C1,nuclear receptor subfamily 3 group C member 1,CORTISONE ACETATE,Small molecule,CHEMBL1650,4.0,[],EFO_0005755,rheumatic disease
449,NR3C1,nuclear receptor subfamily 3 group C member 1,BETAMETHASONE,Small molecule,CHEMBL632,4.0,['NCT03215407'],EFO_0005755,rheumatic disease
450,TRAF3IP2,TRAF3 interacting protein 2,IGURATIMOD,Small molecule,CHEMBL2107455,4.0,['NCT05803135'],EFO_0005755,rheumatic disease
451,PDE4C,phosphodiesterase 4C,ROFLUMILAST,Small molecule,CHEMBL193240,4.0,['NCT01830959'],EFO_0005755,rheumatic disease
452,TNF,tumor necrosis factor,INFLIXIMAB,Antibody,CHEMBL1201581,4.0,['NCT01148901'],EFO_0005755,rheumatic disease
453,PTGS2,prostaglandin-endoperoxide synthase 2,DICLOFENAC,Small molecule,CHEMBL139,4.0,"['NCT01860833', 'NCT01383954']",EFO_0005755,rheumatic disease
454,PDE4C,phosphodiesterase 4C,APREMILAST,Small molecule,CHEMBL514800,4.0,['NCT03747939'],EFO_0005755,rheumatic disease
455,NR3C1,nuclear receptor subfamily 3 group C member 1,DEXAMETHASONE PHOSPHORIC ACID,Small molecule,CHEMBL1201302,4.0,[],EFO_0005755,rheumatic disease
456,SCN10A,sodium voltage-gated channel alpha subunit 10,LIDOCAINE,Small molecule,CHEMBL79,4.0,['NCT00904605'],EFO_0005755,rheumatic disease
457,PTGS2,prostaglandin-endoperoxide synthase 2,ACETAMINOPHEN,Small molecule,CHEMBL112,4.0,"['NCT01382940', 'NCT00246168']",EFO_0005755,rheumatic disease
458,SCN10A,sodium voltage-gated channel alpha subunit 10,ROPIVACAINE,Small molecule,CHEMBL1077896,4.0,['NCT04257682'],EFO_0005755,rheumatic disease
459,TYK2,tyrosine kinase 2,UPADACITINIB,Small molecule,CHEMBL3622821,4.0,[],EFO_0005755,rheumatic disease
460,TLR7,toll like receptor 7,HYDROXYCHLOROQUINE,Small molecule,CHEMBL1535,4.0,"['NCT00413361', 'NCT03122431']",EFO_0005755,rheumatic disease
461,PTGS1,prostaglandin-endoperoxide synthase 1,KETOROLAC,Small molecule,CHEMBL469,4.0,"['NCT03540030', 'NCT02658149']",EFO_0005755,rheumatic disease
462,JAK3,Janus kinase 3,TOFACITINIB,Small molecule,CHEMBL221959,4.0,[],EFO_0005755,rheumatic disease
463,TNF,tumor necrosis factor,INFLIXIMAB,Antibody,CHEMBL1201581,4.0,[],EFO_0005755,rheumatic disease
464,PTGS2,prostaglandin-endoperoxide synthase 2,CELECOXIB,Small molecule,CHEMBL118,4.0,['NCT00807846'],EFO_0005755,rheumatic disease
465,SCN11A,sodium voltage-gated channel alpha subunit 11,ROPIVACAINE HYDROCHLORIDE,Small molecule,CHEMBL1889140,4.0,['NCT00620828'],EFO_0005755,rheumatic disease
466,ALOX5,arachidonate 5-lipoxygenase,MECLOFENAMATE SODIUM,Small molecule,CHEMBL1562610,4.0,[],EFO_0005755,rheumatic disease
467,GABRG3,gamma-aminobutyric acid type A receptor subunit gamma3,REMIMAZOLAM,Small molecule,CHEMBL4297526,4.0,['NCT05760534'],EFO_0005755,rheumatic disease
468,NR3C1,nuclear receptor subfamily 3 group C member 1,BETAMETHASONE,Small molecule,CHEMBL632,4.0,['NCT00542139'],EFO_0005755,rheumatic disease
469,PLG,plasminogen,TRANEXAMIC ACID,Small molecule,CHEMBL877,4.0,"['NCT03328832', 'NCT02540226', 'NCT02458729']",EFO_0005755,rheumatic disease
470,ADRA1D,adrenoceptor alpha 1D,EPINEPHRINE,Small molecule,CHEMBL679,4.0,"['NCT03513276', 'NCT02464176']",EFO_0005755,rheumatic disease
471,CHRNE,cholinergic receptor nicotinic epsilon subunit,ROCURONIUM,Small molecule,CHEMBL1201244,4.0,['NCT03540030'],EFO_0005755,rheumatic disease
472,PTGS1,prostaglandin-endoperoxide synthase 1,BENZYDAMINE,Small molecule,CHEMBL12610,4.0,[],EFO_0005755,rheumatic disease
473,SCN9A,sodium voltage-gated channel alpha subunit 9,ROPIVACAINE,Small molecule,CHEMBL1077896,4.0,['NCT02299271'],EFO_0005755,rheumatic disease
474,PTGS2,prostaglandin-endoperoxide synthase 2,SULINDAC,Small molecule,CHEMBL15770,4.0,[],EFO_0005755,rheumatic disease
475,SCN10A,sodium voltage-gated channel alpha subunit 10,LIDOCAINE,Small molecule,CHEMBL79,4.0,['NCT02176304'],EFO_0005755,rheumatic disease
476,TUBB4A,tubulin beta 4A class IVa,COLCHICINE,Small molecule,CHEMBL107,4.0,['NCT05698680'],EFO_0005755,rheumatic disease
477,IL17A,interleukin 17A,SECUKINUMAB,Antibody,CHEMBL1743068,4.0,"['NCT05527444', 'NCT03445845', 'NCT05303285', 'NCT05622708']",EFO_0005755,rheumatic disease
478,SLC22A11,solute carrier family 22 member 11,PROBENECID,Small molecule,CHEMBL897,4.0,[],EFO_0005755,rheumatic disease
479,GABRE,gamma-aminobutyric acid type A receptor subunit epsilon,DESFLURANE,Small molecule,CHEMBL1200733,4.0,['NCT03540030'],EFO_0005755,rheumatic disease
480,TNFSF13B,TNF superfamily member 13b,BELIMUMAB,Antibody,CHEMBL1789843,4.0,['NCT02270970'],EFO_0005755,rheumatic disease
481,GABRB3,gamma-aminobutyric acid type A receptor subunit beta3,DESFLURANE,Small molecule,CHEMBL1200733,4.0,['NCT03540030'],EFO_0005755,rheumatic disease
482,SCN11A,sodium voltage-gated channel alpha subunit 11,LIDOCAINE,Small molecule,CHEMBL79,4.0,[],EFO_0005755,rheumatic disease
483,NR3C1,nuclear receptor subfamily 3 group C member 1,DEXAMETHASONE PHOSPHORIC ACID,Small molecule,CHEMBL1201302,4.0,[],EFO_0005755,rheumatic disease
484,SCN7A,sodium voltage-gated channel alpha subunit 7,LIDOCAINE,Small molecule,CHEMBL79,4.0,['NCT02102620'],EFO_0005755,rheumatic disease
485,OPRM1,opioid receptor mu 1,TRAMADOL,Small molecule,CHEMBL1237044,4.0,['NCT00246168'],EFO_0005755,rheumatic disease
486,SLC6A2,solute carrier family 6 member 2,MILNACIPRAN,Small molecule,CHEMBL259209,4.0,['NCT01329406'],EFO_0005755,rheumatic disease
487,PTGS2,prostaglandin-endoperoxide synthase 2,IBUPROFEN,Small molecule,CHEMBL521,4.0,[],EFO_0005755,rheumatic disease
488,PTGS2,prostaglandin-endoperoxide synthase 2,NAPROXEN SODIUM,Small molecule,CHEMBL1200806,4.0,[],EFO_0005755,rheumatic disease
489,ADRA2A,adrenoceptor alpha 2A,DEXMEDETOMIDINE,Small molecule,CHEMBL778,4.0,"['NCT05065775', 'NCT02784626']",EFO_0005755,rheumatic disease
490,PTGS2,prostaglandin-endoperoxide synthase 2,DICLOFENAC,Small molecule,CHEMBL139,4.0,['NCT03473665'],EFO_0005755,rheumatic disease
491,SCN1A,sodium voltage-gated channel alpha subunit 1,ROPIVACAINE,Small molecule,CHEMBL1077896,4.0,['NCT04257682'],EFO_0005755,rheumatic disease
492,SCN8A,sodium voltage-gated channel alpha subunit 8,ROPIVACAINE,Small molecule,CHEMBL1077896,4.0,['NCT04257682'],EFO_0005755,rheumatic disease
493,PTGS1,prostaglandin-endoperoxide synthase 1,FENOPROFEN,Small molecule,CHEMBL1297,4.0,[],EFO_0005755,rheumatic disease
494,NR3C1,nuclear receptor subfamily 3 group C member 1,TRIAMCINOLONE HEXACETONIDE,Small molecule,CHEMBL1200878,4.0,[],EFO_0005755,rheumatic disease
495,PTGS2,prostaglandin-endoperoxide synthase 2,PIROXICAM,Small molecule,CHEMBL527,4.0,[],EFO_0005755,rheumatic disease
496,TNF,tumor necrosis factor,INFLIXIMAB,Antibody,CHEMBL1201581,4.0,"['NCT00432432', 'NCT00778869', 'NCT00779012', 'NCT00779935']",EFO_0005755,rheumatic disease
497,NDUFC1,NADH:ubiquinone oxidoreductase subunit C1,METFORMIN,Small molecule,CHEMBL1431,4.0,['NCT02741960'],EFO_0005755,rheumatic disease
498,NR3C1,nuclear receptor subfamily 3 group C member 1,DEXAMETHASONE SODIUM PHOSPHATE,Small molecule,CHEMBL2021430,4.0,[],EFO_0005755,rheumatic disease
499,DHFR,dihydrofolate reductase,METHOTREXATE,Small molecule,CHEMBL34259,4.0,['NCT04077957'],EFO_0005755,rheumatic disease
500,KCNK18,potassium two pore domain channel subfamily K member 18,SEVOFLURANE,Small molecule,CHEMBL1200694,4.0,['NCT03540030'],EFO_0005755,rheumatic disease
501,TNF,tumor necrosis factor,INFLIXIMAB,Antibody,CHEMBL1201581,4.0,[],EFO_0005755,rheumatic disease
502,TUBB,tubulin beta class I,COLCHICINE,Small molecule,CHEMBL107,4.0,[],EFO_0005755,rheumatic disease
503,PTGS2,prostaglandin-endoperoxide synthase 2,SULFASALAZINE,Small molecule,CHEMBL421,4.0,['NCT02466581'],EFO_0005755,rheumatic disease
504,OPRM1,opioid receptor mu 1,TAPENTADOL HYDROCHLORIDE,Small molecule,CHEMBL1201777,4.0,['NCT01631513'],EFO_0005755,rheumatic disease
505,PTGS1,prostaglandin-endoperoxide synthase 1,MECLOFENAMIC ACID,Small molecule,CHEMBL509,4.0,[],EFO_0005755,rheumatic disease
506,HRH2,histamine receptor H2,FAMOTIDINE,Small molecule,CHEMBL902,4.0,['NCT01563185'],EFO_0005755,rheumatic disease
507,NR3C1,nuclear receptor subfamily 3 group C member 1,METHYLPREDNISOLONE ACETATE,Small molecule,CHEMBL1364144,4.0,['NCT04177433'],EFO_0005755,rheumatic disease
508,SCN9A,sodium voltage-gated channel alpha subunit 9,ROPIVACAINE,Small molecule,CHEMBL1077896,4.0,"['NCT03513276', 'NCT03801265']",EFO_0005755,rheumatic disease
509,PTGS2,prostaglandin-endoperoxide synthase 2,CELECOXIB,Small molecule,CHEMBL118,4.0,[],EFO_0005755,rheumatic disease
510,NR3C1,nuclear receptor subfamily 3 group C member 1,PREDNISOLONE,Small molecule,CHEMBL131,4.0,[],EFO_0005755,rheumatic disease
511,NDUFA11,NADH:ubiquinone oxidoreductase subunit A11,METFORMIN,Small molecule,CHEMBL1431,4.0,['NCT02741960'],EFO_0005755,rheumatic disease
512,PTGS1,prostaglandin-endoperoxide synthase 1,SULINDAC,Small molecule,CHEMBL15770,4.0,[],EFO_0005755,rheumatic disease
513,SCN3A,sodium voltage-gated channel alpha subunit 3,LIDOCAINE,Small molecule,CHEMBL79,4.0,['NCT02102620'],EFO_0005755,rheumatic disease
514,SCN5A,sodium voltage-gated channel alpha subunit 5,ROPIVACAINE,Small molecule,CHEMBL1077896,4.0,['NCT02299271'],EFO_0005755,rheumatic disease
515,IL6R,interleukin 6 receptor,TOCILIZUMAB,Antibody,CHEMBL1237022,4.0,['NCT01878318'],EFO_0005755,rheumatic disease
516,CD86,CD86 molecule,ABATACEPT,Protein,CHEMBL1201823,4.0,['NCT02594735'],EFO_0005755,rheumatic disease
517,SCN8A,sodium voltage-gated channel alpha subunit 8,ROPIVACAINE,Small molecule,CHEMBL1077896,4.0,['NCT05336968'],EFO_0005755,rheumatic disease
518,PTGS2,prostaglandin-endoperoxide synthase 2,OXAPROZIN,Small molecule,CHEMBL1071,4.0,[],EFO_0005755,rheumatic disease
519,SCN5A,sodium voltage-gated channel alpha subunit 5,LIDOCAINE,Small molecule,CHEMBL79,4.0,[],EFO_0005755,rheumatic disease
520,NR3C1,nuclear receptor subfamily 3 group C member 1,DEXAMETHASONE,Small molecule,CHEMBL384467,4.0,[],EFO_0005755,rheumatic disease
521,PTGS2,prostaglandin-endoperoxide synthase 2,CELECOXIB,Small molecule,CHEMBL118,4.0,"['NCT00139776', 'NCT00174317']",EFO_0005755,rheumatic disease
522,TUBB1,tubulin beta 1 class VI,COLCHICINE,Small molecule,CHEMBL107,4.0,"['NCT01451645', 'NCT01994226', 'NCT02060552', 'NCT02500641']",EFO_0005755,rheumatic disease
523,PTGS2,prostaglandin-endoperoxide synthase 2,ACETAMINOPHEN,Small molecule,CHEMBL112,4.0,"['NCT05556356', 'NCT03781544']",EFO_0005755,rheumatic disease
524,SCN3A,sodium voltage-gated channel alpha subunit 3,ROPIVACAINE,Small molecule,CHEMBL1077896,4.0,['NCT03219983'],EFO_0005755,rheumatic disease
525,NR3C1,nuclear receptor subfamily 3 group C member 1,DEXAMETHASONE SODIUM PHOSPHATE,Small molecule,CHEMBL2021430,4.0,[],EFO_0005755,rheumatic disease
526,PTGS1,prostaglandin-endoperoxide synthase 1,KETOPROFEN,Small molecule,CHEMBL571,4.0,[],EFO_0005755,rheumatic disease
527,PTGS1,prostaglandin-endoperoxide synthase 1,DIFLUNISAL,Small molecule,CHEMBL898,4.0,[],EFO_0005755,rheumatic disease
528,CD86,CD86 molecule,ABATACEPT,Protein,CHEMBL1201823,4.0,"['NCT01491815', 'NCT02466581', 'NCT03652961']",EFO_0005755,rheumatic disease
529,SCN10A,sodium voltage-gated channel alpha subunit 10,ROPIVACAINE,Small molecule,CHEMBL1077896,4.0,['NCT03219983'],EFO_0005755,rheumatic disease
530,PTGS1,prostaglandin-endoperoxide synthase 1,SULFASALAZINE,Small molecule,CHEMBL421,4.0,['NCT00247962'],EFO_0005755,rheumatic disease
531,IL6R,interleukin 6 receptor,TOCILIZUMAB,Antibody,CHEMBL1237022,4.0,"['NCT02765074', 'NCT03227419', 'NCT03895879']",EFO_0005755,rheumatic disease
532,F10,coagulation factor X,RIVAROXABAN,Small molecule,CHEMBL198362,4.0,"['NCT03328832', 'NCT02458729']",EFO_0005755,rheumatic disease
533,KCNN4,potassium calcium-activated channel subfamily N member 4,CHLORZOXAZONE,Small molecule,CHEMBL1371,4.0,['NCT02405104'],EFO_0005755,rheumatic disease
534,PTGS2,prostaglandin-endoperoxide synthase 2,ACETAMINOPHEN,Small molecule,CHEMBL112,4.0,"['NCT01699815', 'NCT01063842', 'NCT02839876', 'NCT01728246', 'NCT00324038', 'NCT03540030', 'NCT00635349']",EFO_0005755,rheumatic disease
535,TUBB2B,tubulin beta 2B class IIb,COLCHICINE,Small molecule,CHEMBL107,4.0,[],EFO_0005755,rheumatic disease
536,TNF,tumor necrosis factor,CERTOLIZUMAB PEGOL,Antibody,CHEMBL1201831,4.0,[],EFO_0005755,rheumatic disease
537,TNF,tumor necrosis factor,INFLIXIMAB,Antibody,CHEMBL1201581,4.0,[],EFO_0005755,rheumatic disease
538,CD86,CD86 molecule,ABATACEPT,Protein,CHEMBL1201823,4.0,[],EFO_0005755,rheumatic disease
539,JAK2,Janus kinase 2,UPADACITINIB,Small molecule,CHEMBL3622821,4.0,[],EFO_0005755,rheumatic disease
540,TUBB1,tubulin beta 1 class VI,COLCHICINE,Small molecule,CHEMBL107,4.0,[],EFO_0005755,rheumatic disease
541,PTGS1,prostaglandin-endoperoxide synthase 1,IBUPROFEN,Small molecule,CHEMBL521,4.0,"['NCT00346216', 'NCT00145730']",EFO_0005755,rheumatic disease
542,SCN7A,sodium voltage-gated channel alpha subunit 7,LIDOCAINE,Small molecule,CHEMBL79,4.0,['NCT05670236'],EFO_0005755,rheumatic disease
543,TNF,tumor necrosis factor,ETANERCEPT,Protein,CHEMBL1201572,4.0,"['NCT02960035', 'NCT00420303', 'NCT01604629']",EFO_0005755,rheumatic disease
544,MT-ND4,mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 4,METFORMIN,Small molecule,CHEMBL1431,4.0,['NCT02741960'],EFO_0005755,rheumatic disease
545,TUBB8,tubulin beta 8 class VIII,COLCHICINE,Small molecule,CHEMBL107,4.0,"['NCT01451645', 'NCT02500641', 'NCT02060552', 'NCT01994226']",EFO_0005755,rheumatic disease
546,ALOX5,arachidonate 5-lipoxygenase,SULFASALAZINE,Small molecule,CHEMBL421,4.0,[],EFO_0005755,rheumatic disease
547,DHFR,dihydrofolate reductase,METHOTREXATE,Small molecule,CHEMBL34259,4.0,[],EFO_0005755,rheumatic disease
548,TNF,tumor necrosis factor,INFLIXIMAB,Antibody,CHEMBL1201581,4.0,['NCT01144143'],EFO_0005755,rheumatic disease
549,GABRE,gamma-aminobutyric acid type A receptor subunit epsilon,PROPOFOL,Small molecule,CHEMBL526,4.0,"['NCT02784626', 'NCT02292082', 'NCT03540030']",EFO_0005755,rheumatic disease
550,SCN1A,sodium voltage-gated channel alpha subunit 1,LIDOCAINE,Small molecule,CHEMBL79,4.0,['NCT01045694'],EFO_0005755,rheumatic disease
551,SCN10A,sodium voltage-gated channel alpha subunit 10,LIDOCAINE,Small molecule,CHEMBL79,4.0,['NCT02102620'],EFO_0005755,rheumatic disease
552,PTGS2,prostaglandin-endoperoxide synthase 2,MEFENAMIC ACID,Small molecule,CHEMBL686,4.0,[],EFO_0005755,rheumatic disease
553,PTGS2,prostaglandin-endoperoxide synthase 2,KETOROLAC,Small molecule,CHEMBL469,4.0,['NCT03119038'],EFO_0005755,rheumatic disease
554,DHODH,dihydroorotate dehydrogenase (quinone),LEFLUNOMIDE,Small molecule,CHEMBL960,4.0,['NCT03739853'],EFO_0005755,rheumatic disease
555,PDGFRB,platelet derived growth factor receptor beta,NINTEDANIB ESYLATE,Small molecule,CHEMBL3039504,4.0,[],EFO_0005755,rheumatic disease
556,TUBB,tubulin beta class I,COLCHICINE,Small molecule,CHEMBL107,4.0,['NCT02602028'],EFO_0005755,rheumatic disease
557,PTGS1,prostaglandin-endoperoxide synthase 1,MECLOFENAMIC ACID,Small molecule,CHEMBL509,4.0,[],EFO_0005755,rheumatic disease
558,SCN7A,sodium voltage-gated channel alpha subunit 7,MEPIVACAINE,Small molecule,CHEMBL1087,4.0,['NCT04257682'],EFO_0005755,rheumatic disease
559,GABRB1,gamma-aminobutyric acid type A receptor subunit beta1,DESFLURANE,Small molecule,CHEMBL1200733,4.0,['NCT03540030'],EFO_0005755,rheumatic disease
560,NR3C1,nuclear receptor subfamily 3 group C member 1,TRIAMCINOLONE ACETONIDE,Small molecule,CHEMBL1504,4.0,['NCT04731233'],EFO_0005755,rheumatic disease
561,PTGS2,prostaglandin-endoperoxide synthase 2,INDOMETHACIN,Small molecule,CHEMBL6,4.0,[],EFO_0005755,rheumatic disease
562,PTGS2,prostaglandin-endoperoxide synthase 2,DICLOFENAC,Small molecule,CHEMBL139,4.0,"['NCT00141102', 'NCT00140972', 'NCT00447759', 'NCT02183129']",EFO_0005755,rheumatic disease
563,PTGS1,prostaglandin-endoperoxide synthase 1,NAPROXEN SODIUM,Small molecule,CHEMBL1200806,4.0,[],EFO_0005755,rheumatic disease
564,DHODH,dihydroorotate dehydrogenase (quinone),LEFLUNOMIDE,Small molecule,CHEMBL960,4.0,[],EFO_0005755,rheumatic disease
565,TLR9,toll like receptor 9,HYDROXYCHLOROQUINE,Small molecule,CHEMBL1535,4.0,[],EFO_0005755,rheumatic disease
566,JAK1,Janus kinase 1,UPADACITINIB,Small molecule,CHEMBL3622821,4.0,[],EFO_0005755,rheumatic disease
567,IL17A,interleukin 17A,IXEKIZUMAB,Antibody,CHEMBL1743034,4.0,['NCT05080218'],EFO_0005755,rheumatic disease
568,TUBB8,tubulin beta 8 class VIII,COLCHICINE,Small molecule,CHEMBL107,4.0,[],EFO_0005755,rheumatic disease
569,MIF,macrophage migration inhibitory factor,IGURATIMOD,Small molecule,CHEMBL2107455,4.0,"['NCT05626348', 'NCT04928066']",EFO_0005755,rheumatic disease
570,PTGS2,prostaglandin-endoperoxide synthase 2,DICLOFENAC,Small molecule,CHEMBL139,4.0,['NCT03781544'],EFO_0005755,rheumatic disease
571,SCN1A,sodium voltage-gated channel alpha subunit 1,LIDOCAINE HYDROCHLORIDE,Small molecule,CHEMBL1200409,4.0,['NCT05670236'],EFO_0005755,rheumatic disease
572,PTGS2,prostaglandin-endoperoxide synthase 2,DICLOFENAC SODIUM,Small molecule,CHEMBL1034,4.0,['NCT00140972'],EFO_0005755,rheumatic disease
573,JAK1,Janus kinase 1,TOFACITINIB,Small molecule,CHEMBL221959,4.0,[],EFO_0005755,rheumatic disease
574,ADRA1A,adrenoceptor alpha 1A,EPINEPHRINE,Small molecule,CHEMBL679,4.0,['NCT02570503'],EFO_0005755,rheumatic disease
575,SCN3A,sodium voltage-gated channel alpha subunit 3,ROPIVACAINE,Small molecule,CHEMBL1077896,4.0,['NCT02570503'],EFO_0005755,rheumatic disease
576,SCN7A,sodium voltage-gated channel alpha subunit 7,ROPIVACAINE,Small molecule,CHEMBL1077896,4.0,"['NCT00562627', 'NCT02863120', 'NCT00901628']",EFO_0005755,rheumatic disease
577,NDUFB7,NADH:ubiquinone oxidoreductase subunit B7,METFORMIN,Small molecule,CHEMBL1431,4.0,['NCT02741960'],EFO_0005755,rheumatic disease
578,SCN8A,sodium voltage-gated channel alpha subunit 8,PRILOCAINE,Small molecule,CHEMBL1194,4.0,['NCT02384915'],EFO_0005755,rheumatic disease
579,SCN9A,sodium voltage-gated channel alpha subunit 9,LIDOCAINE,Small molecule,CHEMBL79,4.0,['NCT05670236'],EFO_0005755,rheumatic disease
580,GABRB1,gamma-aminobutyric acid type A receptor subunit beta1,PROPOFOL,Small molecule,CHEMBL526,4.0,"['NCT03540030', 'NCT02292082', 'NCT02784626']",EFO_0005755,rheumatic disease
581,PTGS2,prostaglandin-endoperoxide synthase 2,IBUPROFEN,Small molecule,CHEMBL521,4.0,"['NCT00145730', 'NCT00346216']",EFO_0005755,rheumatic disease
582,IL17A,interleukin 17A,IXEKIZUMAB,Antibody,CHEMBL1743034,4.0,['NCT03942042'],EFO_0005755,rheumatic disease
583,PTGS1,prostaglandin-endoperoxide synthase 1,INDOMETHACIN,Small molecule,CHEMBL6,4.0,['NCT03582332'],EFO_0005755,rheumatic disease
584,CD80,CD80 molecule,ABATACEPT,Protein,CHEMBL1201823,4.0,['NCT02594735'],EFO_0005755,rheumatic disease
585,NR3C1,nuclear receptor subfamily 3 group C member 1,METHYLPREDNISOLONE SODIUM SUCCINATE,Small molecule,CHEMBL1201081,4.0,[],EFO_0005755,rheumatic disease
586,TNF,tumor necrosis factor,ADALIMUMAB,Antibody,CHEMBL1201580,4.0,"['NCT01072058', 'NCT02634541', 'NCT02489760', 'NCT00477893']",EFO_0005755,rheumatic disease
587,PTGS1,prostaglandin-endoperoxide synthase 1,IBUPROFEN,Small molecule,CHEMBL521,4.0,['NCT01563185'],EFO_0005755,rheumatic disease
588,TYK2,tyrosine kinase 2,UPADACITINIB,Small molecule,CHEMBL3622821,4.0,['NCT05153200'],EFO_0005755,rheumatic disease
589,TUBB3,tubulin beta 3 class III,COLCHICINE,Small molecule,CHEMBL107,4.0,['NCT04601883'],EFO_0005755,rheumatic disease
590,NR3C1,nuclear receptor subfamily 3 group C member 1,BETAMETHASONE,Small molecule,CHEMBL632,4.0,['NCT00209859'],EFO_0005755,rheumatic disease
591,SCN1A,sodium voltage-gated channel alpha subunit 1,LIDOCAINE,Small molecule,CHEMBL79,4.0,['NCT02102620'],EFO_0005755,rheumatic disease
592,DDB1,damage specific DNA binding protein 1,THALIDOMIDE,Small molecule,CHEMBL468,4.0,['NCT03122431'],EFO_0005755,rheumatic disease
593,TRPV1,transient receptor potential cation channel subfamily V member 1,ACETAMINOPHEN,Small molecule,CHEMBL112,4.0,['NCT01105936'],EFO_0005755,rheumatic disease
594,NR3C1,nuclear receptor subfamily 3 group C member 1,PREDNISOLONE,Small molecule,CHEMBL131,4.0,"['NCT02644499', 'NCT02585258']",EFO_0005755,rheumatic disease
595,DHFR,dihydrofolate reductase,METHOTREXATE,Small molecule,CHEMBL34259,4.0,['NCT04762498'],EFO_0005755,rheumatic disease
596,SCN3A,sodium voltage-gated channel alpha subunit 3,LIDOCAINE HYDROCHLORIDE,Small molecule,CHEMBL1200409,4.0,['NCT05670236'],EFO_0005755,rheumatic disease
597,FDPS,farnesyl diphosphate synthase,ALENDRONATE SODIUM,Small molecule,CHEMBL675,4.0,['NCT04739592'],EFO_0005755,rheumatic disease
598,NR3C1,nuclear receptor subfamily 3 group C member 1,BETAMETHASONE DIPROPIONATE,Small molecule,CHEMBL1200384,4.0,['NCT05139875'],EFO_0005755,rheumatic disease
599,DDB1,damage specific DNA binding protein 1,THALIDOMIDE,Small molecule,CHEMBL468,4.0,['NCT05527444'],EFO_0005755,rheumatic disease
600,PTGS2,prostaglandin-endoperoxide synthase 2,LOXOPROFEN,Small molecule,CHEMBL19299,4.0,['NCT03800797'],EFO_0005755,rheumatic disease
601,ADRA2A,adrenoceptor alpha 2A,CLONIDINE,Small molecule,CHEMBL134,4.0,['NCT03119038'],EFO_0005755,rheumatic disease
602,ADRA1A,adrenoceptor alpha 1A,EPINEPHRINE,Small molecule,CHEMBL679,4.0,"['NCT02658149', 'NCT02697955']",EFO_0005755,rheumatic disease
603,TNF,tumor necrosis factor,GOLIMUMAB,Antibody,CHEMBL1201833,4.0,['NCT02242474'],EFO_0005755,rheumatic disease
604,TLR9,toll like receptor 9,HYDROXYCHLOROQUINE,Small molecule,CHEMBL1535,4.0,['NCT05841758'],EFO_0005755,rheumatic disease
605,IL23A,interleukin 23 subunit alpha,GUSELKUMAB,Antibody,CHEMBL2364648,4.0,[],EFO_0005755,rheumatic disease
606,SCN3A,sodium voltage-gated channel alpha subunit 3,ROPIVACAINE,Small molecule,CHEMBL1077896,4.0,['NCT04257682'],EFO_0005755,rheumatic disease
607,PTGS1,prostaglandin-endoperoxide synthase 1,NAPROXEN,Small molecule,CHEMBL154,4.0,[],EFO_0005755,rheumatic disease
608,TLR9,toll like receptor 9,HYDROXYCHLOROQUINE,Small molecule,CHEMBL1535,4.0,['NCT05666336'],EFO_0005755,rheumatic disease
609,JAK1,Janus kinase 1,TOFACITINIB,Small molecule,CHEMBL221959,4.0,['NCT03504072'],EFO_0005755,rheumatic disease
610,GABRG2,gamma-aminobutyric acid type A receptor subunit gamma2,MIDAZOLAM,Small molecule,CHEMBL655,4.0,['NCT02292082'],EFO_0005755,rheumatic disease
611,GABRP,gamma-aminobutyric acid type A receptor subunit pi,SEVOFLURANE,Small molecule,CHEMBL1200694,4.0,['NCT03540030'],EFO_0005755,rheumatic disease
612,TNFSF13B,TNF superfamily member 13b,BELIMUMAB,Antibody,CHEMBL1789843,4.0,['NCT04893161'],EFO_0005755,rheumatic disease
613,SCN1A,sodium voltage-gated channel alpha subunit 1,MEPIVACAINE,Small molecule,CHEMBL1087,4.0,['NCT02384915'],EFO_0005755,rheumatic disease
614,JAK1,Janus kinase 1,TOFACITINIB,Small molecule,CHEMBL221959,4.0,"['NCT02157012', 'NCT04928066', 'NCT04485325', 'NCT05606107', 'NCT03976245', 'NCT04927000']",EFO_0005755,rheumatic disease
615,SLC6A2,solute carrier family 6 member 2,DULOXETINE,Small molecule,CHEMBL1175,4.0,['NCT04532684'],EFO_0005755,rheumatic disease
616,DHODH,dihydroorotate dehydrogenase (quinone),LEFLUNOMIDE,Small molecule,CHEMBL960,4.0,"['NCT02275299', 'NCT02878161']",EFO_0005755,rheumatic disease
617,PTGS2,prostaglandin-endoperoxide synthase 2,SULFASALAZINE,Small molecule,CHEMBL421,4.0,['NCT00247962'],EFO_0005755,rheumatic disease
618,SCN11A,sodium voltage-gated channel alpha subunit 11,LIDOCAINE,Small molecule,CHEMBL79,4.0,['NCT02176304'],EFO_0005755,rheumatic disease
619,SCN9A,sodium voltage-gated channel alpha subunit 9,LIDOCAINE,Small molecule,CHEMBL79,4.0,['NCT00904605'],EFO_0005755,rheumatic disease
620,JAK2,Janus kinase 2,BARICITINIB,Small molecule,CHEMBL2105759,4.0,['NCT05080218'],EFO_0005755,rheumatic disease
621,PTGS1,prostaglandin-endoperoxide synthase 1,IBUPROFEN,Small molecule,CHEMBL521,4.0,"['NCT00145730', 'NCT01066676']",EFO_0005755,rheumatic disease
622,PTGS2,prostaglandin-endoperoxide synthase 2,ACECLOFENAC,Small molecule,CHEMBL93645,4.0,"['NCT02682524', 'NCT00635349']",EFO_0005755,rheumatic disease
623,TRPV1,transient receptor potential cation channel subfamily V member 1,ACETAMINOPHEN,Small molecule,CHEMBL112,4.0,"['NCT01699815', 'NCT03540030', 'NCT02839876', 'NCT01728246', 'NCT00324038', 'NCT00635349', 'NCT01063842']",EFO_0005755,rheumatic disease
624,F10,coagulation factor X,RIVAROXABAN,Small molecule,CHEMBL198362,4.0,['NCT02453802'],EFO_0005755,rheumatic disease
625,TLR7,toll like receptor 7,HYDROXYCHLOROQUINE,Small molecule,CHEMBL1535,4.0,['NCT02466581'],EFO_0005755,rheumatic disease
626,SCN11A,sodium voltage-gated channel alpha subunit 11,LIDOCAINE,Small molecule,CHEMBL79,4.0,['NCT04143165'],EFO_0005755,rheumatic disease
627,SCN5A,sodium voltage-gated channel alpha subunit 5,MEPIVACAINE,Small molecule,CHEMBL1087,4.0,['NCT04257682'],EFO_0005755,rheumatic disease
628,CD80,CD80 molecule,ABATACEPT,Protein,CHEMBL1201823,4.0,['NCT02652273'],EFO_0005755,rheumatic disease
629,SCN9A,sodium voltage-gated channel alpha subunit 9,ROPIVACAINE,Small molecule,CHEMBL1077896,4.0,['NCT04257682'],EFO_0005755,rheumatic disease
630,SCN5A,sodium voltage-gated channel alpha subunit 5,ROPIVACAINE,Small molecule,CHEMBL1077896,4.0,['NCT02365727'],EFO_0005755,rheumatic disease
631,PLG,plasminogen,AMINOCAPROIC ACID,Small molecule,CHEMBL1046,4.0,['NCT01873768'],EFO_0005755,rheumatic disease
632,PTGS2,prostaglandin-endoperoxide synthase 2,MECLOFENAMIC ACID,Small molecule,CHEMBL509,4.0,[],EFO_0005755,rheumatic disease
633,PTGS2,prostaglandin-endoperoxide synthase 2,NAPROXEN,Small molecule,CHEMBL154,4.0,[],EFO_0005755,rheumatic disease
634,PTGS1,prostaglandin-endoperoxide synthase 1,NAPROXEN,Small molecule,CHEMBL154,4.0,['NCT02355236'],EFO_0005755,rheumatic disease
635,NR3C1,nuclear receptor subfamily 3 group C member 1,PREDNICARBATE,Small molecule,CHEMBL1200386,4.0,[],EFO_0005755,rheumatic disease
636,SCN7A,sodium voltage-gated channel alpha subunit 7,ROPIVACAINE,Small molecule,CHEMBL1077896,4.0,['NCT03119038'],EFO_0005755,rheumatic disease
637,ALOX5,arachidonate 5-lipoxygenase,MECLOFENAMIC ACID,Small molecule,CHEMBL509,4.0,[],EFO_0005755,rheumatic disease
638,SCN7A,sodium voltage-gated channel alpha subunit 7,ROPIVACAINE,Small molecule,CHEMBL1077896,4.0,"['NCT02365181', 'NCT02576249', 'NCT01537146', 'NCT00620828', 'NCT02658149']",EFO_0005755,rheumatic disease
639,SCN4A,sodium voltage-gated channel alpha subunit 4,ROPIVACAINE,Small molecule,CHEMBL1077896,4.0,"['NCT00562627', 'NCT02863120', 'NCT00901628']",EFO_0005755,rheumatic disease
640,VDR,vitamin D receptor,CHOLECALCIFEROL,Small molecule,CHEMBL1042,4.0,['NCT04739592'],EFO_0005755,rheumatic disease
641,ADRA2B,adrenoceptor alpha 2B,EPINEPHRINE,Small molecule,CHEMBL679,4.0,['NCT02570503'],EFO_0005755,rheumatic disease
642,GABRB2,gamma-aminobutyric acid type A receptor subunit beta2,DESFLURANE,Small molecule,CHEMBL1200733,4.0,['NCT03540030'],EFO_0005755,rheumatic disease
643,NR3C1,nuclear receptor subfamily 3 group C member 1,METHYLPREDNISOLONE,Small molecule,CHEMBL650,4.0,['NCT05859269'],EFO_0005755,rheumatic disease
644,FDPS,farnesyl diphosphate synthase,ALENDRONIC ACID,Small molecule,CHEMBL870,4.0,['NCT04739592'],EFO_0005755,rheumatic disease
645,OPRD1,opioid receptor delta 1,NALTREXONE,Small molecule,CHEMBL19019,4.0,['NCT00908089'],EFO_0005755,rheumatic disease
646,NR3C1,nuclear receptor subfamily 3 group C member 1,PREDNICARBATE,Small molecule,CHEMBL1200386,4.0,[],EFO_0005755,rheumatic disease
647,JAK2,Janus kinase 2,TOFACITINIB,Small molecule,CHEMBL221959,4.0,['NCT05803135'],EFO_0005755,rheumatic disease
648,CUL4A,cullin 4A,THALIDOMIDE,Small molecule,CHEMBL468,4.0,['NCT03122431'],EFO_0005755,rheumatic disease
649,NR3C1,nuclear receptor subfamily 3 group C member 1,DEXAMETHASONE SODIUM PHOSPHATE,Small molecule,CHEMBL2021430,4.0,[],EFO_0005755,rheumatic disease
650,OPRM1,opioid receptor mu 1,MORPHINE,Small molecule,CHEMBL70,4.0,['NCT01281891'],EFO_0005755,rheumatic disease
651,NR3C1,nuclear receptor subfamily 3 group C member 1,METHYLPREDNISOLONE ACETATE,Small molecule,CHEMBL1364144,4.0,[],EFO_0005755,rheumatic disease
652,TUBB4A,tubulin beta 4A class IVa,COLCHICINE,Small molecule,CHEMBL107,4.0,[],EFO_0005755,rheumatic disease
653,PTGS2,prostaglandin-endoperoxide synthase 2,KETOPROFEN,Small molecule,CHEMBL571,4.0,[],EFO_0005755,rheumatic disease
654,PTGS2,prostaglandin-endoperoxide synthase 2,LUMIRACOXIB,Small molecule,CHEMBL404108,4.0,[],EFO_0005755,rheumatic disease
655,ADRA2B,adrenoceptor alpha 2B,CLONIDINE,Small molecule,CHEMBL134,4.0,['NCT02365727'],EFO_0005755,rheumatic disease
656,PTGS1,prostaglandin-endoperoxide synthase 1,MECLOFENAMIC ACID,Small molecule,CHEMBL509,4.0,[],EFO_0005755,rheumatic disease
657,NR3C1,nuclear receptor subfamily 3 group C member 1,CORTISONE ACETATE,Small molecule,CHEMBL1650,4.0,[],EFO_0005755,rheumatic disease
658,DHFR,dihydrofolate reductase,METHOTREXATE,Small molecule,CHEMBL34259,4.0,"['NCT03739853', 'NCT01123265']",EFO_0005755,rheumatic disease
659,PTGS2,prostaglandin-endoperoxide synthase 2,VALDECOXIB,Small molecule,CHEMBL865,4.0,[],EFO_0005755,rheumatic disease
660,PTGS2,prostaglandin-endoperoxide synthase 2,OXAPROZIN,Small molecule,CHEMBL1071,4.0,[],EFO_0005755,rheumatic disease
661,ADRA2A,adrenoceptor alpha 2A,EPINEPHRINE,Small molecule,CHEMBL679,4.0,"['NCT02365727', 'NCT02765815']",EFO_0005755,rheumatic disease
662,PTGS2,prostaglandin-endoperoxide synthase 2,FENOPROFEN,Small molecule,CHEMBL1297,4.0,[],EFO_0005755,rheumatic disease
663,SCN4A,sodium voltage-gated channel alpha subunit 4,ROPIVACAINE,Small molecule,CHEMBL1077896,4.0,['NCT04257682'],EFO_0005755,rheumatic disease
664,PTGS2,prostaglandin-endoperoxide synthase 2,MELOXICAM,Small molecule,CHEMBL599,4.0,[],EFO_0005755,rheumatic disease
665,NR3C1,nuclear receptor subfamily 3 group C member 1,DEXAMETHASONE PHOSPHORIC ACID,Small molecule,CHEMBL1201302,4.0,[],EFO_0005755,rheumatic disease
666,DHFR,dihydrofolate reductase,METHOTREXATE,Small molecule,CHEMBL34259,4.0,['NCT00291915'],EFO_0005755,rheumatic disease
667,IL1R1,interleukin 1 receptor type 1,ANAKINRA,Protein,CHEMBL1201570,4.0,[],EFO_0005755,rheumatic disease
668,CACNA2D1,calcium voltage-gated channel auxiliary subunit alpha2delta 1,PREGABALIN,Small molecule,CHEMBL1059,4.0,['NCT05460871'],EFO_0005755,rheumatic disease
669,PTGS2,prostaglandin-endoperoxide synthase 2,NAPROXEN,Small molecule,CHEMBL154,4.0,[],EFO_0005755,rheumatic disease
670,MIF,macrophage migration inhibitory factor,IGURATIMOD,Small molecule,CHEMBL2107455,4.0,"['NCT01893151', 'NCT02275299', 'NCT01548001']",EFO_0005755,rheumatic disease
671,TNF,tumor necrosis factor,ADALIMUMAB,Antibody,CHEMBL1201580,4.0,['NCT05527444'],EFO_0005755,rheumatic disease
672,KCNK2,potassium two pore domain channel subfamily K member 2,SEVOFLURANE,Small molecule,CHEMBL1200694,4.0,['NCT03540030'],EFO_0005755,rheumatic disease
673,SCN10A,sodium voltage-gated channel alpha subunit 10,ROPIVACAINE,Small molecule,CHEMBL1077896,4.0,['NCT02570503'],EFO_0005755,rheumatic disease
674,SCN8A,sodium voltage-gated channel alpha subunit 8,ROPIVACAINE,Small molecule,CHEMBL1077896,4.0,['NCT02570503'],EFO_0005755,rheumatic disease
675,PPAT,phosphoribosyl pyrophosphate amidotransferase,AZATHIOPRINE,Small molecule,CHEMBL1542,4.0,['NCT03449758'],EFO_0005755,rheumatic disease
676,TLR7,toll like receptor 7,HYDROXYCHLOROQUINE SULFATE,Small molecule,CHEMBL1690,4.0,['NCT00422227'],EFO_0005755,rheumatic disease
677,ADRA2B,adrenoceptor alpha 2B,EPINEPHRINE,Small molecule,CHEMBL679,4.0,['NCT03119038'],EFO_0005755,rheumatic disease
678,PTGS1,prostaglandin-endoperoxide synthase 1,DICLOFENAC POTASSIUM,Small molecule,CHEMBL1200804,4.0,[],EFO_0005755,rheumatic disease
679,ADRA2B,adrenoceptor alpha 2B,DEXMEDETOMIDINE,Small molecule,CHEMBL778,4.0,"['NCT05065775', 'NCT02784626']",EFO_0005755,rheumatic disease
680,TUBB4B,tubulin beta 4B class IVb,COLCHICINE,Small molecule,CHEMBL107,4.0,['NCT03913442'],EFO_0005755,rheumatic disease
681,TNF,tumor necrosis factor,ADALIMUMAB,Antibody,CHEMBL1201580,4.0,"['NCT01895764', 'NCT02492217', 'NCT01029847']",EFO_0005755,rheumatic disease
682,SCN4A,sodium voltage-gated channel alpha subunit 4,BUPIVACAINE,Small molecule,CHEMBL1098,4.0,['NCT04257682'],EFO_0005755,rheumatic disease
683,PPAT,phosphoribosyl pyrophosphate amidotransferase,AZATHIOPRINE,Small molecule,CHEMBL1542,4.0,['NCT01112215'],EFO_0005755,rheumatic disease
684,PDE4A,phosphodiesterase 4A,ROFLUMILAST,Small molecule,CHEMBL193240,4.0,['NCT01830959'],EFO_0005755,rheumatic disease
685,ACE,angiotensin I converting enzyme,CAPTOPRIL,Small molecule,CHEMBL1560,4.0,[],EFO_0005755,rheumatic disease
686,TLR7,toll like receptor 7,HYDROXYCHLOROQUINE,Small molecule,CHEMBL1535,4.0,"['NCT02433184', 'NCT00259610', 'NCT00422227', 'NCT02374021', 'NCT02451748', 'NCT03449758', 'NCT00764725', 'NCT02644499']",EFO_0005755,rheumatic disease
687,ADRA2C,adrenoceptor alpha 2C,EPINEPHRINE,Small molecule,CHEMBL679,4.0,"['NCT02464176', 'NCT03513276']",EFO_0005755,rheumatic disease
688,PTGS1,prostaglandin-endoperoxide synthase 1,ACETAMINOPHEN,Small molecule,CHEMBL112,4.0,['NCT01105936'],EFO_0005755,rheumatic disease
689,GABRA6,gamma-aminobutyric acid type A receptor subunit alpha6,DESFLURANE,Small molecule,CHEMBL1200733,4.0,['NCT03540030'],EFO_0005755,rheumatic disease
690,NR3C1,nuclear receptor subfamily 3 group C member 1,DEXAMETHASONE,Small molecule,CHEMBL384467,4.0,[],EFO_0005755,rheumatic disease
691,SCN11A,sodium voltage-gated channel alpha subunit 11,ROPIVACAINE,Small molecule,CHEMBL1077896,4.0,"['NCT03801265', 'NCT03513276']",EFO_0005755,rheumatic disease
692,SCN1A,sodium voltage-gated channel alpha subunit 1,LIDOCAINE,Small molecule,CHEMBL79,4.0,['NCT03540030'],EFO_0005755,rheumatic disease
693,ADRA2A,adrenoceptor alpha 2A,EPINEPHRINE,Small molecule,CHEMBL679,4.0,"['NCT02462148', 'NCT00562627', 'NCT00901628']",EFO_0005755,rheumatic disease
694,TNF,tumor necrosis factor,ETANERCEPT,Protein,CHEMBL1201572,4.0,['NCT00443430'],EFO_0005755,rheumatic disease
695,DHFR,dihydrofolate reductase,METHOTREXATE,Small molecule,CHEMBL34259,4.0,['NCT04579848'],EFO_0005755,rheumatic disease
696,NR3C1,nuclear receptor subfamily 3 group C member 1,TRIAMCINOLONE ACETONIDE,Small molecule,CHEMBL1504,4.0,"['NCT03895840', 'NCT05058209', 'NCT01874574']",EFO_0005755,rheumatic disease
697,HRH2,histamine receptor H2,FAMOTIDINE,Small molecule,CHEMBL902,4.0,[],EFO_0005755,rheumatic disease
698,PTGS1,prostaglandin-endoperoxide synthase 1,FENOPROFEN CALCIUM,Small molecule,CHEMBL2103736,4.0,[],EFO_0005755,rheumatic disease
699,TUBB4B,tubulin beta 4B class IVb,COLCHICINE,Small molecule,CHEMBL107,4.0,"['NCT01451645', 'NCT02060552', 'NCT02500641', 'NCT01994226']",EFO_0005755,rheumatic disease
700,DHFR,dihydrofolate reductase,METHOTREXATE,Small molecule,CHEMBL34259,4.0,"['NCT01283971', 'NCT00233558', 'NCT01927757', 'NCT01661140', 'NCT01659242', 'NCT01117129', 'NCT00706797']",EFO_0005755,rheumatic disease
701,PTGS1,prostaglandin-endoperoxide synthase 1,INDOMETHACIN,Small molecule,CHEMBL6,4.0,[],EFO_0005755,rheumatic disease
702,NR3C1,nuclear receptor subfamily 3 group C member 1,PREDNISOLONE,Small molecule,CHEMBL131,4.0,[],EFO_0005755,rheumatic disease
703,PTGS2,prostaglandin-endoperoxide synthase 2,CELECOXIB,Small molecule,CHEMBL118,4.0,['NCT03404479'],EFO_0005755,rheumatic disease
704,ADRA1B,adrenoceptor alpha 1B,EPINEPHRINE,Small molecule,CHEMBL679,4.0,"['NCT02697955', 'NCT02658149']",EFO_0005755,rheumatic disease
705,SCN2A,sodium voltage-gated channel alpha subunit 2,ROPIVACAINE,Small molecule,CHEMBL1077896,4.0,['NCT03219983'],EFO_0005755,rheumatic disease
706,PTGS2,prostaglandin-endoperoxide synthase 2,PIROXICAM,Small molecule,CHEMBL527,4.0,[],EFO_0005755,rheumatic disease
707,SCN7A,sodium voltage-gated channel alpha subunit 7,LIDOCAINE,Small molecule,CHEMBL79,4.0,['NCT00904605'],EFO_0005755,rheumatic disease
708,CD80,CD80 molecule,ABATACEPT,Protein,CHEMBL1201823,4.0,['NCT03669367'],EFO_0005755,rheumatic disease
709,NDUFA4L2,NDUFA4 mitochondrial complex associated like 2,METFORMIN,Small molecule,CHEMBL1431,4.0,['NCT02741960'],EFO_0005755,rheumatic disease
710,PTGS2,prostaglandin-endoperoxide synthase 2,CELECOXIB,Small molecule,CHEMBL118,4.0,"['NCT00373685', 'NCT00447759', 'NCT03067194', 'NCT00141102', 'NCT03540030', 'NCT00598234']",EFO_0005755,rheumatic disease
711,IL17A,interleukin 17A,IXEKIZUMAB,Antibody,CHEMBL1743034,4.0,['NCT03151551'],EFO_0005755,rheumatic disease
712,CACNA2D1,calcium voltage-gated channel auxiliary subunit alpha2delta 1,PREGABALIN,Small molecule,CHEMBL1059,4.0,"['NCT03604354', 'NCT04532684']",EFO_0005755,rheumatic disease
713,JAK1,Janus kinase 1,BARICITINIB,Small molecule,CHEMBL2105759,4.0,"['NCT05238896', 'NCT05660655', 'NCT04086745', 'NCT05827497']",EFO_0005755,rheumatic disease
714,PTGS1,prostaglandin-endoperoxide synthase 1,NAPROXEN SODIUM,Small molecule,CHEMBL1200806,4.0,[],EFO_0005755,rheumatic disease
715,GABRG2,gamma-aminobutyric acid type A receptor subunit gamma2,SEVOFLURANE,Small molecule,CHEMBL1200694,4.0,['NCT03540030'],EFO_0005755,rheumatic disease
716,SCN8A,sodium voltage-gated channel alpha subunit 8,MEPIVACAINE,Small molecule,CHEMBL1087,4.0,['NCT04257682'],EFO_0005755,rheumatic disease
717,TUBB1,tubulin beta 1 class VI,COLCHICINE,Small molecule,CHEMBL107,4.0,['NCT02602028'],EFO_0005755,rheumatic disease
718,SCN10A,sodium voltage-gated channel alpha subunit 10,ROPIVACAINE,Small molecule,CHEMBL1077896,4.0,['NCT05336968'],EFO_0005755,rheumatic disease
719,PTGS2,prostaglandin-endoperoxide synthase 2,NAPROXEN,Small molecule,CHEMBL154,4.0,[],EFO_0005755,rheumatic disease
720,NR3C1,nuclear receptor subfamily 3 group C member 1,DEXAMETHASONE PHOSPHORIC ACID,Small molecule,CHEMBL1201302,4.0,[],EFO_0005755,rheumatic disease
721,SLC6A4,solute carrier family 6 member 4,DULOXETINE,Small molecule,CHEMBL1175,4.0,['NCT01558700'],EFO_0005755,rheumatic disease
722,PTGS1,prostaglandin-endoperoxide synthase 1,OXYPHENBUTAZONE,Small molecule,CHEMBL1228,4.0,[],EFO_0005755,rheumatic disease
723,SCN3A,sodium voltage-gated channel alpha subunit 3,PRILOCAINE,Small molecule,CHEMBL1194,4.0,['NCT02384915'],EFO_0005755,rheumatic disease
724,CUL4A,cullin 4A,THALIDOMIDE,Small molecule,CHEMBL468,4.0,['NCT03122431'],EFO_0005755,rheumatic disease
725,SCN3A,sodium voltage-gated channel alpha subunit 3,LIDOCAINE,Small molecule,CHEMBL79,4.0,['NCT01045694'],EFO_0005755,rheumatic disease
726,FDPS,farnesyl diphosphate synthase,PAMIDRONIC ACID,Small molecule,CHEMBL834,4.0,['NCT01718951'],EFO_0005755,rheumatic disease
727,TUBB,tubulin beta class I,COLCHICINE,Small molecule,CHEMBL107,4.0,['NCT03913442'],EFO_0005755,rheumatic disease
728,PTGS1,prostaglandin-endoperoxide synthase 1,SULFASALAZINE,Small molecule,CHEMBL421,4.0,[],EFO_0005755,rheumatic disease
729,MC2R,melanocortin 2 receptor,CORTICOTROPIN,Protein,CHEMBL1201610,4.0,['NCT02523092'],EFO_0005755,rheumatic disease
730,ADRA2C,adrenoceptor alpha 2C,EPINEPHRINE,Small molecule,CHEMBL679,4.0,"['NCT02697955', 'NCT02658149']",EFO_0005755,rheumatic disease
731,IMPDH1,inosine monophosphate dehydrogenase 1,MYCOPHENOLATE MOFETIL,Small molecule,CHEMBL1456,4.0,['NCT05666336'],EFO_0005755,rheumatic disease
732,NR3C1,nuclear receptor subfamily 3 group C member 1,PREDNISOLONE,Small molecule,CHEMBL131,4.0,['NCT03265405'],EFO_0005755,rheumatic disease
733,SCN1A,sodium voltage-gated channel alpha subunit 1,ROPIVACAINE,Small molecule,CHEMBL1077896,4.0,['NCT04257682'],EFO_0005755,rheumatic disease
734,GUCY1A1,guanylate cyclase 1 soluble subunit alpha 1,RIOCIGUAT,Small molecule,CHEMBL2107834,4.0,['NCT02625558'],EFO_0005755,rheumatic disease
735,SCN4A,sodium voltage-gated channel alpha subunit 4,LEVOBUPIVACAINE,Small molecule,CHEMBL1201193,4.0,['NCT01106001'],EFO_0005755,rheumatic disease
736,TNF,tumor necrosis factor,ADALIMUMAB,Antibody,CHEMBL1201580,4.0,['NCT03505008'],EFO_0005755,rheumatic disease
737,TUBB1,tubulin beta 1 class VI,COLCHICINE,Small molecule,CHEMBL107,4.0,['NCT03913442'],EFO_0005755,rheumatic disease
738,PTGS2,prostaglandin-endoperoxide synthase 2,NABUMETONE,Small molecule,CHEMBL1070,4.0,[],EFO_0005755,rheumatic disease
739,GABRD,gamma-aminobutyric acid type A receptor subunit delta,PROPOFOL,Small molecule,CHEMBL526,4.0,"['NCT02784626', 'NCT03540030', 'NCT02292082']",EFO_0005755,rheumatic disease
740,SCN1A,sodium voltage-gated channel alpha subunit 1,ROPIVACAINE,Small molecule,CHEMBL1077896,4.0,['NCT02365727'],EFO_0005755,rheumatic disease
741,SCN7A,sodium voltage-gated channel alpha subunit 7,MEPIVACAINE,Small molecule,CHEMBL1087,4.0,['NCT02384915'],EFO_0005755,rheumatic disease
742,JAK2,Janus kinase 2,TOFACITINIB,Small molecule,CHEMBL221959,4.0,[],EFO_0005755,rheumatic disease
743,SCN5A,sodium voltage-gated channel alpha subunit 5,MEPIVACAINE,Small molecule,CHEMBL1087,4.0,['NCT04257682'],EFO_0005755,rheumatic disease
744,NR3C1,nuclear receptor subfamily 3 group C member 1,DEXAMETHASONE,Small molecule,CHEMBL384467,4.0,[],EFO_0005755,rheumatic disease
745,ADRA2B,adrenoceptor alpha 2B,EPINEPHRINE,Small molecule,CHEMBL679,4.0,"['NCT02462148', 'NCT00562627', 'NCT00901628']",EFO_0005755,rheumatic disease
746,NR3C1,nuclear receptor subfamily 3 group C member 1,METHYLPREDNISOLONE,Small molecule,CHEMBL650,4.0,[],EFO_0005755,rheumatic disease
747,JAK2,Janus kinase 2,BARICITINIB,Small molecule,CHEMBL2105759,4.0,"['NCT05238896', 'NCT04086745', 'NCT05660655', 'NCT05827497']",EFO_0005755,rheumatic disease
748,OPRM1,opioid receptor mu 1,TRAMADOL,Small molecule,CHEMBL1237044,4.0,['NCT00647517'],EFO_0005755,rheumatic disease
749,HTR3B,5-hydroxytryptamine receptor 3B,RAMOSETRON,Small molecule,CHEMBL1643895,4.0,['NCT01102491'],EFO_0005755,rheumatic disease
750,TNF,tumor necrosis factor,ETANERCEPT,Protein,CHEMBL1201572,4.0,[],EFO_0005755,rheumatic disease
751,NDUFS7,NADH:ubiquinone oxidoreductase core subunit S7,METFORMIN,Small molecule,CHEMBL1431,4.0,['NCT02741960'],EFO_0005755,rheumatic disease
752,THRB,thyroid hormone receptor beta,LEVOTHYROXINE,Small molecule,CHEMBL1624,4.0,['NCT01276782'],EFO_0005755,rheumatic disease
753,GABRB2,gamma-aminobutyric acid type A receptor subunit beta2,SEVOFLURANE,Small molecule,CHEMBL1200694,4.0,['NCT03540030'],EFO_0005755,rheumatic disease
754,PTGS1,prostaglandin-endoperoxide synthase 1,INDOMETHACIN,Small molecule,CHEMBL6,4.0,[],EFO_0005755,rheumatic disease
755,IL6R,interleukin 6 receptor,TOCILIZUMAB,Antibody,CHEMBL1237022,4.0,"['NCT01163747', 'NCT01149057', 'NCT01399697', 'NCT00996203', 'NCT01557374', 'NCT02010216', 'NCT01034397', 'NCT02843789', 'NCT01089023', 'NCT01638715', 'NCT01219933', 'NCT01715831', 'NCT01010503', 'NCT03737708', 'NCT01331837', 'NCT01000441', 'NCT01717859', 'NCT01195272', 'NCT01120366', 'NCT02682823', 'NCT01119859', 'NCT02573012', 'NCT04157010']",EFO_0005755,rheumatic disease
756,NR3C1,nuclear receptor subfamily 3 group C member 1,PREDNISONE,Small molecule,CHEMBL635,4.0,['NCT03855007'],EFO_0005755,rheumatic disease
757,ADRA2A,adrenoceptor alpha 2A,EPINEPHRINE,Small molecule,CHEMBL679,4.0,"['NCT02658149', 'NCT02697955']",EFO_0005755,rheumatic disease
758,IL6R,interleukin 6 receptor,TOCILIZUMAB,Antibody,CHEMBL1237022,4.0,"['NCT01734382', 'NCT03301883']",EFO_0005755,rheumatic disease
759,NR3C1,nuclear receptor subfamily 3 group C member 1,DEXAMETHASONE,Small molecule,CHEMBL384467,4.0,['NCT02292082'],EFO_0005755,rheumatic disease
760,TUBB4A,tubulin beta 4A class IVa,COLCHICINE,Small molecule,CHEMBL107,4.0,['NCT04601883'],EFO_0005755,rheumatic disease
761,OPRM1,opioid receptor mu 1,NALTREXONE,Small molecule,CHEMBL19019,4.0,['NCT00908089'],EFO_0005755,rheumatic disease
762,FGFR2,fibroblast growth factor receptor 2,NINTEDANIB ESYLATE,Small molecule,CHEMBL3039504,4.0,[],EFO_0005755,rheumatic disease
763,CD80,CD80 molecule,ABATACEPT,Protein,CHEMBL1201823,4.0,['NCT03882008'],EFO_0005755,rheumatic disease
764,PTGS2,prostaglandin-endoperoxide synthase 2,MECLOFENAMATE SODIUM,Small molecule,CHEMBL1562610,4.0,[],EFO_0005755,rheumatic disease
765,NR3C1,nuclear receptor subfamily 3 group C member 1,BETAMETHASONE SODIUM PHOSPHATE,Small molecule,CHEMBL1200762,4.0,['NCT05058209'],EFO_0005755,rheumatic disease
766,PTGS2,prostaglandin-endoperoxide synthase 2,TOLMETIN SODIUM,Small molecule,CHEMBL1200613,4.0,[],EFO_0005755,rheumatic disease
767,SCN4A,sodium voltage-gated channel alpha subunit 4,LIDOCAINE,Small molecule,CHEMBL79,4.0,['NCT01045694'],EFO_0005755,rheumatic disease
768,XDH,xanthine dehydrogenase,FEBUXOSTAT,Small molecule,CHEMBL1164729,4.0,"['NCT01654276', 'NCT02500641', 'NCT02060552']",EFO_0005755,rheumatic disease
769,TRPA1,transient receptor potential cation channel subfamily A member 1,MENTHOL,Small molecule,CHEMBL256087,4.0,[],EFO_0005755,rheumatic disease
770,TNF,tumor necrosis factor,ADALIMUMAB,Antibody,CHEMBL1201580,4.0,"['NCT03739853', 'NCT05080218']",EFO_0005755,rheumatic disease
771,CRBN,cereblon,LENALIDOMIDE,Small molecule,CHEMBL848,4.0,['NCT01408199'],EFO_0005755,rheumatic disease
772,NR3C1,nuclear receptor subfamily 3 group C member 1,DEXAMETHASONE SODIUM PHOSPHATE,Small molecule,CHEMBL2021430,4.0,[],EFO_0005755,rheumatic disease
773,FGFR2,fibroblast growth factor receptor 2,NINTEDANIB,Small molecule,CHEMBL502835,4.0,[],EFO_0005755,rheumatic disease
774,PTGS1,prostaglandin-endoperoxide synthase 1,DICLOFENAC,Small molecule,CHEMBL139,4.0,"['NCT00447759', 'NCT00141102']",EFO_0005755,rheumatic disease
775,SLC6A2,solute carrier family 6 member 2,DULOXETINE,Small molecule,CHEMBL1175,4.0,['NCT02612233'],EFO_0005755,rheumatic disease
776,JAK2,Janus kinase 2,TOFACITINIB CITRATE,Small molecule,CHEMBL2103743,4.0,['NCT02157012'],EFO_0005755,rheumatic disease
777,SCN2A,sodium voltage-gated channel alpha subunit 2,PRILOCAINE,Small molecule,CHEMBL1194,4.0,['NCT02384915'],EFO_0005755,rheumatic disease
778,TRPV1,transient receptor potential cation channel subfamily V member 1,ACETAMINOPHEN,Small molecule,CHEMBL112,4.0,[],EFO_0005755,rheumatic disease
779,NR3C1,nuclear receptor subfamily 3 group C member 1,PREDNISONE,Small molecule,CHEMBL635,4.0,[],EFO_0005755,rheumatic disease
780,CD86,CD86 molecule,ABATACEPT,Protein,CHEMBL1201823,4.0,"['NCT01638715', 'NCT01557374', 'NCT03737708', 'NCT01758198', 'NCT01000441', 'NCT03492658', 'NCT02557100', 'NCT01295151', 'NCT01846975', 'NCT04255134']",EFO_0005755,rheumatic disease
781,PTGS2,prostaglandin-endoperoxide synthase 2,NAPROXEN SODIUM,Small molecule,CHEMBL1200806,4.0,['NCT02501564'],EFO_0005755,rheumatic disease
782,NR3C1,nuclear receptor subfamily 3 group C member 1,METHYLPREDNISOLONE,Small molecule,CHEMBL650,4.0,['NCT05666336'],EFO_0005755,rheumatic disease
783,SCN4A,sodium voltage-gated channel alpha subunit 4,ROPIVACAINE,Small molecule,CHEMBL1077896,4.0,['NCT02365727'],EFO_0005755,rheumatic disease
784,TUBB,tubulin beta class I,COLCHICINE,Small molecule,CHEMBL107,4.0,['NCT05698680'],EFO_0005755,rheumatic disease
785,PTGS2,prostaglandin-endoperoxide synthase 2,KETOPROFEN,Small molecule,CHEMBL571,4.0,[],EFO_0005755,rheumatic disease
786,NR3C1,nuclear receptor subfamily 3 group C member 1,DEXAMETHASONE,Small molecule,CHEMBL384467,4.0,['NCT03166761'],EFO_0005755,rheumatic disease
787,PTGS2,prostaglandin-endoperoxide synthase 2,MECLOFENAMATE SODIUM,Small molecule,CHEMBL1562610,4.0,[],EFO_0005755,rheumatic disease
788,ADRB2,adrenoceptor beta 2,EPINEPHRINE,Small molecule,CHEMBL679,4.0,"['NCT00901628', 'NCT00562627', 'NCT02462148']",EFO_0005755,rheumatic disease
789,TRPV1,transient receptor potential cation channel subfamily V member 1,CAPSAICIN,Small molecule,CHEMBL294199,4.0,[],EFO_0005755,rheumatic disease
790,SCN4A,sodium voltage-gated channel alpha subunit 4,LIDOCAINE,Small molecule,CHEMBL79,4.0,[],EFO_0005755,rheumatic disease
791,PTGS2,prostaglandin-endoperoxide synthase 2,MELOXICAM,Small molecule,CHEMBL599,4.0,[],EFO_0005755,rheumatic disease
792,NR3C1,nuclear receptor subfamily 3 group C member 1,METHYLPREDNISOLONE SODIUM SUCCINATE,Small molecule,CHEMBL1201081,4.0,[],EFO_0005755,rheumatic disease
793,DDB1,damage specific DNA binding protein 1,THALIDOMIDE,Small molecule,CHEMBL468,4.0,['NCT03122431'],EFO_0005755,rheumatic disease
794,TUBB3,tubulin beta 3 class III,COLCHICINE,Small molecule,CHEMBL107,4.0,[],EFO_0005755,rheumatic disease
795,SCN9A,sodium voltage-gated channel alpha subunit 9,LIDOCAINE,Small molecule,CHEMBL79,4.0,[],EFO_0005755,rheumatic disease
796,PTGS1,prostaglandin-endoperoxide synthase 1,NAPROXEN,Small molecule,CHEMBL154,4.0,[],EFO_0005755,rheumatic disease
797,GABRG3,gamma-aminobutyric acid type A receptor subunit gamma3,PROPOFOL,Small molecule,CHEMBL526,4.0,"['NCT03540030', 'NCT02292082', 'NCT02784626']",EFO_0005755,rheumatic disease
798,SCN10A,sodium voltage-gated channel alpha subunit 10,LIDOCAINE,Small molecule,CHEMBL79,4.0,['NCT05670236'],EFO_0005755,rheumatic disease
799,PTGS2,prostaglandin-endoperoxide synthase 2,ETODOLAC,Small molecule,CHEMBL622,4.0,[],EFO_0005755,rheumatic disease
800,MT-ND3,mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 3,METFORMIN,Small molecule,CHEMBL1431,4.0,['NCT02741960'],EFO_0005755,rheumatic disease
801,SCN1A,sodium voltage-gated channel alpha subunit 1,LIDOCAINE,Small molecule,CHEMBL79,4.0,['NCT04143165'],EFO_0005755,rheumatic disease
802,JAK1,Janus kinase 1,BARICITINIB,Small molecule,CHEMBL2105759,4.0,['NCT05080218'],EFO_0005755,rheumatic disease
803,PTGS2,prostaglandin-endoperoxide synthase 2,NAPROXEN,Small molecule,CHEMBL154,4.0,"['NCT00650455', 'NCT02451748', 'NCT00157872', 'NCT00346216']",EFO_0005755,rheumatic disease
804,PTGS2,prostaglandin-endoperoxide synthase 2,ACECLOFENAC,Small molecule,CHEMBL93645,4.0,[],EFO_0005755,rheumatic disease
805,NR3C1,nuclear receptor subfamily 3 group C member 1,DEXAMETHASONE,Small molecule,CHEMBL384467,4.0,[],EFO_0005755,rheumatic disease
806,SCN3A,sodium voltage-gated channel alpha subunit 3,MEPIVACAINE,Small molecule,CHEMBL1087,4.0,['NCT04257682'],EFO_0005755,rheumatic disease
807,SCN5A,sodium voltage-gated channel alpha subunit 5,ROPIVACAINE,Small molecule,CHEMBL1077896,4.0,['NCT05336968'],EFO_0005755,rheumatic disease
808,NR3C1,nuclear receptor subfamily 3 group C member 1,TRIAMCINOLONE,Small molecule,CHEMBL1451,4.0,['NCT03090698'],EFO_0005755,rheumatic disease
809,PTGS2,prostaglandin-endoperoxide synthase 2,PIROXICAM,Small molecule,CHEMBL527,4.0,[],EFO_0005755,rheumatic disease
810,SCN1A,sodium voltage-gated channel alpha subunit 1,ROPIVACAINE,Small molecule,CHEMBL1077896,4.0,['NCT04155983'],EFO_0005755,rheumatic disease
811,ADRA1B,adrenoceptor alpha 1B,EPINEPHRINE,Small molecule,CHEMBL679,4.0,"['NCT03513276', 'NCT02464176']",EFO_0005755,rheumatic disease
812,CHRNA1,cholinergic receptor nicotinic alpha 1 subunit,ROCURONIUM,Small molecule,CHEMBL1201244,4.0,['NCT03540030'],EFO_0005755,rheumatic disease
813,JAK1,Janus kinase 1,TOFACITINIB,Small molecule,CHEMBL221959,4.0,['NCT05080218'],EFO_0005755,rheumatic disease
814,SCN7A,sodium voltage-gated channel alpha subunit 7,MEPIVACAINE,Small molecule,CHEMBL1087,4.0,['NCT04257682'],EFO_0005755,rheumatic disease
815,OPRM1,opioid receptor mu 1,BUPRENORPHINE,Small molecule,CHEMBL511142,4.0,"['NCT01019265', 'NCT00324038']",EFO_0005755,rheumatic disease
816,TNF,tumor necrosis factor,ETANERCEPT,Protein,CHEMBL1201572,4.0,"['NCT02489760', 'NCT01072058', 'NCT03504072', 'NCT02638896']",EFO_0005755,rheumatic disease
817,OPRM1,opioid receptor mu 1,TAPENTADOL,Small molecule,CHEMBL1201776,4.0,['NCT01631513'],EFO_0005755,rheumatic disease
818,PTGS2,prostaglandin-endoperoxide synthase 2,FENOPROFEN,Small molecule,CHEMBL1297,4.0,[],EFO_0005755,rheumatic disease
819,PTGS1,prostaglandin-endoperoxide synthase 1,SULFASALAZINE,Small molecule,CHEMBL421,4.0,['NCT03739853'],EFO_0005755,rheumatic disease
820,PTGS2,prostaglandin-endoperoxide synthase 2,LORNOXICAM,Small molecule,CHEMBL1569487,4.0,[],EFO_0005755,rheumatic disease
821,PTGS2,prostaglandin-endoperoxide synthase 2,ETODOLAC,Small molecule,CHEMBL622,4.0,[],EFO_0005755,rheumatic disease
822,PTGS2,prostaglandin-endoperoxide synthase 2,IGURATIMOD,Small molecule,CHEMBL2107455,4.0,['NCT05803135'],EFO_0005755,rheumatic disease
823,ADRB3,adrenoceptor beta 3,EPINEPHRINE,Small molecule,CHEMBL679,4.0,"['NCT02464176', 'NCT03513276']",EFO_0005755,rheumatic disease
824,PTGS2,prostaglandin-endoperoxide synthase 2,CELECOXIB,Small molecule,CHEMBL118,4.0,['NCT02355236'],EFO_0005755,rheumatic disease
825,SCN9A,sodium voltage-gated channel alpha subunit 9,LIDOCAINE,Small molecule,CHEMBL79,4.0,['NCT03540030'],EFO_0005755,rheumatic disease
826,TNF,tumor necrosis factor,GOLIMUMAB,Antibody,CHEMBL1201833,4.0,['NCT05164198'],EFO_0005755,rheumatic disease
827,OPRK1,opioid receptor kappa 1,CODEINE,Small molecule,CHEMBL485,4.0,"['NCT02501564', 'NCT00324038']",EFO_0005755,rheumatic disease
828,SCN3A,sodium voltage-gated channel alpha subunit 3,LIDOCAINE,Small molecule,CHEMBL79,4.0,[],EFO_0005755,rheumatic disease
829,TLR9,toll like receptor 9,HYDROXYCHLOROQUINE,Small molecule,CHEMBL1535,4.0,"['NCT00413361', 'NCT03122431']",EFO_0005755,rheumatic disease
830,PTGS1,prostaglandin-endoperoxide synthase 1,FENOPROFEN,Small molecule,CHEMBL1297,4.0,[],EFO_0005755,rheumatic disease
831,NR3C1,nuclear receptor subfamily 3 group C member 1,TRIAMCINOLONE,Small molecule,CHEMBL1451,4.0,['NCT05220527'],EFO_0005755,rheumatic disease
832,CUL4A,cullin 4A,LENALIDOMIDE,Small molecule,CHEMBL848,4.0,['NCT01408199'],EFO_0005755,rheumatic disease
833,GABRG3,gamma-aminobutyric acid type A receptor subunit gamma3,SEVOFLURANE,Small molecule,CHEMBL1200694,4.0,['NCT03540030'],EFO_0005755,rheumatic disease
834,PTGS2,prostaglandin-endoperoxide synthase 2,DICLOFENAC POTASSIUM,Small molecule,CHEMBL1200804,4.0,[],EFO_0005755,rheumatic disease
835,SCN3A,sodium voltage-gated channel alpha subunit 3,ROPIVACAINE,Small molecule,CHEMBL1077896,4.0,['NCT05336968'],EFO_0005755,rheumatic disease
836,PDE4B,phosphodiesterase 4B,APREMILAST,Small molecule,CHEMBL514800,4.0,['NCT03783026'],EFO_0005755,rheumatic disease
837,NDUFB3,NADH:ubiquinone oxidoreductase subunit B3,METFORMIN,Small molecule,CHEMBL1431,4.0,['NCT02741960'],EFO_0005755,rheumatic disease
838,NDUFB10,NADH:ubiquinone oxidoreductase subunit B10,METFORMIN,Small molecule,CHEMBL1431,4.0,['NCT02741960'],EFO_0005755,rheumatic disease
839,PTGS2,prostaglandin-endoperoxide synthase 2,MECLOFENAMIC ACID,Small molecule,CHEMBL509,4.0,[],EFO_0005755,rheumatic disease
840,KCNK2,potassium two pore domain channel subfamily K member 2,DESFLURANE,Small molecule,CHEMBL1200733,4.0,['NCT03540030'],EFO_0005755,rheumatic disease
841,PTGS2,prostaglandin-endoperoxide synthase 2,ASPIRIN,Small molecule,CHEMBL25,4.0,['NCT03558854'],EFO_0005755,rheumatic disease
842,PTGS2,prostaglandin-endoperoxide synthase 2,MELOXICAM,Small molecule,CHEMBL599,4.0,['NCT03473665'],EFO_0005755,rheumatic disease
843,PTGS2,prostaglandin-endoperoxide synthase 2,DICLOFENAC SODIUM,Small molecule,CHEMBL1034,4.0,[],EFO_0005755,rheumatic disease
844,ALOX5,arachidonate 5-lipoxygenase,MECLOFENAMATE SODIUM,Small molecule,CHEMBL1562610,4.0,[],EFO_0005755,rheumatic disease
845,JAK3,Janus kinase 3,TOFACITINIB,Small molecule,CHEMBL221959,4.0,['NCT05803135'],EFO_0005755,rheumatic disease
846,SCN7A,sodium voltage-gated channel alpha subunit 7,ROPIVACAINE,Small molecule,CHEMBL1077896,4.0,"['NCT03513276', 'NCT03801265']",EFO_0005755,rheumatic disease
847,CD80,CD80 molecule,ABATACEPT,Protein,CHEMBL1201823,4.0,['NCT01717846'],EFO_0005755,rheumatic disease
848,GABRA3,gamma-aminobutyric acid type A receptor subunit alpha3,MIDAZOLAM,Small molecule,CHEMBL655,4.0,['NCT02292082'],EFO_0005755,rheumatic disease
849,SCN4A,sodium voltage-gated channel alpha subunit 4,LIDOCAINE,Small molecule,CHEMBL79,4.0,['NCT02102620'],EFO_0005755,rheumatic disease
850,NDUFA8,NADH:ubiquinone oxidoreductase subunit A8,METFORMIN,Small molecule,CHEMBL1431,4.0,['NCT02741960'],EFO_0005755,rheumatic disease
851,SCN4A,sodium voltage-gated channel alpha subunit 4,BUPIVACAINE,Small molecule,CHEMBL1098,4.0,['NCT04257682'],EFO_0005755,rheumatic disease
852,PTGS1,prostaglandin-endoperoxide synthase 1,INDOPROFEN,Small molecule,CHEMBL15870,4.0,[],EFO_0005755,rheumatic disease
853,PTGS2,prostaglandin-endoperoxide synthase 2,SULFASALAZINE,Small molecule,CHEMBL421,4.0,['NCT03739853'],EFO_0005755,rheumatic disease
854,PTGS1,prostaglandin-endoperoxide synthase 1,KETOROLAC,Small molecule,CHEMBL469,4.0,"['NCT00562627', 'NCT00901628']",EFO_0005755,rheumatic disease
855,PTGS1,prostaglandin-endoperoxide synthase 1,SULFASALAZINE,Small molecule,CHEMBL421,4.0,['NCT02638896'],EFO_0005755,rheumatic disease
856,ADRA2B,adrenoceptor alpha 2B,EPINEPHRINE,Small molecule,CHEMBL679,4.0,"['NCT02365727', 'NCT02765815']",EFO_0005755,rheumatic disease
857,SLC22A8,solute carrier family 22 member 8,PROBENECID,Small molecule,CHEMBL897,4.0,[],EFO_0005755,rheumatic disease
858,NDUFB2,NADH:ubiquinone oxidoreductase subunit B2,METFORMIN,Small molecule,CHEMBL1431,4.0,['NCT02741960'],EFO_0005755,rheumatic disease
859,TNF,tumor necrosis factor,INFLIXIMAB,Antibody,CHEMBL1201581,4.0,"['NCT03100253', 'NCT02353780', 'NCT01602302']",EFO_0005755,rheumatic disease
860,PTGS1,prostaglandin-endoperoxide synthase 1,NAPROXEN,Small molecule,CHEMBL154,4.0,"['NCT02451748', 'NCT00157872', 'NCT00650455', 'NCT00346216']",EFO_0005755,rheumatic disease
861,CD86,CD86 molecule,ABATACEPT,Protein,CHEMBL1201823,4.0,[],EFO_0005755,rheumatic disease
862,PTGS2,prostaglandin-endoperoxide synthase 2,SULFASALAZINE,Small molecule,CHEMBL421,4.0,[],EFO_0005755,rheumatic disease
863,PTGS1,prostaglandin-endoperoxide synthase 1,APAZONE,Small molecule,CHEMBL1565476,4.0,[],EFO_0005755,rheumatic disease
864,XDH,xanthine dehydrogenase,ALLOPURINOL,Small molecule,CHEMBL1467,4.0,['NCT03336203'],EFO_0005755,rheumatic disease
865,ADRA2B,adrenoceptor alpha 2B,CLONIDINE,Small molecule,CHEMBL134,4.0,['NCT03119038'],EFO_0005755,rheumatic disease
866,ALOX5,arachidonate 5-lipoxygenase,MECLOFENAMIC ACID,Small molecule,CHEMBL509,4.0,[],EFO_0005755,rheumatic disease
867,SCN5A,sodium voltage-gated channel alpha subunit 5,LIDOCAINE,Small molecule,CHEMBL79,4.0,['NCT04143165'],EFO_0005755,rheumatic disease
868,ALOX5,arachidonate 5-lipoxygenase,SULFASALAZINE,Small molecule,CHEMBL421,4.0,['NCT02714634'],EFO_0005755,rheumatic disease
869,DHFR,dihydrofolate reductase,METHOTREXATE,Small molecule,CHEMBL34259,4.0,['NCT04314193'],EFO_0005755,rheumatic disease
870,MIF,macrophage migration inhibitory factor,IGURATIMOD,Small molecule,CHEMBL2107455,4.0,['NCT03855007'],EFO_0005755,rheumatic disease
871,GABRA5,gamma-aminobutyric acid type A receptor subunit alpha5,REMIMAZOLAM,Small molecule,CHEMBL4297526,4.0,['NCT05760534'],EFO_0005755,rheumatic disease
872,JAK1,Janus kinase 1,TOFACITINIB CITRATE,Small molecule,CHEMBL2103743,4.0,['NCT02157012'],EFO_0005755,rheumatic disease
873,PTGS1,prostaglandin-endoperoxide synthase 1,INDOMETHACIN,Small molecule,CHEMBL6,4.0,[],EFO_0005755,rheumatic disease
874,CHRNG,cholinergic receptor nicotinic gamma subunit,ROCURONIUM,Small molecule,CHEMBL1201244,4.0,['NCT03540030'],EFO_0005755,rheumatic disease
875,PTGS1,prostaglandin-endoperoxide synthase 1,KETOROLAC,Small molecule,CHEMBL469,4.0,['NCT02612272'],EFO_0005755,rheumatic disease
876,TYK2,tyrosine kinase 2,TOFACITINIB,Small molecule,CHEMBL221959,4.0,['NCT03504072'],EFO_0005755,rheumatic disease
877,JAK1,Janus kinase 1,TOFACITINIB,Small molecule,CHEMBL221959,4.0,[],EFO_0005755,rheumatic disease
878,SCN4A,sodium voltage-gated channel alpha subunit 4,BUPIVACAINE,Small molecule,CHEMBL1098,4.0,"['NCT03948386', 'NCT02464176', 'NCT03090152', 'NCT02086474']",EFO_0005755,rheumatic disease
879,NR3C1,nuclear receptor subfamily 3 group C member 1,TRIAMCINOLONE HEXACETONIDE,Small molecule,CHEMBL1200878,4.0,['NCT02437461'],EFO_0005755,rheumatic disease
880,PTGS1,prostaglandin-endoperoxide synthase 1,IBUPROFEN,Small molecule,CHEMBL521,4.0,[],EFO_0005755,rheumatic disease
881,GABRG2,gamma-aminobutyric acid type A receptor subunit gamma2,REMIMAZOLAM,Small molecule,CHEMBL4297526,4.0,['NCT05760534'],EFO_0005755,rheumatic disease
882,SERPINC1,serpin family C member 1,ENOXAPARIN SODIUM,Oligosaccharide,CHEMBL1201476,4.0,['NCT02865174'],EFO_0005755,rheumatic disease
883,SCN3A,sodium voltage-gated channel alpha subunit 3,LIDOCAINE,Small molecule,CHEMBL79,4.0,['NCT04143165'],EFO_0005755,rheumatic disease
884,PTGS2,prostaglandin-endoperoxide synthase 2,INDOMETHACIN,Small molecule,CHEMBL6,4.0,['NCT00142558'],EFO_0005755,rheumatic disease
885,PTGS1,prostaglandin-endoperoxide synthase 1,ALCLOFENAC,Small molecule,CHEMBL94081,4.0,[],EFO_0005755,rheumatic disease
886,SCN8A,sodium voltage-gated channel alpha subunit 8,ROPIVACAINE,Small molecule,CHEMBL1077896,4.0,"['NCT03513276', 'NCT03801265']",EFO_0005755,rheumatic disease
887,TNF,tumor necrosis factor,ADALIMUMAB,Antibody,CHEMBL1201580,4.0,[],EFO_0005755,rheumatic disease
888,PTGS1,prostaglandin-endoperoxide synthase 1,ASPIRIN,Small molecule,CHEMBL25,4.0,['NCT03558854'],EFO_0005755,rheumatic disease
889,ADRB1,adrenoceptor beta 1,EPINEPHRINE,Small molecule,CHEMBL679,4.0,"['NCT02658149', 'NCT02697955']",EFO_0005755,rheumatic disease
890,VDR,vitamin D receptor,CHOLECALCIFEROL,Small molecule,CHEMBL1042,4.0,['NCT00599807'],EFO_0005755,rheumatic disease
891,ATP4A,ATPase H+/K+ transporting subunit alpha,OMEPRAZOLE,Small molecule,CHEMBL1503,4.0,['NCT00141102'],EFO_0005755,rheumatic disease
892,TYK2,tyrosine kinase 2,TOFACITINIB,Small molecule,CHEMBL221959,4.0,[],EFO_0005755,rheumatic disease
893,SCN10A,sodium voltage-gated channel alpha subunit 10,ROPIVACAINE,Small molecule,CHEMBL1077896,4.0,['NCT03119038'],EFO_0005755,rheumatic disease
894,SCN3A,sodium voltage-gated channel alpha subunit 3,LIDOCAINE,Small molecule,CHEMBL79,4.0,[],EFO_0005755,rheumatic disease
895,PTGS2,prostaglandin-endoperoxide synthase 2,IGURATIMOD,Small molecule,CHEMBL2107455,4.0,['NCT01554917'],EFO_0005755,rheumatic disease
896,KCNK9,potassium two pore domain channel subfamily K member 9,SEVOFLURANE,Small molecule,CHEMBL1200694,4.0,['NCT03540030'],EFO_0005755,rheumatic disease
897,ADRA1A,adrenoceptor alpha 1A,EPINEPHRINE,Small molecule,CHEMBL679,4.0,"['NCT02765815', 'NCT02365727']",EFO_0005755,rheumatic disease
898,KCNK3,potassium two pore domain channel subfamily K member 3,DESFLURANE,Small molecule,CHEMBL1200733,4.0,['NCT03540030'],EFO_0005755,rheumatic disease
899,CUL4A,cullin 4A,THALIDOMIDE,Small molecule,CHEMBL468,4.0,['NCT05527444'],EFO_0005755,rheumatic disease
900,JAK3,Janus kinase 3,TOFACITINIB,Small molecule,CHEMBL221959,4.0,['NCT05080218'],EFO_0005755,rheumatic disease
901,GABRA6,gamma-aminobutyric acid type A receptor subunit alpha6,SEVOFLURANE,Small molecule,CHEMBL1200694,4.0,['NCT03540030'],EFO_0005755,rheumatic disease
902,ESR2,estrogen receptor 2,"ESTROGENS, CONJUGATED",Small molecule,CHEMBL1201649,4.0,['NCT00392093'],EFO_0005755,rheumatic disease
903,TUBB2A,tubulin beta 2A class IIa,COLCHICINE,Small molecule,CHEMBL107,4.0,[],EFO_0005755,rheumatic disease
904,PTGS1,prostaglandin-endoperoxide synthase 1,SULFASALAZINE,Small molecule,CHEMBL421,4.0,['NCT04077957'],EFO_0005755,rheumatic disease
905,TUBB6,tubulin beta 6 class V,COLCHICINE,Small molecule,CHEMBL107,4.0,['NCT03913442'],EFO_0005755,rheumatic disease
906,SCN7A,sodium voltage-gated channel alpha subunit 7,ROPIVACAINE,Small molecule,CHEMBL1077896,4.0,['NCT03219983'],EFO_0005755,rheumatic disease
907,PTGS2,prostaglandin-endoperoxide synthase 2,NAPROXEN,Small molecule,CHEMBL154,4.0,[],EFO_0005755,rheumatic disease
908,TUBB6,tubulin beta 6 class V,COLCHICINE,Small molecule,CHEMBL107,4.0,['NCT05698680'],EFO_0005755,rheumatic disease
909,ALOX5,arachidonate 5-lipoxygenase,MECLOFENAMATE SODIUM,Small molecule,CHEMBL1562610,4.0,[],EFO_0005755,rheumatic disease
910,TRPA1,transient receptor potential cation channel subfamily A member 1,MENTHOL,Small molecule,CHEMBL256087,4.0,[],EFO_0005755,rheumatic disease
911,SCN8A,sodium voltage-gated channel alpha subunit 8,ROPIVACAINE,Small molecule,CHEMBL1077896,4.0,['NCT04257682'],EFO_0005755,rheumatic disease
912,SCN2A,sodium voltage-gated channel alpha subunit 2,ROPIVACAINE,Small molecule,CHEMBL1077896,4.0,['NCT04257682'],EFO_0005755,rheumatic disease
913,SCN2A,sodium voltage-gated channel alpha subunit 2,ROPIVACAINE,Small molecule,CHEMBL1077896,4.0,"['NCT02658149', 'NCT02576249', 'NCT01537146', 'NCT02365181', 'NCT00620828']",EFO_0005755,rheumatic disease
914,PDE4D,phosphodiesterase 4D,ROFLUMILAST,Small molecule,CHEMBL193240,4.0,['NCT01830959'],EFO_0005755,rheumatic disease
915,PDE4A,phosphodiesterase 4A,APREMILAST,Small molecule,CHEMBL514800,4.0,['NCT03747939'],EFO_0005755,rheumatic disease
916,SCN9A,sodium voltage-gated channel alpha subunit 9,LIDOCAINE,Small molecule,CHEMBL79,4.0,['NCT04143165'],EFO_0005755,rheumatic disease
917,NR3C1,nuclear receptor subfamily 3 group C member 1,METHYLPREDNISOLONE,Small molecule,CHEMBL650,4.0,['NCT03797872'],EFO_0005755,rheumatic disease
918,FGFR1,fibroblast growth factor receptor 1,NINTEDANIB ESYLATE,Small molecule,CHEMBL3039504,4.0,[],EFO_0005755,rheumatic disease
919,SCN9A,sodium voltage-gated channel alpha subunit 9,ROPIVACAINE,Small molecule,CHEMBL1077896,4.0,"['NCT00901628', 'NCT00562627', 'NCT02863120']",EFO_0005755,rheumatic disease
920,CD80,CD80 molecule,ABATACEPT,Protein,CHEMBL1201823,4.0,"['NCT02353780', 'NCT01602302']",EFO_0005755,rheumatic disease
921,SCN1A,sodium voltage-gated channel alpha subunit 1,ROPIVACAINE,Small molecule,CHEMBL1077896,4.0,"['NCT00562627', 'NCT00901628', 'NCT02863120']",EFO_0005755,rheumatic disease
922,TRAF3IP2,TRAF3 interacting protein 2,IGURATIMOD,Small molecule,CHEMBL2107455,4.0,"['NCT05626348', 'NCT04928066']",EFO_0005755,rheumatic disease
923,ADRA2B,adrenoceptor alpha 2B,CLONIDINE,Small molecule,CHEMBL134,4.0,['NCT02570503'],EFO_0005755,rheumatic disease
924,TNF,tumor necrosis factor,CERTOLIZUMAB PEGOL,Antibody,CHEMBL1201831,4.0,"['NCT01491815', 'NCT02466581']",EFO_0005755,rheumatic disease
925,NDUFB11,NADH:ubiquinone oxidoreductase subunit B11,METFORMIN,Small molecule,CHEMBL1431,4.0,['NCT02741960'],EFO_0005755,rheumatic disease
926,MT-ND2,mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 2,METFORMIN,Small molecule,CHEMBL1431,4.0,['NCT02741960'],EFO_0005755,rheumatic disease
927,ADRA1B,adrenoceptor alpha 1B,EPINEPHRINE,Small molecule,CHEMBL679,4.0,['NCT02570503'],EFO_0005755,rheumatic disease
928,PDE4B,phosphodiesterase 4B,ROFLUMILAST,Small molecule,CHEMBL193240,4.0,['NCT01830959'],EFO_0005755,rheumatic disease
929,NR3C1,nuclear receptor subfamily 3 group C member 1,PREDNISONE,Small molecule,CHEMBL635,4.0,['NCT04928066'],EFO_0005755,rheumatic disease
930,NR3C1,nuclear receptor subfamily 3 group C member 1,DEXAMETHASONE,Small molecule,CHEMBL384467,4.0,[],EFO_0005755,rheumatic disease
931,GABRG3,gamma-aminobutyric acid type A receptor subunit gamma3,DESFLURANE,Small molecule,CHEMBL1200733,4.0,['NCT03540030'],EFO_0005755,rheumatic disease
932,CACNA2D1,calcium voltage-gated channel auxiliary subunit alpha2delta 1,PREGABALIN,Small molecule,CHEMBL1059,4.0,['NCT02612233'],EFO_0005755,rheumatic disease
933,TNF,tumor necrosis factor,ETANERCEPT,Protein,CHEMBL1201572,4.0,"['NCT01927757', 'NCT00796705', 'NCT01783015', 'NCT03100253', 'NCT00706797', 'NCT02353780', 'NCT01602302']",EFO_0005755,rheumatic disease
934,PTGS1,prostaglandin-endoperoxide synthase 1,DICLOFENAC POTASSIUM,Small molecule,CHEMBL1200804,4.0,[],EFO_0005755,rheumatic disease
935,SCN11A,sodium voltage-gated channel alpha subunit 11,ROPIVACAINE,Small molecule,CHEMBL1077896,4.0,['NCT03119038'],EFO_0005755,rheumatic disease
936,SCN4A,sodium voltage-gated channel alpha subunit 4,ROPIVACAINE,Small molecule,CHEMBL1077896,4.0,['NCT02570503'],EFO_0005755,rheumatic disease
937,PTGS2,prostaglandin-endoperoxide synthase 2,ETORICOXIB,Small molecule,CHEMBL416146,4.0,['NCT01429168'],EFO_0005755,rheumatic disease
938,TNFSF13B,TNF superfamily member 13b,BELIMUMAB,Antibody,CHEMBL1789843,4.0,[],EFO_0005755,rheumatic disease
939,PTGS2,prostaglandin-endoperoxide synthase 2,IBUPROFEN,Small molecule,CHEMBL521,4.0,[],EFO_0005755,rheumatic disease
940,SCN4A,sodium voltage-gated channel alpha subunit 4,ROPIVACAINE,Small molecule,CHEMBL1077896,4.0,['NCT04257682'],EFO_0005755,rheumatic disease
941,SCN9A,sodium voltage-gated channel alpha subunit 9,MEPIVACAINE,Small molecule,CHEMBL1087,4.0,['NCT04257682'],EFO_0005755,rheumatic disease
942,NR3C1,nuclear receptor subfamily 3 group C member 1,PREDNISONE,Small molecule,CHEMBL635,4.0,['NCT05666336'],EFO_0005755,rheumatic disease
943,PPAT,phosphoribosyl pyrophosphate amidotransferase,AZATHIOPRINE,Small molecule,CHEMBL1542,4.0,[],EFO_0005755,rheumatic disease
944,XDH,xanthine dehydrogenase,FEBUXOSTAT,Small molecule,CHEMBL1164729,4.0,['NCT03336203'],EFO_0005755,rheumatic disease
945,PTGS2,prostaglandin-endoperoxide synthase 2,TOLMETIN,Small molecule,CHEMBL1020,4.0,[],EFO_0005755,rheumatic disease
946,PTGS2,prostaglandin-endoperoxide synthase 2,SULINDAC,Small molecule,CHEMBL15770,4.0,[],EFO_0005755,rheumatic disease
947,NR3C1,nuclear receptor subfamily 3 group C member 1,DEXAMETHASONE,Small molecule,CHEMBL384467,4.0,[],EFO_0005755,rheumatic disease
948,SCN2A,sodium voltage-gated channel alpha subunit 2,ROPIVACAINE,Small molecule,CHEMBL1077896,4.0,"['NCT03513276', 'NCT03801265']",EFO_0005755,rheumatic disease
949,KCNK9,potassium two pore domain channel subfamily K member 9,DESFLURANE,Small molecule,CHEMBL1200733,4.0,['NCT03540030'],EFO_0005755,rheumatic disease
950,PTGS2,prostaglandin-endoperoxide synthase 2,INDOMETHACIN,Small molecule,CHEMBL6,4.0,['NCT03473665'],EFO_0005755,rheumatic disease
951,PTGS1,prostaglandin-endoperoxide synthase 1,OXAPROZIN,Small molecule,CHEMBL1071,4.0,[],EFO_0005755,rheumatic disease
952,SCN4A,sodium voltage-gated channel alpha subunit 4,BUPIVACAINE,Small molecule,CHEMBL1098,4.0,['NCT03375112'],EFO_0005755,rheumatic disease
953,GLRA1,glycine receptor alpha 1,SEVOFLURANE,Small molecule,CHEMBL1200694,4.0,['NCT03540030'],EFO_0005755,rheumatic disease
954,SCN8A,sodium voltage-gated channel alpha subunit 8,LIDOCAINE,Small molecule,CHEMBL79,4.0,['NCT04143165'],EFO_0005755,rheumatic disease
955,SCN5A,sodium voltage-gated channel alpha subunit 5,ROPIVACAINE,Small molecule,CHEMBL1077896,4.0,['NCT03119038'],EFO_0005755,rheumatic disease
956,MC2R,melanocortin 2 receptor,CORTICOTROPIN,Protein,CHEMBL1201610,4.0,"['NCT02298491', 'NCT03320070']",EFO_0005755,rheumatic disease
957,MC2R,melanocortin 2 receptor,CORTICOTROPIN,Protein,CHEMBL1201610,4.0,"['NCT01769937', 'NCT01753401', 'NCT02953821']",EFO_0005755,rheumatic disease
958,PTGS2,prostaglandin-endoperoxide synthase 2,FENOPROFEN,Small molecule,CHEMBL1297,4.0,[],EFO_0005755,rheumatic disease
959,SCN7A,sodium voltage-gated channel alpha subunit 7,ROPIVACAINE,Small molecule,CHEMBL1077896,4.0,['NCT05336968'],EFO_0005755,rheumatic disease
960,NR3C1,nuclear receptor subfamily 3 group C member 1,TRIAMCINOLONE,Small molecule,CHEMBL1451,4.0,['NCT02451748'],EFO_0005755,rheumatic disease
961,PTGS2,prostaglandin-endoperoxide synthase 2,TOLMETIN,Small molecule,CHEMBL1020,4.0,[],EFO_0005755,rheumatic disease
962,TNF,tumor necrosis factor,ADALIMUMAB,Antibody,CHEMBL1201580,4.0,['NCT05164198'],EFO_0005755,rheumatic disease
963,SCN11A,sodium voltage-gated channel alpha subunit 11,MEPIVACAINE,Small molecule,CHEMBL1087,4.0,['NCT04257682'],EFO_0005755,rheumatic disease
964,SCN4A,sodium voltage-gated channel alpha subunit 4,LIDOCAINE,Small molecule,CHEMBL79,4.0,['NCT03540030'],EFO_0005755,rheumatic disease
965,PTGS1,prostaglandin-endoperoxide synthase 1,NAPROXEN,Small molecule,CHEMBL154,4.0,[],EFO_0005755,rheumatic disease
966,GABRA5,gamma-aminobutyric acid type A receptor subunit alpha5,SEVOFLURANE,Small molecule,CHEMBL1200694,4.0,['NCT03540030'],EFO_0005755,rheumatic disease
967,GABRQ,gamma-aminobutyric acid type A receptor subunit theta,DESFLURANE,Small molecule,CHEMBL1200733,4.0,['NCT03540030'],EFO_0005755,rheumatic disease
968,PTGS2,prostaglandin-endoperoxide synthase 2,ETODOLAC,Small molecule,CHEMBL622,4.0,[],EFO_0005755,rheumatic disease
969,SERPINC1,serpin family C member 1,HEPARIN SODIUM,Oligosaccharide,CHEMBL1201657,4.0,['NCT00253851'],EFO_0005755,rheumatic disease
970,TRPM8,transient receptor potential cation channel subfamily M member 8,MENTHOL,Small molecule,CHEMBL256087,4.0,[],EFO_0005755,rheumatic disease
971,PTGS2,prostaglandin-endoperoxide synthase 2,SULFASALAZINE,Small molecule,CHEMBL421,4.0,['NCT00637780'],EFO_0005755,rheumatic disease
972,NR3C1,nuclear receptor subfamily 3 group C member 1,PREDNISOLONE,Small molecule,CHEMBL131,4.0,[],EFO_0005755,rheumatic disease
973,NR3C1,nuclear receptor subfamily 3 group C member 1,TRIAMCINOLONE,Small molecule,CHEMBL1451,4.0,['NCT03797872'],EFO_0005755,rheumatic disease
974,PTGS2,prostaglandin-endoperoxide synthase 2,ETORICOXIB,Small molecule,CHEMBL416146,4.0,[],EFO_0005755,rheumatic disease
975,XDH,xanthine dehydrogenase,ALLOPURINOL,Small molecule,CHEMBL1467,4.0,"['NCT01451645', 'NCT01391325', 'NCT02500641', 'NCT01988402', 'NCT01310673']",EFO_0005755,rheumatic disease
976,PTGS2,prostaglandin-endoperoxide synthase 2,OXYPHENBUTAZONE,Small molecule,CHEMBL3989676,4.0,[],EFO_0005755,rheumatic disease
977,SCN3A,sodium voltage-gated channel alpha subunit 3,MEPIVACAINE,Small molecule,CHEMBL1087,4.0,['NCT02384915'],EFO_0005755,rheumatic disease
978,PDE4D,phosphodiesterase 4D,APREMILAST,Small molecule,CHEMBL514800,4.0,[],EFO_0005755,rheumatic disease
979,PTGS2,prostaglandin-endoperoxide synthase 2,NAPROXEN,Small molecule,CHEMBL154,4.0,['NCT00643799'],EFO_0005755,rheumatic disease
980,FGA,fibrinogen alpha chain,"FIBRINOGEN, HUMAN",Unknown,CHEMBL2109072,4.0,['NCT01235715'],EFO_0005755,rheumatic disease
981,NR3C1,nuclear receptor subfamily 3 group C member 1,PREDNISOLONE,Small molecule,CHEMBL131,4.0,[],EFO_0005755,rheumatic disease
982,ALOX5,arachidonate 5-lipoxygenase,SULFASALAZINE,Small molecule,CHEMBL421,4.0,['NCT00908089'],EFO_0005755,rheumatic disease
983,PTGS2,prostaglandin-endoperoxide synthase 2,OXAPROZIN,Small molecule,CHEMBL1071,4.0,[],EFO_0005755,rheumatic disease
984,NDUFB5,NADH:ubiquinone oxidoreductase subunit B5,METFORMIN,Small molecule,CHEMBL1431,4.0,['NCT02741960'],EFO_0005755,rheumatic disease
985,TNF,tumor necrosis factor,ETANERCEPT,Protein,CHEMBL1201572,4.0,"['NCT02242474', 'NCT01793519', 'NCT02878161', 'NCT00523692']",EFO_0005755,rheumatic disease
986,PTGS2,prostaglandin-endoperoxide synthase 2,IBUPROFEN,Small molecule,CHEMBL521,4.0,[],EFO_0005755,rheumatic disease
987,CACNA2D1,calcium voltage-gated channel auxiliary subunit alpha2delta 1,PREGABALIN,Small molecule,CHEMBL1059,4.0,['NCT05447364'],EFO_0005755,rheumatic disease
988,XDH,xanthine dehydrogenase,ALLOPURINOL,Small molecule,CHEMBL1467,4.0,[],EFO_0005755,rheumatic disease
989,TLR7,toll like receptor 7,HYDROXYCHLOROQUINE,Small molecule,CHEMBL1535,4.0,['NCT03122431'],EFO_0005755,rheumatic disease
990,SCN11A,sodium voltage-gated channel alpha subunit 11,ROPIVACAINE,Small molecule,CHEMBL1077896,4.0,"['NCT02863120', 'NCT00562627', 'NCT00901628']",EFO_0005755,rheumatic disease
991,PTGS1,prostaglandin-endoperoxide synthase 1,NAPROXEN,Small molecule,CHEMBL154,4.0,"['NCT01994226', 'NCT02500641']",EFO_0005755,rheumatic disease
992,PTGS1,prostaglandin-endoperoxide synthase 1,TOLMETIN,Small molecule,CHEMBL1020,4.0,[],EFO_0005755,rheumatic disease
993,NR3C1,nuclear receptor subfamily 3 group C member 1,TRIAMCINOLONE,Small molecule,CHEMBL1451,4.0,"['NCT00731289', 'NCT01335321']",EFO_0005755,rheumatic disease
994,HRH1,histamine receptor H1,DIPHENHYDRAMINE,Small molecule,CHEMBL657,4.0,['NCT01382940'],EFO_0005755,rheumatic disease
995,PTGS2,prostaglandin-endoperoxide synthase 2,PIRPROFEN,Small molecule,CHEMBL188952,4.0,[],EFO_0005755,rheumatic disease
996,JAK2,Janus kinase 2,BARICITINIB,Small molecule,CHEMBL2105759,4.0,['NCT05300932'],EFO_0005755,rheumatic disease
997,ATP4A,ATPase H+/K+ transporting subunit alpha,ESOMEPRAZOLE MAGNESIUM,Small molecule,CHEMBL2146133,4.0,[],EFO_0005755,rheumatic disease
998,SCN9A,sodium voltage-gated channel alpha subunit 9,PRILOCAINE,Small molecule,CHEMBL1194,4.0,['NCT02384915'],EFO_0005755,rheumatic disease
999,PTGS2,prostaglandin-endoperoxide synthase 2,SULINDAC,Small molecule,CHEMBL15770,4.0,[],EFO_0005755,rheumatic disease
1000,PTGS1,prostaglandin-endoperoxide synthase 1,SULFASALAZINE,Small molecule,CHEMBL421,4.0,['NCT01659242'],EFO_0005755,rheumatic disease
1001,SCN11A,sodium voltage-gated channel alpha subunit 11,LIDOCAINE HYDROCHLORIDE,Small molecule,CHEMBL1200409,4.0,['NCT05670236'],EFO_0005755,rheumatic disease
1002,TNF,tumor necrosis factor,ETANERCEPT,Protein,CHEMBL1201572,4.0,[],EFO_0005755,rheumatic disease
1003,PTGS2,prostaglandin-endoperoxide synthase 2,DEXIBUPROFEN,Small molecule,CHEMBL175,4.0,['NCT01066676'],EFO_0005755,rheumatic disease
1004,TRPV1,transient receptor potential cation channel subfamily V member 1,CAPSAICIN,Small molecule,CHEMBL294199,4.0,['NCT03124407'],EFO_0005755,rheumatic disease
1005,NR3C1,nuclear receptor subfamily 3 group C member 1,DEXAMETHASONE,Small molecule,CHEMBL384467,4.0,['NCT02760459'],EFO_0005755,rheumatic disease
1006,HTR3E,5-hydroxytryptamine receptor 3E,RAMOSETRON,Small molecule,CHEMBL1643895,4.0,['NCT01102491'],EFO_0005755,rheumatic disease
1007,MT-ND4L,mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 4L,METFORMIN,Small molecule,CHEMBL1431,4.0,['NCT02741960'],EFO_0005755,rheumatic disease
1008,SCN2A,sodium voltage-gated channel alpha subunit 2,ROPIVACAINE,Small molecule,CHEMBL1077896,4.0,['NCT03119038'],EFO_0005755,rheumatic disease
1009,PTGS1,prostaglandin-endoperoxide synthase 1,NAPROXEN,Small molecule,CHEMBL154,4.0,[],EFO_0005755,rheumatic disease
1010,TUBB1,tubulin beta 1 class VI,COLCHICINE,Small molecule,CHEMBL107,4.0,[],EFO_0005755,rheumatic disease
1011,NR3C1,nuclear receptor subfamily 3 group C member 1,TRIAMCINOLONE ACETONIDE,Small molecule,CHEMBL1504,4.0,['NCT03166761'],EFO_0005755,rheumatic disease
1012,MC2R,melanocortin 2 receptor,CORTICOTROPIN,Protein,CHEMBL1201610,4.0,"['NCT02919761', 'NCT01966718', 'NCT01948388']",EFO_0005755,rheumatic disease
1013,PTGS1,prostaglandin-endoperoxide synthase 1,NAPROXEN,Small molecule,CHEMBL154,4.0,[],EFO_0005755,rheumatic disease
1014,PTGS2,prostaglandin-endoperoxide synthase 2,KETOROLAC,Small molecule,CHEMBL469,4.0,['NCT05336968'],EFO_0005755,rheumatic disease
1015,SCN1A,sodium voltage-gated channel alpha subunit 1,ROPIVACAINE,Small molecule,CHEMBL1077896,4.0,['NCT05336968'],EFO_0005755,rheumatic disease
1016,SCN2A,sodium voltage-gated channel alpha subunit 2,MEPIVACAINE,Small molecule,CHEMBL1087,4.0,['NCT04257682'],EFO_0005755,rheumatic disease
1017,ADRA1D,adrenoceptor alpha 1D,EPINEPHRINE,Small molecule,CHEMBL679,4.0,['NCT02570503'],EFO_0005755,rheumatic disease
1018,KDR,kinase insert domain receptor,NINTEDANIB,Small molecule,CHEMBL502835,4.0,[],EFO_0005755,rheumatic disease
1019,TNF,tumor necrosis factor,ADALIMUMAB,Antibody,CHEMBL1201580,4.0,[],EFO_0005755,rheumatic disease
1020,PTGS1,prostaglandin-endoperoxide synthase 1,DICLOFENAC,Small molecule,CHEMBL139,4.0,"['NCT01383954', 'NCT01860833']",EFO_0005755,rheumatic disease
1021,NR3C1,nuclear receptor subfamily 3 group C member 1,METHYLPREDNISOLONE,Small molecule,CHEMBL650,4.0,"['NCT00396747', 'NCT01308255', 'NCT01219933', 'NCT01000610', 'NCT01382940']",EFO_0005755,rheumatic disease
1022,TLR9,toll like receptor 9,HYDROXYCHLOROQUINE,Small molecule,CHEMBL1535,4.0,['NCT03122431'],EFO_0005755,rheumatic disease
1023,SCN1A,sodium voltage-gated channel alpha subunit 1,PRILOCAINE,Small molecule,CHEMBL1194,4.0,['NCT02384915'],EFO_0005755,rheumatic disease
1024,PDGFRA,platelet derived growth factor receptor alpha,NINTEDANIB,Small molecule,CHEMBL502835,4.0,[],EFO_0005755,rheumatic disease
1025,PTGS2,prostaglandin-endoperoxide synthase 2,MECLOFENAMIC ACID,Small molecule,CHEMBL509,4.0,[],EFO_0005755,rheumatic disease
1026,HMGCR,3-hydroxy-3-methylglutaryl-CoA reductase,ATORVASTATIN,Small molecule,CHEMBL1487,4.0,['NCT00356473'],EFO_0005755,rheumatic disease
1027,TNF,tumor necrosis factor,CERTOLIZUMAB PEGOL,Antibody,CHEMBL1201831,4.0,['NCT02242474'],EFO_0005755,rheumatic disease
1028,NR3C1,nuclear receptor subfamily 3 group C member 1,PREDNISONE,Small molecule,CHEMBL635,4.0,['NCT01169597'],EFO_0005755,rheumatic disease
1029,FKBP1A,FKBP prolyl isomerase 1A,TACROLIMUS,Small molecule,CHEMBL269732,4.0,"['NCT00319917', 'NCT01224041', 'NCT01224418', 'NCT03737708', 'NCT01511003', 'NCT01746680']",EFO_0005755,rheumatic disease
1030,PTGS2,prostaglandin-endoperoxide synthase 2,SULFASALAZINE,Small molecule,CHEMBL421,4.0,['NCT04077957'],EFO_0005755,rheumatic disease
1031,SCN10A,sodium voltage-gated channel alpha subunit 10,ROPIVACAINE,Small molecule,CHEMBL1077896,4.0,['NCT04257682'],EFO_0005755,rheumatic disease
1032,TNF,tumor necrosis factor,ADALIMUMAB,Antibody,CHEMBL1201580,4.0,"['NCT02814175', 'NCT03151551', 'NCT01465438']",EFO_0005755,rheumatic disease
1033,NDUFS8,NADH:ubiquinone oxidoreductase core subunit S8,METFORMIN,Small molecule,CHEMBL1431,4.0,['NCT02741960'],EFO_0005755,rheumatic disease
1034,SLC6A4,solute carrier family 6 member 4,MILNACIPRAN,Small molecule,CHEMBL259209,4.0,['NCT01329406'],EFO_0005755,rheumatic disease
1035,PTGS2,prostaglandin-endoperoxide synthase 2,ETORICOXIB,Small molecule,CHEMBL416146,4.0,['NCT04144101'],EFO_0005755,rheumatic disease
1036,DHODH,dihydroorotate dehydrogenase (quinone),LEFLUNOMIDE,Small molecule,CHEMBL960,4.0,"['NCT02714634', 'NCT05626348']",EFO_0005755,rheumatic disease
1037,SCN4A,sodium voltage-gated channel alpha subunit 4,ROPIVACAINE,Small molecule,CHEMBL1077896,4.0,['NCT03219983'],EFO_0005755,rheumatic disease
1038,SCN9A,sodium voltage-gated channel alpha subunit 9,MEPIVACAINE,Small molecule,CHEMBL1087,4.0,['NCT04257682'],EFO_0005755,rheumatic disease
1039,SCN4A,sodium voltage-gated channel alpha subunit 4,MEPIVACAINE,Small molecule,CHEMBL1087,4.0,['NCT04257682'],EFO_0005755,rheumatic disease
1040,MC2R,melanocortin 2 receptor,CORTICOTROPIN,Protein,CHEMBL1201610,4.0,['NCT01939132'],EFO_0005755,rheumatic disease
1041,PTGS2,prostaglandin-endoperoxide synthase 2,ETORICOXIB,Small molecule,CHEMBL416146,4.0,['NCT03582332'],EFO_0005755,rheumatic disease
1042,SCN2A,sodium voltage-gated channel alpha subunit 2,MEPIVACAINE,Small molecule,CHEMBL1087,4.0,['NCT04257682'],EFO_0005755,rheumatic disease
1043,ESR1,estrogen receptor 1,"ESTROGENS, CONJUGATED",Small molecule,CHEMBL1201649,4.0,['NCT00392093'],EFO_0005755,rheumatic disease
1044,FKBP1A,FKBP prolyl isomerase 1A,TACROLIMUS,Small molecule,CHEMBL269732,4.0,['NCT05666336'],EFO_0005755,rheumatic disease
1045,NDUFV1,NADH:ubiquinone oxidoreductase core subunit V1,METFORMIN,Small molecule,CHEMBL1431,4.0,['NCT02741960'],EFO_0005755,rheumatic disease
1046,SLC6A2,solute carrier family 6 member 2,MILNACIPRAN,Small molecule,CHEMBL259209,4.0,"['NCT01207453', 'NCT01225991']",EFO_0005755,rheumatic disease
1047,SCN2A,sodium voltage-gated channel alpha subunit 2,ROPIVACAINE HYDROCHLORIDE,Small molecule,CHEMBL1889140,4.0,['NCT00620828'],EFO_0005755,rheumatic disease
1048,SCN10A,sodium voltage-gated channel alpha subunit 10,LIDOCAINE,Small molecule,CHEMBL79,4.0,[],EFO_0005755,rheumatic disease
1049,SCN3A,sodium voltage-gated channel alpha subunit 3,MEPIVACAINE,Small molecule,CHEMBL1087,4.0,['NCT04257682'],EFO_0005755,rheumatic disease
1050,TUBB8,tubulin beta 8 class VIII,COLCHICINE,Small molecule,CHEMBL107,4.0,[],EFO_0005755,rheumatic disease
1051,TNF,tumor necrosis factor,ADALIMUMAB,Antibody,CHEMBL1201580,4.0,['NCT01604629'],EFO_0005755,rheumatic disease
1052,OPRM1,opioid receptor mu 1,FENTANYL,Small molecule,CHEMBL596,4.0,['NCT00524160'],EFO_0005755,rheumatic disease
1053,IL17A,interleukin 17A,SECUKINUMAB,Antibody,CHEMBL1743068,4.0,['NCT03639740'],EFO_0005755,rheumatic disease
1054,TNF,tumor necrosis factor,GOLIMUMAB,Antibody,CHEMBL1201833,4.0,[],EFO_0005755,rheumatic disease
1055,FGFR4,fibroblast growth factor receptor 4,NINTEDANIB,Small molecule,CHEMBL502835,4.0,[],EFO_0005755,rheumatic disease
1056,SCN7A,sodium voltage-gated channel alpha subunit 7,ROPIVACAINE,Small molecule,CHEMBL1077896,4.0,['NCT04257682'],EFO_0005755,rheumatic disease
1057,SCN5A,sodium voltage-gated channel alpha subunit 5,ROPIVACAINE,Small molecule,CHEMBL1077896,4.0,"['NCT03513276', 'NCT03801265']",EFO_0005755,rheumatic disease
1058,SCN1A,sodium voltage-gated channel alpha subunit 1,LIDOCAINE,Small molecule,CHEMBL79,4.0,['NCT05670236'],EFO_0005755,rheumatic disease
1059,GABRB1,gamma-aminobutyric acid type A receptor subunit beta1,SEVOFLURANE,Small molecule,CHEMBL1200694,4.0,['NCT03540030'],EFO_0005755,rheumatic disease
1060,TUBB6,tubulin beta 6 class V,COLCHICINE,Small molecule,CHEMBL107,4.0,"['NCT01451645', 'NCT02060552', 'NCT02500641', 'NCT01994226']",EFO_0005755,rheumatic disease
1061,HMGCR,3-hydroxy-3-methylglutaryl-CoA reductase,SIMVASTATIN,Small molecule,CHEMBL1064,4.0,['NCT00739050'],EFO_0005755,rheumatic disease
1062,NDUFA12,NADH:ubiquinone oxidoreductase subunit A12,METFORMIN,Small molecule,CHEMBL1431,4.0,['NCT02741960'],EFO_0005755,rheumatic disease
1063,NR3C1,nuclear receptor subfamily 3 group C member 1,PREDNICARBATE,Small molecule,CHEMBL1200386,4.0,[],EFO_0005755,rheumatic disease
1064,SCN10A,sodium voltage-gated channel alpha subunit 10,MEPIVACAINE,Small molecule,CHEMBL1087,4.0,['NCT04257682'],EFO_0005755,rheumatic disease
1065,PTGS1,prostaglandin-endoperoxide synthase 1,LOXOPROFEN,Small molecule,CHEMBL19299,4.0,['NCT03800797'],EFO_0005755,rheumatic disease
1066,JAK1,Janus kinase 1,FILGOTINIB,Small molecule,CHEMBL3301607,4.0,['NCT05502731'],EFO_0005755,rheumatic disease
1067,ADRB1,adrenoceptor beta 1,EPINEPHRINE,Small molecule,CHEMBL679,4.0,"['NCT02365727', 'NCT02765815']",EFO_0005755,rheumatic disease
1068,PTGS2,prostaglandin-endoperoxide synthase 2,INDOMETHACIN,Small molecule,CHEMBL6,4.0,['NCT03582332'],EFO_0005755,rheumatic disease
1069,NDUFAF4,NADH:ubiquinone oxidoreductase complex assembly factor 4,METFORMIN,Small molecule,CHEMBL1431,4.0,['NCT02741960'],EFO_0005755,rheumatic disease
1070,HTR3D,5-hydroxytryptamine receptor 3D,RAMOSETRON,Small molecule,CHEMBL1643895,4.0,['NCT01102491'],EFO_0005755,rheumatic disease
1071,OPRM1,opioid receptor mu 1,MORPHINE,Small molecule,CHEMBL70,4.0,['NCT02765815'],EFO_0005755,rheumatic disease
1072,GABRA2,gamma-aminobutyric acid type A receptor subunit alpha2,DESFLURANE,Small molecule,CHEMBL1200733,4.0,['NCT03540030'],EFO_0005755,rheumatic disease
1073,PTGS1,prostaglandin-endoperoxide synthase 1,MECLOFENAMATE SODIUM,Small molecule,CHEMBL1562610,4.0,[],EFO_0005755,rheumatic disease
1074,TRAF3IP2,TRAF3 interacting protein 2,IGURATIMOD,Small molecule,CHEMBL2107455,4.0,['NCT01554917'],EFO_0005755,rheumatic disease
1075,TUBB1,tubulin beta 1 class VI,COLCHICINE,Small molecule,CHEMBL107,4.0,['NCT05698680'],EFO_0005755,rheumatic disease
1076,SCN11A,sodium voltage-gated channel alpha subunit 11,ROPIVACAINE,Small molecule,CHEMBL1077896,4.0,"['NCT02658149', 'NCT02576249', 'NCT00620828', 'NCT02365181', 'NCT01537146']",EFO_0005755,rheumatic disease
1077,PTGS1,prostaglandin-endoperoxide synthase 1,INDOMETHACIN,Small molecule,CHEMBL6,4.0,['NCT02770950'],EFO_0005755,rheumatic disease
1078,TNF,tumor necrosis factor,GOLIMUMAB,Antibody,CHEMBL1201833,4.0,"['NCT01212653', 'NCT02758782', 'NCT01668004', 'NCT03253796']",EFO_0005755,rheumatic disease
1079,SCN11A,sodium voltage-gated channel alpha subunit 11,ROPIVACAINE,Small molecule,CHEMBL1077896,4.0,['NCT04257682'],EFO_0005755,rheumatic disease
1080,OPRM1,opioid receptor mu 1,MORPHINE SULFATE,Small molecule,CHEMBL2103744,4.0,['NCT01281891'],EFO_0005755,rheumatic disease
1081,IL1B,interleukin 1 beta,RILONACEPT,Protein,CHEMBL1201830,4.0,[],EFO_0005755,rheumatic disease
1082,MC2R,melanocortin 2 receptor,CORTICOTROPIN,Protein,CHEMBL1201610,4.0,['NCT02245841'],EFO_0005755,rheumatic disease
1083,PTGS2,prostaglandin-endoperoxide synthase 2,PHENYLBUTAZONE,Small molecule,CHEMBL101,4.0,[],EFO_0005755,rheumatic disease
1084,SCN10A,sodium voltage-gated channel alpha subunit 10,MEPIVACAINE,Small molecule,CHEMBL1087,4.0,['NCT02384915'],EFO_0005755,rheumatic disease
1085,TNF,tumor necrosis factor,ADALIMUMAB,Antibody,CHEMBL1201580,4.0,['NCT05540743'],EFO_0005755,rheumatic disease
1086,JAK3,Janus kinase 3,UPADACITINIB,Small molecule,CHEMBL3622821,4.0,['NCT05080218'],EFO_0005755,rheumatic disease
1087,GABRD,gamma-aminobutyric acid type A receptor subunit delta,DESFLURANE,Small molecule,CHEMBL1200733,4.0,['NCT03540030'],EFO_0005755,rheumatic disease
1088,GLRA1,glycine receptor alpha 1,DESFLURANE,Small molecule,CHEMBL1200733,4.0,['NCT03540030'],EFO_0005755,rheumatic disease
1089,IMPDH1,inosine monophosphate dehydrogenase 1,MYCOPHENOLIC ACID,Small molecule,CHEMBL866,4.0,['NCT01112215'],EFO_0005755,rheumatic disease
1090,JAK2,Janus kinase 2,TOFACITINIB,Small molecule,CHEMBL221959,4.0,"['NCT02187055', 'NCT02092467', 'NCT02831855', 'NCT02321930']",EFO_0005755,rheumatic disease
1091,PTGS2,prostaglandin-endoperoxide synthase 2,ASPIRIN,Small molecule,CHEMBL25,4.0,[],EFO_0005755,rheumatic disease
1092,SCN5A,sodium voltage-gated channel alpha subunit 5,ROPIVACAINE HYDROCHLORIDE,Small molecule,CHEMBL1889140,4.0,['NCT00620828'],EFO_0005755,rheumatic disease
1093,OPRD1,opioid receptor delta 1,CODEINE,Small molecule,CHEMBL485,4.0,"['NCT00324038', 'NCT02501564']",EFO_0005755,rheumatic disease
1094,NR3C1,nuclear receptor subfamily 3 group C member 1,PREDNISOLONE,Small molecule,CHEMBL131,4.0,['NCT05698680'],EFO_0005755,rheumatic disease
1095,GABRG1,gamma-aminobutyric acid type A receptor subunit gamma1,DESFLURANE,Small molecule,CHEMBL1200733,4.0,['NCT03540030'],EFO_0005755,rheumatic disease
1096,TYK2,tyrosine kinase 2,UPADACITINIB,Small molecule,CHEMBL3622821,4.0,['NCT05080218'],EFO_0005755,rheumatic disease
1097,SCN7A,sodium voltage-gated channel alpha subunit 7,ROPIVACAINE,Small molecule,CHEMBL1077896,4.0,['NCT04155983'],EFO_0005755,rheumatic disease
1098,PTGS1,prostaglandin-endoperoxide synthase 1,FENOPROFEN CALCIUM,Small molecule,CHEMBL2103736,4.0,[],EFO_0005755,rheumatic disease
1099,NR3C1,nuclear receptor subfamily 3 group C member 1,CORTISONE ACETATE,Small molecule,CHEMBL1650,4.0,[],EFO_0005755,rheumatic disease
1100,TNF,tumor necrosis factor,ADALIMUMAB,Antibody,CHEMBL1201580,4.0,"['NCT03100253', 'NCT01602302', 'NCT00796705', 'NCT00233558', 'NCT01283971', 'NCT00761514']",EFO_0005755,rheumatic disease
1101,SCN2A,sodium voltage-gated channel alpha subunit 2,ROPIVACAINE,Small molecule,CHEMBL1077896,4.0,['NCT05336968'],EFO_0005755,rheumatic disease
1102,NR3C1,nuclear receptor subfamily 3 group C member 1,DEXAMETHASONE,Small molecule,CHEMBL384467,4.0,['NCT02464176'],EFO_0005755,rheumatic disease
1103,IL6R,interleukin 6 receptor,TOCILIZUMAB,Antibody,CHEMBL1237022,4.0,[],EFO_0005755,rheumatic disease
1104,SCN5A,sodium voltage-gated channel alpha subunit 5,ROPIVACAINE,Small molecule,CHEMBL1077896,4.0,['NCT04257682'],EFO_0005755,rheumatic disease
1105,SCN10A,sodium voltage-gated channel alpha subunit 10,LIDOCAINE,Small molecule,CHEMBL79,4.0,['NCT03540030'],EFO_0005755,rheumatic disease
1106,SCN7A,sodium voltage-gated channel alpha subunit 7,ROPIVACAINE HYDROCHLORIDE,Small molecule,CHEMBL1889140,4.0,['NCT00620828'],EFO_0005755,rheumatic disease
1107,PTGS2,prostaglandin-endoperoxide synthase 2,ETODOLAC,Small molecule,CHEMBL622,4.0,[],EFO_0005755,rheumatic disease
1108,THRA,thyroid hormone receptor alpha,LEVOTHYROXINE,Small molecule,CHEMBL1624,4.0,['NCT01276782'],EFO_0005755,rheumatic disease
1109,PTGS2,prostaglandin-endoperoxide synthase 2,NAPROXEN SODIUM,Small molecule,CHEMBL1200806,4.0,[],EFO_0005755,rheumatic disease
1110,PDE4C,phosphodiesterase 4C,APREMILAST,Small molecule,CHEMBL514800,4.0,['NCT02558361'],EFO_0005755,rheumatic disease
1111,JAK1,Janus kinase 1,TOFACITINIB,Small molecule,CHEMBL221959,4.0,['NCT05803135'],EFO_0005755,rheumatic disease
1112,PTGS2,prostaglandin-endoperoxide synthase 2,ETORICOXIB,Small molecule,CHEMBL416146,4.0,['NCT01067430'],EFO_0005755,rheumatic disease
1113,ADRB3,adrenoceptor beta 3,EPINEPHRINE,Small molecule,CHEMBL679,4.0,['NCT03119038'],EFO_0005755,rheumatic disease
1114,ALOX5,arachidonate 5-lipoxygenase,MECLOFENAMIC ACID,Small molecule,CHEMBL509,4.0,[],EFO_0005755,rheumatic disease
1115,PTGS1,prostaglandin-endoperoxide synthase 1,PIROXICAM,Small molecule,CHEMBL527,4.0,[],EFO_0005755,rheumatic disease
1116,PDE4A,phosphodiesterase 4A,APREMILAST,Small molecule,CHEMBL514800,4.0,['NCT02558361'],EFO_0005755,rheumatic disease
1117,JAK2,Janus kinase 2,TOFACITINIB,Small molecule,CHEMBL221959,4.0,['NCT03504072'],EFO_0005755,rheumatic disease
1118,NR3C1,nuclear receptor subfamily 3 group C member 1,DEXAMETHASONE,Small molecule,CHEMBL384467,4.0,['NCT03542617'],EFO_0005755,rheumatic disease
1119,NR3C1,nuclear receptor subfamily 3 group C member 1,PREDNISOLONE,Small molecule,CHEMBL131,4.0,['NCT04314193'],EFO_0005755,rheumatic disease
1120,PTGS2,prostaglandin-endoperoxide synthase 2,CELECOXIB,Small molecule,CHEMBL118,4.0,['NCT02638896'],EFO_0005755,rheumatic disease
1121,PTGS2,prostaglandin-endoperoxide synthase 2,VALDECOXIB,Small molecule,CHEMBL865,4.0,['NCT00650455'],EFO_0005755,rheumatic disease
1122,PTGS1,prostaglandin-endoperoxide synthase 1,DICLOFENAC POTASSIUM,Small molecule,CHEMBL1200804,4.0,['NCT00141102'],EFO_0005755,rheumatic disease
1123,PTGS1,prostaglandin-endoperoxide synthase 1,KETOROLAC,Small molecule,CHEMBL469,4.0,['NCT03119038'],EFO_0005755,rheumatic disease
1124,CD80,CD80 molecule,ABATACEPT,Protein,CHEMBL1201823,4.0,['NCT05080218'],EFO_0005755,rheumatic disease
1125,PTGS2,prostaglandin-endoperoxide synthase 2,OXYPHENBUTAZONE,Small molecule,CHEMBL1228,4.0,[],EFO_0005755,rheumatic disease
1126,PTGS2,prostaglandin-endoperoxide synthase 2,IBUPROFEN,Small molecule,CHEMBL521,4.0,"['NCT00145730', 'NCT01066676']",EFO_0005755,rheumatic disease
1127,SCN10A,sodium voltage-gated channel alpha subunit 10,ROPIVACAINE HYDROCHLORIDE,Small molecule,CHEMBL1889140,4.0,['NCT00620828'],EFO_0005755,rheumatic disease
1128,CD80,CD80 molecule,ABATACEPT,Protein,CHEMBL1201823,4.0,[],EFO_0005755,rheumatic disease
1129,NR3C1,nuclear receptor subfamily 3 group C member 1,DEXAMETHASONE SODIUM PHOSPHATE,Small molecule,CHEMBL2021430,4.0,[],EFO_0005755,rheumatic disease
1130,ADRA2A,adrenoceptor alpha 2A,EPINEPHRINE,Small molecule,CHEMBL679,4.0,['NCT03119038'],EFO_0005755,rheumatic disease
1131,NDUFAF1,NADH:ubiquinone oxidoreductase complex assembly factor 1,METFORMIN,Small molecule,CHEMBL1431,4.0,['NCT02741960'],EFO_0005755,rheumatic disease
1132,PTGS2,prostaglandin-endoperoxide synthase 2,NAPROXEN SODIUM,Small molecule,CHEMBL1200806,4.0,[],EFO_0005755,rheumatic disease
1133,IL17A,interleukin 17A,SECUKINUMAB,Antibody,CHEMBL1743068,4.0,['NCT02798211'],EFO_0005755,rheumatic disease
1134,EDNRB,endothelin receptor type B,BOSENTAN,Small molecule,CHEMBL957,4.0,"['NCT01395732', 'NCT02480335']",EFO_0005755,rheumatic disease
1135,PTGS2,prostaglandin-endoperoxide synthase 2,NAPROXEN SODIUM,Small molecule,CHEMBL1200806,4.0,[],EFO_0005755,rheumatic disease
1136,TNF,tumor necrosis factor,INFLIXIMAB,Antibody,CHEMBL1201581,4.0,"['NCT01282528', 'NCT00216177', 'NCT02242474', 'NCT02878161', 'NCT00908089', 'NCT01793519']",EFO_0005755,rheumatic disease
1137,PTGS2,prostaglandin-endoperoxide synthase 2,ACEMETACIN,Small molecule,CHEMBL189171,4.0,[],EFO_0005755,rheumatic disease
1138,CD86,CD86 molecule,ABATACEPT,Protein,CHEMBL1201823,4.0,[],EFO_0005755,rheumatic disease
1139,IL17A,interleukin 17A,SECUKINUMAB,Antibody,CHEMBL1743068,4.0,[],EFO_0005755,rheumatic disease
1140,NR3C1,nuclear receptor subfamily 3 group C member 1,METHYLPREDNISOLONE SODIUM SUCCINATE,Small molecule,CHEMBL1201081,4.0,[],EFO_0005755,rheumatic disease
1141,MIF,macrophage migration inhibitory factor,IGURATIMOD,Small molecule,CHEMBL2107455,4.0,['NCT01554917'],EFO_0005755,rheumatic disease
1142,ATP4A,ATPase H+/K+ transporting subunit alpha,OMEPRAZOLE,Small molecule,CHEMBL1503,4.0,['NCT00141102'],EFO_0005755,rheumatic disease
1143,SCN2A,sodium voltage-gated channel alpha subunit 2,ROPIVACAINE,Small molecule,CHEMBL1077896,4.0,['NCT04257682'],EFO_0005755,rheumatic disease
1144,GABRE,gamma-aminobutyric acid type A receptor subunit epsilon,SEVOFLURANE,Small molecule,CHEMBL1200694,4.0,['NCT03540030'],EFO_0005755,rheumatic disease
1145,PTGS2,prostaglandin-endoperoxide synthase 2,ACETAMINOPHEN,Small molecule,CHEMBL112,4.0,['NCT03994731'],EFO_0005755,rheumatic disease
1146,DHFR,dihydrofolate reductase,METHOTREXATE,Small molecule,CHEMBL34259,4.0,"['NCT00783536', 'NCT01878318']",EFO_0005755,rheumatic disease
1147,SCN5A,sodium voltage-gated channel alpha subunit 5,MEPIVACAINE,Small molecule,CHEMBL1087,4.0,['NCT02384915'],EFO_0005755,rheumatic disease
1148,GABRG2,gamma-aminobutyric acid type A receptor subunit gamma2,DESFLURANE,Small molecule,CHEMBL1200733,4.0,['NCT03540030'],EFO_0005755,rheumatic disease
1149,PTGS1,prostaglandin-endoperoxide synthase 1,SULFASALAZINE,Small molecule,CHEMBL421,4.0,['NCT00637780'],EFO_0005755,rheumatic disease
1150,OPRM1,opioid receptor mu 1,MORPHINE,Small molecule,CHEMBL70,4.0,"['NCT00901628', 'NCT00562627']",EFO_0005755,rheumatic disease
1151,SCN4A,sodium voltage-gated channel alpha subunit 4,ROPIVACAINE,Small molecule,CHEMBL1077896,4.0,['NCT03119038'],EFO_0005755,rheumatic disease
1152,NR3C1,nuclear receptor subfamily 3 group C member 1,PREDNISONE,Small molecule,CHEMBL635,4.0,[],EFO_0005755,rheumatic disease
1153,SCN4A,sodium voltage-gated channel alpha subunit 4,ROPIVACAINE,Small molecule,CHEMBL1077896,4.0,['NCT05336968'],EFO_0005755,rheumatic disease
1154,PTGS1,prostaglandin-endoperoxide synthase 1,NAPROXEN,Small molecule,CHEMBL154,4.0,"['NCT01544114', 'NCT00807846']",EFO_0005755,rheumatic disease
1155,TUBB,tubulin beta class I,COLCHICINE,Small molecule,CHEMBL107,4.0,"['NCT02060552', 'NCT02500641', 'NCT01451645', 'NCT01994226']",EFO_0005755,rheumatic disease
1156,TUBB6,tubulin beta 6 class V,COLCHICINE,Small molecule,CHEMBL107,4.0,[],EFO_0005755,rheumatic disease
1157,GABRA4,gamma-aminobutyric acid type A receptor subunit alpha4,SEVOFLURANE,Small molecule,CHEMBL1200694,4.0,['NCT03540030'],EFO_0005755,rheumatic disease
1158,SCN1A,sodium voltage-gated channel alpha subunit 1,ROPIVACAINE,Small molecule,CHEMBL1077896,4.0,['NCT02299271'],EFO_0005755,rheumatic disease
1159,SCN4A,sodium voltage-gated channel alpha subunit 4,MEPIVACAINE,Small molecule,CHEMBL1087,4.0,['NCT02384915'],EFO_0005755,rheumatic disease
1160,TRPM8,transient receptor potential cation channel subfamily M member 8,MENTHOL,Small molecule,CHEMBL256087,4.0,[],EFO_0005755,rheumatic disease
1161,SCN4A,sodium voltage-gated channel alpha subunit 4,ROPIVACAINE,Small molecule,CHEMBL1077896,4.0,['NCT02299271'],EFO_0005755,rheumatic disease
1162,ADRA1D,adrenoceptor alpha 1D,EPINEPHRINE,Small molecule,CHEMBL679,4.0,"['NCT00562627', 'NCT02462148', 'NCT00901628']",EFO_0005755,rheumatic disease
1163,IL1B,interleukin 1 beta,RILONACEPT,Protein,CHEMBL1201830,4.0,[],EFO_0005755,rheumatic disease
1164,PTGS2,prostaglandin-endoperoxide synthase 2,DICLOFENAC POTASSIUM,Small molecule,CHEMBL1200804,4.0,['NCT00141102'],EFO_0005755,rheumatic disease
1165,NDUFS3,NADH:ubiquinone oxidoreductase core subunit S3,METFORMIN,Small molecule,CHEMBL1431,4.0,['NCT02741960'],EFO_0005755,rheumatic disease
1166,SCN11A,sodium voltage-gated channel alpha subunit 11,ROPIVACAINE,Small molecule,CHEMBL1077896,4.0,['NCT02365727'],EFO_0005755,rheumatic disease
1167,TRAF3IP2,TRAF3 interacting protein 2,IGURATIMOD,Small molecule,CHEMBL2107455,4.0,"['NCT01548001', 'NCT01893151', 'NCT02275299']",EFO_0005755,rheumatic disease
1168,TUBB4B,tubulin beta 4B class IVb,COLCHICINE,Small molecule,CHEMBL107,4.0,['NCT04601883'],EFO_0005755,rheumatic disease
1169,TNF,tumor necrosis factor,GOLIMUMAB,Antibody,CHEMBL1201833,4.0,[],EFO_0005755,rheumatic disease
1170,PTGS2,prostaglandin-endoperoxide synthase 2,ACECLOFENAC,Small molecule,CHEMBL93645,4.0,[],EFO_0005755,rheumatic disease
1171,TNF,tumor necrosis factor,INFLIXIMAB,Antibody,CHEMBL1201581,4.0,['NCT01604629'],EFO_0005755,rheumatic disease
1172,NR3C1,nuclear receptor subfamily 3 group C member 1,DEXAMETHASONE,Small molecule,CHEMBL384467,4.0,"['NCT01612702', 'NCT02462148']",EFO_0005755,rheumatic disease
1173,PTGS1,prostaglandin-endoperoxide synthase 1,PIROXICAM,Small molecule,CHEMBL527,4.0,[],EFO_0005755,rheumatic disease
1174,SCN7A,sodium voltage-gated channel alpha subunit 7,ROPIVACAINE,Small molecule,CHEMBL1077896,4.0,['NCT02570503'],EFO_0005755,rheumatic disease
1175,PTGS1,prostaglandin-endoperoxide synthase 1,DEXIBUPROFEN,Small molecule,CHEMBL175,4.0,['NCT01066676'],EFO_0005755,rheumatic disease
1176,ADRA2A,adrenoceptor alpha 2A,CLONIDINE,Small molecule,CHEMBL134,4.0,['NCT02365727'],EFO_0005755,rheumatic disease
1177,NDUFS4,NADH:ubiquinone oxidoreductase subunit S4,METFORMIN,Small molecule,CHEMBL1431,4.0,['NCT02741960'],EFO_0005755,rheumatic disease
1178,IMPDH2,inosine monophosphate dehydrogenase 2,MYCOPHENOLATE SODIUM,Small molecule,CHEMBL2106643,4.0,['NCT01112215'],EFO_0005755,rheumatic disease
1179,SCN10A,sodium voltage-gated channel alpha subunit 10,ROPIVACAINE,Small molecule,CHEMBL1077896,4.0,"['NCT00620828', 'NCT01537146', 'NCT02658149', 'NCT02576249', 'NCT02365181']",EFO_0005755,rheumatic disease
1180,SLC6A4,solute carrier family 6 member 4,DULOXETINE,Small molecule,CHEMBL1175,4.0,['NCT02612233'],EFO_0005755,rheumatic disease
1181,CD80,CD80 molecule,ABATACEPT,Protein,CHEMBL1201823,4.0,"['NCT02466581', 'NCT03652961', 'NCT01491815']",EFO_0005755,rheumatic disease
1182,IL6R,interleukin 6 receptor,TOCILIZUMAB,Antibody,CHEMBL1237022,4.0,"['NCT02353780', 'NCT01661140', 'NCT02659150', 'NCT01251120', 'NCT03100253', 'NCT01283971']",EFO_0005755,rheumatic disease
1183,SCN11A,sodium voltage-gated channel alpha subunit 11,PRILOCAINE,Small molecule,CHEMBL1194,4.0,['NCT02384915'],EFO_0005755,rheumatic disease
1184,IMPDH2,inosine monophosphate dehydrogenase 2,MYCOPHENOLATE MOFETIL,Small molecule,CHEMBL1456,4.0,['NCT05666336'],EFO_0005755,rheumatic disease
1185,CHRNE,cholinergic receptor nicotinic epsilon subunit,VECURONIUM,Small molecule,CHEMBL1201219,4.0,['NCT03540030'],EFO_0005755,rheumatic disease
1186,TYK2,tyrosine kinase 2,TOFACITINIB,Small molecule,CHEMBL221959,4.0,['NCT05080218'],EFO_0005755,rheumatic disease
1187,NR3C1,nuclear receptor subfamily 3 group C member 1,METHYLPREDNISOLONE ACETATE,Small molecule,CHEMBL1364144,4.0,['NCT00523692'],EFO_0005755,rheumatic disease
1188,SCN9A,sodium voltage-gated channel alpha subunit 9,ROPIVACAINE,Small molecule,CHEMBL1077896,4.0,['NCT03219983'],EFO_0005755,rheumatic disease
1189,ATP4A,ATPase H+/K+ transporting subunit alpha,OMEPRAZOLE,Small molecule,CHEMBL1503,4.0,['NCT02500641'],EFO_0005755,rheumatic disease
1190,TNF,tumor necrosis factor,ETANERCEPT,Protein,CHEMBL1201572,4.0,['NCT03636373'],EFO_0005755,rheumatic disease
1191,NR3C1,nuclear receptor subfamily 3 group C member 1,PREDNISOLONE,Small molecule,CHEMBL131,4.0,['NCT00443430'],EFO_0005755,rheumatic disease
1192,GABRQ,gamma-aminobutyric acid type A receptor subunit theta,PROPOFOL,Small molecule,CHEMBL526,4.0,"['NCT02784626', 'NCT02292082', 'NCT03540030']",EFO_0005755,rheumatic disease
1193,ALOX5,arachidonate 5-lipoxygenase,SULFASALAZINE,Small molecule,CHEMBL421,4.0,['NCT01659242'],EFO_0005755,rheumatic disease
1194,ALOX5,arachidonate 5-lipoxygenase,SULFASALAZINE,Small molecule,CHEMBL421,4.0,['NCT00247962'],EFO_0005755,rheumatic disease
1195,PTGS1,prostaglandin-endoperoxide synthase 1,INDOMETHACIN,Small molecule,CHEMBL6,4.0,[],EFO_0005755,rheumatic disease
1196,PTGS1,prostaglandin-endoperoxide synthase 1,DICLOFENAC SODIUM,Small molecule,CHEMBL1034,4.0,['NCT00140972'],EFO_0005755,rheumatic disease
1197,NDUFA1,NADH:ubiquinone oxidoreductase subunit A1,METFORMIN,Small molecule,CHEMBL1431,4.0,['NCT02741960'],EFO_0005755,rheumatic disease
1198,TUBB2A,tubulin beta 2A class IIa,COLCHICINE,Small molecule,CHEMBL107,4.0,['NCT04601883'],EFO_0005755,rheumatic disease
1199,NR3C1,nuclear receptor subfamily 3 group C member 1,PREDNISOLONE,Small molecule,CHEMBL131,4.0,['NCT02466581'],EFO_0005755,rheumatic disease
1200,HRH1,histamine receptor H1,FEXOFENADINE,Small molecule,CHEMBL914,4.0,['NCT03994731'],EFO_0005755,rheumatic disease
1201,SCN8A,sodium voltage-gated channel alpha subunit 8,LIDOCAINE HYDROCHLORIDE,Small molecule,CHEMBL1200409,4.0,['NCT05670236'],EFO_0005755,rheumatic disease
1202,SCN5A,sodium voltage-gated channel alpha subunit 5,ROPIVACAINE,Small molecule,CHEMBL1077896,4.0,['NCT04155983'],EFO_0005755,rheumatic disease
1203,SCN2A,sodium voltage-gated channel alpha subunit 2,ROPIVACAINE,Small molecule,CHEMBL1077896,4.0,['NCT02365727'],EFO_0005755,rheumatic disease
1204,PTGS1,prostaglandin-endoperoxide synthase 1,KETOROLAC TROMETHAMINE,Small molecule,CHEMBL1201124,4.0,"['NCT03540030', 'NCT02658149']",EFO_0005755,rheumatic disease
1205,PTGS1,prostaglandin-endoperoxide synthase 1,SULFASALAZINE,Small molecule,CHEMBL421,4.0,"['NCT01172639', 'NCT00422227', 'NCT00259610', 'NCT02451748', 'NCT00764725', 'NCT02433184', 'NCT02374021', 'NCT03449758']",EFO_0005755,rheumatic disease
1206,NR3C1,nuclear receptor subfamily 3 group C member 1,DEXAMETHASONE SODIUM PHOSPHATE,Small molecule,CHEMBL2021430,4.0,[],EFO_0005755,rheumatic disease
1207,NR3C1,nuclear receptor subfamily 3 group C member 1,DEXAMETHASONE,Small molecule,CHEMBL384467,4.0,['NCT01275014'],EFO_0005755,rheumatic disease
1208,PTGS2,prostaglandin-endoperoxide synthase 2,TOLMETIN SODIUM,Small molecule,CHEMBL1200613,4.0,[],EFO_0005755,rheumatic disease
1209,NR3C1,nuclear receptor subfamily 3 group C member 1,PREDNISONE,Small molecule,CHEMBL635,4.0,[],EFO_0005755,rheumatic disease
1210,NR3C1,nuclear receptor subfamily 3 group C member 1,METHYLPREDNISOLONE ACETATE,Small molecule,CHEMBL1364144,4.0,"['NCT01144143', 'NCT02176304']",EFO_0005755,rheumatic disease
1211,PTGS2,prostaglandin-endoperoxide synthase 2,DICLOFENAC,Small molecule,CHEMBL139,4.0,[],EFO_0005755,rheumatic disease
1212,PTGS1,prostaglandin-endoperoxide synthase 1,NAPROXEN SODIUM,Small molecule,CHEMBL1200806,4.0,[],EFO_0005755,rheumatic disease
1213,PTGS1,prostaglandin-endoperoxide synthase 1,INDOMETHACIN,Small molecule,CHEMBL6,4.0,['NCT00142558'],EFO_0005755,rheumatic disease
1214,SCN8A,sodium voltage-gated channel alpha subunit 8,ROPIVACAINE,Small molecule,CHEMBL1077896,4.0,"['NCT02576249', 'NCT00620828', 'NCT01537146', 'NCT02365181', 'NCT02658149']",EFO_0005755,rheumatic disease
1215,SCN7A,sodium voltage-gated channel alpha subunit 7,LIDOCAINE,Small molecule,CHEMBL79,4.0,['NCT01045694'],EFO_0005755,rheumatic disease
1216,JAK3,Janus kinase 3,UPADACITINIB,Small molecule,CHEMBL3622821,4.0,[],EFO_0005755,rheumatic disease
1217,SCN2A,sodium voltage-gated channel alpha subunit 2,LIDOCAINE,Small molecule,CHEMBL79,4.0,['NCT02176304'],EFO_0005755,rheumatic disease
1218,DHFR,dihydrofolate reductase,METHOTREXATE,Small molecule,CHEMBL34259,4.0,"['NCT02814175', 'NCT03797872']",EFO_0005755,rheumatic disease
1219,SCN9A,sodium voltage-gated channel alpha subunit 9,ROPIVACAINE,Small molecule,CHEMBL1077896,4.0,['NCT04155983'],EFO_0005755,rheumatic disease
1220,PTGS2,prostaglandin-endoperoxide synthase 2,IBUPROFEN,Small molecule,CHEMBL521,4.0,['NCT01563185'],EFO_0005755,rheumatic disease
1221,VDR,vitamin D receptor,ERGOCALCIFEROL,Small molecule,CHEMBL1536,4.0,['NCT01400516'],EFO_0005755,rheumatic disease
1222,FGFR1,fibroblast growth factor receptor 1,NINTEDANIB,Small molecule,CHEMBL502835,4.0,[],EFO_0005755,rheumatic disease
1223,PTGS1,prostaglandin-endoperoxide synthase 1,DICLOFENAC SODIUM,Small molecule,CHEMBL1034,4.0,[],EFO_0005755,rheumatic disease
1224,PTGS1,prostaglandin-endoperoxide synthase 1,LORNOXICAM,Small molecule,CHEMBL1569487,4.0,[],EFO_0005755,rheumatic disease
1225,JAK1,Janus kinase 1,TOFACITINIB CITRATE,Small molecule,CHEMBL2103743,4.0,[],EFO_0005755,rheumatic disease
1226,SCN9A,sodium voltage-gated channel alpha subunit 9,ROPIVACAINE,Small molecule,CHEMBL1077896,4.0,['NCT02570503'],EFO_0005755,rheumatic disease
1227,SCN4A,sodium voltage-gated channel alpha subunit 4,PRILOCAINE,Small molecule,CHEMBL1194,4.0,['NCT02384915'],EFO_0005755,rheumatic disease
1228,NR3C1,nuclear receptor subfamily 3 group C member 1,TRIAMCINOLONE ACETONIDE,Small molecule,CHEMBL1504,4.0,['NCT01045694'],EFO_0005755,rheumatic disease
1229,SCN4A,sodium voltage-gated channel alpha subunit 4,ROPIVACAINE,Small molecule,CHEMBL1077896,4.0,"['NCT02658149', 'NCT01537146', 'NCT00620828', 'NCT02365181', 'NCT02576249']",EFO_0005755,rheumatic disease
1230,KCNK18,potassium two pore domain channel subfamily K member 18,DESFLURANE,Small molecule,CHEMBL1200733,4.0,['NCT03540030'],EFO_0005755,rheumatic disease
1231,TRPV1,transient receptor potential cation channel subfamily V member 1,ACETAMINOPHEN,Small molecule,CHEMBL112,4.0,['NCT03994731'],EFO_0005755,rheumatic disease
1232,PTGS2,prostaglandin-endoperoxide synthase 2,CELECOXIB,Small molecule,CHEMBL118,4.0,[],EFO_0005755,rheumatic disease
1233,PTGS2,prostaglandin-endoperoxide synthase 2,FLURBIPROFEN,Small molecule,CHEMBL563,4.0,[],EFO_0005755,rheumatic disease
1234,SCN11A,sodium voltage-gated channel alpha subunit 11,ROPIVACAINE,Small molecule,CHEMBL1077896,4.0,['NCT04257682'],EFO_0005755,rheumatic disease
1235,CD86,CD86 molecule,ABATACEPT,Protein,CHEMBL1201823,4.0,"['NCT02353780', 'NCT01602302']",EFO_0005755,rheumatic disease
1236,PTGS1,prostaglandin-endoperoxide synthase 1,DIFLUNISAL,Small molecule,CHEMBL898,4.0,[],EFO_0005755,rheumatic disease
1237,PTGS1,prostaglandin-endoperoxide synthase 1,KETOROLAC,Small molecule,CHEMBL469,4.0,['NCT02570503'],EFO_0005755,rheumatic disease
1238,ADRB3,adrenoceptor beta 3,EPINEPHRINE,Small molecule,CHEMBL679,4.0,"['NCT02658149', 'NCT02697955']",EFO_0005755,rheumatic disease
1239,SCN11A,sodium voltage-gated channel alpha subunit 11,ROPIVACAINE,Small molecule,CHEMBL1077896,4.0,['NCT04155983'],EFO_0005755,rheumatic disease
1240,SCN5A,sodium voltage-gated channel alpha subunit 5,LIDOCAINE,Small molecule,CHEMBL79,4.0,[],EFO_0005755,rheumatic disease
1241,PTGS2,prostaglandin-endoperoxide synthase 2,NABUMETONE,Small molecule,CHEMBL1070,4.0,[],EFO_0005755,rheumatic disease
1242,SCN2A,sodium voltage-gated channel alpha subunit 2,LIDOCAINE,Small molecule,CHEMBL79,4.0,[],EFO_0005755,rheumatic disease
1243,ADRA2C,adrenoceptor alpha 2C,EPINEPHRINE,Small molecule,CHEMBL679,4.0,"['NCT00901628', 'NCT00562627', 'NCT02462148']",EFO_0005755,rheumatic disease
1244,NR3C1,nuclear receptor subfamily 3 group C member 1,PREDNISOLONE,Small molecule,CHEMBL131,4.0,['NCT00805519'],EFO_0005755,rheumatic disease
1245,PTGS1,prostaglandin-endoperoxide synthase 1,NAPROXEN,Small molecule,CHEMBL154,4.0,['NCT02501564'],EFO_0005755,rheumatic disease
1246,IL1B,interleukin 1 beta,CANAKINUMAB,Antibody,CHEMBL1201834,4.0,[],EFO_0005755,rheumatic disease
1247,TUBB3,tubulin beta 3 class III,COLCHICINE,Small molecule,CHEMBL107,4.0,['NCT05698680'],EFO_0005755,rheumatic disease
1248,GABRA2,gamma-aminobutyric acid type A receptor subunit alpha2,SEVOFLURANE,Small molecule,CHEMBL1200694,4.0,['NCT03540030'],EFO_0005755,rheumatic disease
1249,TLR7,toll like receptor 7,HYDROXYCHLOROQUINE SULFATE,Small molecule,CHEMBL1690,4.0,[],EFO_0005755,rheumatic disease
1250,FGFR3,fibroblast growth factor receptor 3,NINTEDANIB ESYLATE,Small molecule,CHEMBL3039504,4.0,[],EFO_0005755,rheumatic disease
1251,NR3C1,nuclear receptor subfamily 3 group C member 1,TRIAMCINOLONE HEXACETONIDE,Small molecule,CHEMBL1200878,4.0,['NCT03086759'],EFO_0005755,rheumatic disease
1252,SNAP25,synaptosome associated protein 25,ONABOTULINUMTOXINA,Unknown,CHEMBL1201574,4.0,['NCT02829281'],EFO_0005755,rheumatic disease
1253,PTGS1,prostaglandin-endoperoxide synthase 1,DICLOFENAC,Small molecule,CHEMBL139,4.0,['NCT01067430'],EFO_0005755,rheumatic disease
1254,CHRND,cholinergic receptor nicotinic delta subunit,ROCURONIUM,Small molecule,CHEMBL1201244,4.0,['NCT03540030'],EFO_0005755,rheumatic disease
1255,TUBB4B,tubulin beta 4B class IVb,COLCHICINE,Small molecule,CHEMBL107,4.0,[],EFO_0005755,rheumatic disease
1256,ALOX5,arachidonate 5-lipoxygenase,SULFASALAZINE,Small molecule,CHEMBL421,4.0,"['NCT00764725', 'NCT02451748', 'NCT00422227', 'NCT02374021', 'NCT00259610', 'NCT01172639', 'NCT03449758', 'NCT02433184']",EFO_0005755,rheumatic disease
1257,CD86,CD86 molecule,ABATACEPT,Protein,CHEMBL1201823,4.0,['NCT03227419'],EFO_0005755,rheumatic disease
1258,SCN7A,sodium voltage-gated channel alpha subunit 7,LIDOCAINE,Small molecule,CHEMBL79,4.0,['NCT02176304'],EFO_0005755,rheumatic disease
1259,ADRB2,adrenoceptor beta 2,EPINEPHRINE,Small molecule,CHEMBL679,4.0,"['NCT02365727', 'NCT02765815']",EFO_0005755,rheumatic disease
1260,PTGS1,prostaglandin-endoperoxide synthase 1,KETOPROFEN,Small molecule,CHEMBL571,4.0,[],EFO_0005755,rheumatic disease
1261,TUBB2B,tubulin beta 2B class IIb,COLCHICINE,Small molecule,CHEMBL107,4.0,['NCT04601883'],EFO_0005755,rheumatic disease
1262,CHRNB1,cholinergic receptor nicotinic beta 1 subunit,ROCURONIUM,Small molecule,CHEMBL1201244,4.0,['NCT03540030'],EFO_0005755,rheumatic disease
1263,PPIA,peptidylprolyl isomerase A,CYCLOSPORINE,Protein,CHEMBL160,4.0,['NCT00209859'],EFO_0005755,rheumatic disease
1264,PTGS2,prostaglandin-endoperoxide synthase 2,CELECOXIB,Small molecule,CHEMBL118,4.0,"['NCT02528201', 'NCT01934933', 'NCT02758782']",EFO_0005755,rheumatic disease
1265,SCN5A,sodium voltage-gated channel alpha subunit 5,ROPIVACAINE,Small molecule,CHEMBL1077896,4.0,"['NCT00620828', 'NCT02658149', 'NCT02576249', 'NCT01537146', 'NCT02365181']",EFO_0005755,rheumatic disease
1266,NR3C1,nuclear receptor subfamily 3 group C member 1,DEXAMETHASONE,Small molecule,CHEMBL384467,4.0,[],EFO_0005755,rheumatic disease
1267,PTGS2,prostaglandin-endoperoxide synthase 2,INDOMETHACIN,Small molecule,CHEMBL6,4.0,[],EFO_0005755,rheumatic disease
1268,OPRM1,opioid receptor mu 1,FENTANYL,Small molecule,CHEMBL596,4.0,"['NCT01774929', 'NCT00236366', 'NCT00524160']",EFO_0005755,rheumatic disease
1269,OPRM1,opioid receptor mu 1,OXYCODONE,Small molecule,CHEMBL656,4.0,['NCT00484718'],EFO_0005755,rheumatic disease
1270,MC2R,melanocortin 2 receptor,CORTICOTROPIN,Protein,CHEMBL1201610,4.0,['NCT02188017'],EFO_0005755,rheumatic disease
1271,NR3C1,nuclear receptor subfamily 3 group C member 1,PREDNISOLONE,Small molecule,CHEMBL131,4.0,[],EFO_0005755,rheumatic disease
1272,ADRA1A,adrenoceptor alpha 1A,EPINEPHRINE,Small molecule,CHEMBL679,4.0,"['NCT02462148', 'NCT00901628', 'NCT00562627']",EFO_0005755,rheumatic disease
1273,GABRA1,gamma-aminobutyric acid type A receptor subunit alpha1,PROPOFOL,Small molecule,CHEMBL526,4.0,"['NCT02292082', 'NCT03540030', 'NCT02784626']",EFO_0005755,rheumatic disease
1274,PTGS1,prostaglandin-endoperoxide synthase 1,NAPROXEN,Small molecule,CHEMBL154,4.0,['NCT05430230'],EFO_0005755,rheumatic disease
1275,SCN9A,sodium voltage-gated channel alpha subunit 9,ROPIVACAINE,Small molecule,CHEMBL1077896,4.0,['NCT03119038'],EFO_0005755,rheumatic disease
1276,NR3C1,nuclear receptor subfamily 3 group C member 1,METHYLPREDNISOLONE SODIUM SUCCINATE,Small molecule,CHEMBL1201081,4.0,['NCT00396747'],EFO_0005755,rheumatic disease
1277,P2RY12,purinergic receptor P2Y12,TICAGRELOR,Small molecule,CHEMBL398435,4.0,['NCT02874092'],EFO_0005755,rheumatic disease
1278,ESR2,estrogen receptor 2,BAZEDOXIFENE,Small molecule,CHEMBL46740,4.0,['NCT02602704'],EFO_0005755,rheumatic disease
1279,SCN9A,sodium voltage-gated channel alpha subunit 9,MEPIVACAINE,Small molecule,CHEMBL1087,4.0,['NCT02384915'],EFO_0005755,rheumatic disease
1280,TLR9,toll like receptor 9,HYDROXYCHLOROQUINE,Small molecule,CHEMBL1535,4.0,['NCT03813771'],EFO_0005755,rheumatic disease
1281,PTGS1,prostaglandin-endoperoxide synthase 1,IBUPROFEN,Small molecule,CHEMBL521,4.0,[],EFO_0005755,rheumatic disease
1282,DHFR,dihydrofolate reductase,METHOTREXATE,Small molecule,CHEMBL34259,4.0,['NCT00298012'],EFO_0005755,rheumatic disease
1283,NR3C1,nuclear receptor subfamily 3 group C member 1,PREDNISONE,Small molecule,CHEMBL635,4.0,"['NCT01172639', 'NCT02573012', 'NCT00480272', 'NCT02451748', 'NCT02072200']",EFO_0005755,rheumatic disease
1284,NR3C1,nuclear receptor subfamily 3 group C member 1,METHYLPREDNISOLONE HEMISUCCINATE,Small molecule,CHEMBL1201265,4.0,[],EFO_0005755,rheumatic disease
1285,SCN3A,sodium voltage-gated channel alpha subunit 3,ROPIVACAINE,Small molecule,CHEMBL1077896,4.0,['NCT03119038'],EFO_0005755,rheumatic disease
1286,SCN5A,sodium voltage-gated channel alpha subunit 5,LIDOCAINE,Small molecule,CHEMBL79,4.0,['NCT02176304'],EFO_0005755,rheumatic disease
1287,ALOX5,arachidonate 5-lipoxygenase,SULFASALAZINE,Small molecule,CHEMBL421,4.0,['NCT03813771'],EFO_0005755,rheumatic disease
1288,NR3C1,nuclear receptor subfamily 3 group C member 1,CORTISONE ACETATE,Small molecule,CHEMBL1650,4.0,[],EFO_0005755,rheumatic disease
1289,SCN10A,sodium voltage-gated channel alpha subunit 10,LIDOCAINE,Small molecule,CHEMBL79,4.0,['NCT01045694'],EFO_0005755,rheumatic disease
1290,GABRA5,gamma-aminobutyric acid type A receptor subunit alpha5,DESFLURANE,Small molecule,CHEMBL1200733,4.0,['NCT03540030'],EFO_0005755,rheumatic disease
1291,NR3C1,nuclear receptor subfamily 3 group C member 1,HYDROCORTISONE,Small molecule,CHEMBL389621,4.0,[],EFO_0005755,rheumatic disease
1292,TUBB8,tubulin beta 8 class VIII,COLCHICINE,Small molecule,CHEMBL107,4.0,['NCT05698680'],EFO_0005755,rheumatic disease
1293,JAK2,Janus kinase 2,BARICITINIB,Small molecule,CHEMBL2105759,4.0,[],EFO_0005755,rheumatic disease
1294,PTGER3,prostaglandin E receptor 3,MISOPROSTOL,Small molecule,CHEMBL606,4.0,[],EFO_0005755,rheumatic disease
1295,JAK2,Janus kinase 2,UPADACITINIB,Small molecule,CHEMBL3622821,4.0,['NCT05080218'],EFO_0005755,rheumatic disease
1296,SCN10A,sodium voltage-gated channel alpha subunit 10,LIDOCAINE,Small molecule,CHEMBL79,4.0,['NCT04143165'],EFO_0005755,rheumatic disease
1297,PDE4C,phosphodiesterase 4C,APREMILAST,Small molecule,CHEMBL514800,4.0,[],EFO_0005755,rheumatic disease
1298,TYK2,tyrosine kinase 2,TOFACITINIB CITRATE,Small molecule,CHEMBL2103743,4.0,[],EFO_0005755,rheumatic disease
1299,TUBB1,tubulin beta 1 class VI,COLCHICINE,Small molecule,CHEMBL107,4.0,['NCT04601883'],EFO_0005755,rheumatic disease
1300,NDUFA3,NADH:ubiquinone oxidoreductase subunit A3,METFORMIN,Small molecule,CHEMBL1431,4.0,['NCT02741960'],EFO_0005755,rheumatic disease
1301,NR3C1,nuclear receptor subfamily 3 group C member 1,TRIAMCINOLONE,Small molecule,CHEMBL1451,4.0,['NCT04143165'],EFO_0005755,rheumatic disease
1302,JAK1,Janus kinase 1,UPADACITINIB,Small molecule,CHEMBL3622821,4.0,['NCT05153200'],EFO_0005755,rheumatic disease
1303,IL17A,interleukin 17A,SECUKINUMAB,Antibody,CHEMBL1743068,4.0,"['NCT02763046', 'NCT03350815']",EFO_0005755,rheumatic disease
1304,GABRA3,gamma-aminobutyric acid type A receptor subunit alpha3,REMIMAZOLAM,Small molecule,CHEMBL4297526,4.0,['NCT05760534'],EFO_0005755,rheumatic disease
1305,GABRG3,gamma-aminobutyric acid type A receptor subunit gamma3,MIDAZOLAM,Small molecule,CHEMBL655,4.0,['NCT02292082'],EFO_0005755,rheumatic disease
1306,MT-ND5,mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 5,METFORMIN,Small molecule,CHEMBL1431,4.0,['NCT02741960'],EFO_0005755,rheumatic disease
1307,NR3C1,nuclear receptor subfamily 3 group C member 1,PREDNISONE,Small molecule,CHEMBL635,4.0,[],EFO_0005755,rheumatic disease
1308,SNAP25,synaptosome associated protein 25,ONABOTULINUMTOXINA,Unknown,CHEMBL1201574,4.0,['NCT01045694'],EFO_0005755,rheumatic disease
1309,PTGS1,prostaglandin-endoperoxide synthase 1,DICLOFENAC,Small molecule,CHEMBL139,4.0,['NCT03473665'],EFO_0005755,rheumatic disease
1310,TUBB,tubulin beta class I,COLCHICINE,Small molecule,CHEMBL107,4.0,['NCT04601883'],EFO_0005755,rheumatic disease
1311,IFNAR1,interferon alpha and beta receptor subunit 1,ANIFROLUMAB,Antibody,CHEMBL2364653,4.0,[],EFO_0005755,rheumatic disease
1312,ALOX5,arachidonate 5-lipoxygenase,SULFASALAZINE,Small molecule,CHEMBL421,4.0,[],EFO_0005755,rheumatic disease
1313,PTGS1,prostaglandin-endoperoxide synthase 1,IBUPROFEN,Small molecule,CHEMBL521,4.0,[],EFO_0005755,rheumatic disease
1314,PTGS2,prostaglandin-endoperoxide synthase 2,LUMIRACOXIB,Small molecule,CHEMBL404108,4.0,['NCT00419796'],EFO_0005755,rheumatic disease
1315,CD86,CD86 molecule,ABATACEPT,Protein,CHEMBL1201823,4.0,['NCT03669367'],EFO_0005755,rheumatic disease
1316,PTGS2,prostaglandin-endoperoxide synthase 2,ROFECOXIB,Small molecule,CHEMBL122,4.0,['NCT00157872'],EFO_0005755,rheumatic disease
1317,PTGS1,prostaglandin-endoperoxide synthase 1,DEXIBUPROFEN,Small molecule,CHEMBL175,4.0,['NCT01066676'],EFO_0005755,rheumatic disease
1318,PTGS1,prostaglandin-endoperoxide synthase 1,KETOROLAC,Small molecule,CHEMBL469,4.0,['NCT02765815'],EFO_0005755,rheumatic disease
1319,TYK2,tyrosine kinase 2,TOFACITINIB CITRATE,Small molecule,CHEMBL2103743,4.0,['NCT02157012'],EFO_0005755,rheumatic disease
1320,JAK1,Janus kinase 1,BARICITINIB,Small molecule,CHEMBL2105759,4.0,['NCT03915964'],EFO_0005755,rheumatic disease
1321,PDE4A,phosphodiesterase 4A,APREMILAST,Small molecule,CHEMBL514800,4.0,['NCT03783026'],EFO_0005755,rheumatic disease
1322,NDUFB8,NADH:ubiquinone oxidoreductase subunit B8,METFORMIN,Small molecule,CHEMBL1431,4.0,['NCT02741960'],EFO_0005755,rheumatic disease
1323,TUBB8,tubulin beta 8 class VIII,COLCHICINE,Small molecule,CHEMBL107,4.0,['NCT03913442'],EFO_0005755,rheumatic disease
1324,TNF,tumor necrosis factor,ADALIMUMAB,Antibody,CHEMBL1201580,4.0,"['NCT00216177', 'NCT01793519', 'NCT02035800', 'NCT02878161', 'NCT01270035', 'NCT02242474', 'NCT01405326', 'NCT00291915']",EFO_0005755,rheumatic disease
1325,PTGS2,prostaglandin-endoperoxide synthase 2,LUMIRACOXIB,Small molecule,CHEMBL404108,4.0,['NCT00170781'],EFO_0005755,rheumatic disease
1326,TUBB2A,tubulin beta 2A class IIa,COLCHICINE,Small molecule,CHEMBL107,4.0,['NCT05698680'],EFO_0005755,rheumatic disease
1327,PDE4B,phosphodiesterase 4B,APREMILAST,Small molecule,CHEMBL514800,4.0,['NCT02558361'],EFO_0005755,rheumatic disease
1328,NR3C1,nuclear receptor subfamily 3 group C member 1,METHYLPREDNISOLONE ACETATE,Small molecule,CHEMBL1364144,4.0,[],EFO_0005755,rheumatic disease
1329,PTGS2,prostaglandin-endoperoxide synthase 2,SULFASALAZINE,Small molecule,CHEMBL421,4.0,['NCT02638896'],EFO_0005755,rheumatic disease
1330,NR3C1,nuclear receptor subfamily 3 group C member 1,METHYLPREDNISOLONE,Small molecule,CHEMBL650,4.0,[],EFO_0005755,rheumatic disease
1331,SCN1A,sodium voltage-gated channel alpha subunit 1,ROPIVACAINE,Small molecule,CHEMBL1077896,4.0,['NCT03219983'],EFO_0005755,rheumatic disease
1332,SLC6A4,solute carrier family 6 member 4,MILNACIPRAN,Small molecule,CHEMBL259209,4.0,"['NCT01207453', 'NCT01225991']",EFO_0005755,rheumatic disease
1333,FAAH,fatty acid amide hydrolase,ACETAMINOPHEN,Small molecule,CHEMBL112,4.0,"['NCT03781544', 'NCT05556356']",EFO_0005755,rheumatic disease
1334,TUBB2B,tubulin beta 2B class IIb,COLCHICINE,Small molecule,CHEMBL107,4.0,"['NCT02060552', 'NCT02500641', 'NCT01451645', 'NCT01994226']",EFO_0005755,rheumatic disease
1335,SCN9A,sodium voltage-gated channel alpha subunit 9,LIDOCAINE,Small molecule,CHEMBL79,4.0,['NCT02176304'],EFO_0005755,rheumatic disease
1336,SLC6A2,solute carrier family 6 member 2,TAPENTADOL HYDROCHLORIDE,Small molecule,CHEMBL1201777,4.0,['NCT01631513'],EFO_0005755,rheumatic disease
1337,PTGS1,prostaglandin-endoperoxide synthase 1,SULFASALAZINE,Small molecule,CHEMBL421,4.0,[],EFO_0005755,rheumatic disease
1338,NDUFS5,NADH:ubiquinone oxidoreductase subunit S5,METFORMIN,Small molecule,CHEMBL1431,4.0,['NCT02741960'],EFO_0005755,rheumatic disease
1339,PTGS1,prostaglandin-endoperoxide synthase 1,IBUPROFEN,Small molecule,CHEMBL521,4.0,[],EFO_0005755,rheumatic disease
1340,ADRA2C,adrenoceptor alpha 2C,EPINEPHRINE,Small molecule,CHEMBL679,4.0,['NCT02570503'],EFO_0005755,rheumatic disease
1341,DHFR,dihydrofolate reductase,METHOTREXATE,Small molecule,CHEMBL34259,4.0,"['NCT03635957', 'NCT03994731']",EFO_0005755,rheumatic disease
1342,PTGS1,prostaglandin-endoperoxide synthase 1,DICLOFENAC,Small molecule,CHEMBL139,4.0,[],EFO_0005755,rheumatic disease
1343,RBX1,ring-box 1,THALIDOMIDE,Small molecule,CHEMBL468,4.0,['NCT03122431'],EFO_0005755,rheumatic disease
1344,NR3C1,nuclear receptor subfamily 3 group C member 1,DEXAMETHASONE PHOSPHORIC ACID,Small molecule,CHEMBL1201302,4.0,[],EFO_0005755,rheumatic disease
1345,PTGS1,prostaglandin-endoperoxide synthase 1,SULINDAC,Small molecule,CHEMBL15770,4.0,[],EFO_0005755,rheumatic disease
1346,NR3C1,nuclear receptor subfamily 3 group C member 1,METHYLPREDNISOLONE HEMISUCCINATE,Small molecule,CHEMBL1201265,4.0,['NCT00396747'],EFO_0005755,rheumatic disease
1347,TNFSF13B,TNF superfamily member 13b,BELIMUMAB,Antibody,CHEMBL1789843,4.0,"['NCT04956484', 'NCT01632241', 'NCT01597492', 'NCT01705977']",EFO_0005755,rheumatic disease
1348,PTGS1,prostaglandin-endoperoxide synthase 1,OXAPROZIN,Small molecule,CHEMBL1071,4.0,[],EFO_0005755,rheumatic disease
1349,SCN11A,sodium voltage-gated channel alpha subunit 11,LIDOCAINE,Small molecule,CHEMBL79,4.0,['NCT02102620'],EFO_0005755,rheumatic disease
1350,DHFR,dihydrofolate reductase,METHOTREXATE,Small molecule,CHEMBL34259,4.0,[],EFO_0005755,rheumatic disease
1351,PTGS2,prostaglandin-endoperoxide synthase 2,DICLOFENAC,Small molecule,CHEMBL139,4.0,[],EFO_0005755,rheumatic disease
1352,PTGS1,prostaglandin-endoperoxide synthase 1,NAPROXEN SODIUM,Small molecule,CHEMBL1200806,4.0,['NCT02501564'],EFO_0005755,rheumatic disease
1353,SCN1A,sodium voltage-gated channel alpha subunit 1,LIDOCAINE,Small molecule,CHEMBL79,4.0,[],EFO_0005755,rheumatic disease
1354,JAK2,Janus kinase 2,TOFACITINIB CITRATE,Small molecule,CHEMBL2103743,4.0,[],EFO_0005755,rheumatic disease
1355,SCN1A,sodium voltage-gated channel alpha subunit 1,ROPIVACAINE,Small molecule,CHEMBL1077896,4.0,['NCT03119038'],EFO_0005755,rheumatic disease
1356,PTGS1,prostaglandin-endoperoxide synthase 1,TOLMETIN,Small molecule,CHEMBL1020,4.0,[],EFO_0005755,rheumatic disease
1357,ADRA2C,adrenoceptor alpha 2C,CLONIDINE,Small molecule,CHEMBL134,4.0,['NCT02570503'],EFO_0005755,rheumatic disease
1358,PTGS2,prostaglandin-endoperoxide synthase 2,CELECOXIB,Small molecule,CHEMBL118,4.0,['NCT00484718'],EFO_0005755,rheumatic disease
1359,TXNRD1,thioredoxin reductase 1,AUROTHIOGLUCOSE,Small molecule,CHEMBL2354773,4.0,[],EFO_0005755,rheumatic disease
1360,PDE4D,phosphodiesterase 4D,APREMILAST,Small molecule,CHEMBL514800,4.0,['NCT03783026'],EFO_0005755,rheumatic disease
1361,SCN10A,sodium voltage-gated channel alpha subunit 10,ROPIVACAINE,Small molecule,CHEMBL1077896,4.0,"['NCT00901628', 'NCT02863120', 'NCT00562627']",EFO_0005755,rheumatic disease
1362,CD86,CD86 molecule,ABATACEPT,Protein,CHEMBL1201823,4.0,['NCT02652273'],EFO_0005755,rheumatic disease
1363,PTGS2,prostaglandin-endoperoxide synthase 2,CELECOXIB,Small molecule,CHEMBL118,4.0,"['NCT00638807', 'NCT01860833', 'NCT00194090', 'NCT01425853', 'NCT00139776', 'NCT00630929', 'NCT00640627', 'NCT00620867', 'NCT00643799']",EFO_0005755,rheumatic disease
1364,TUBB6,tubulin beta 6 class V,COLCHICINE,Small molecule,CHEMBL107,4.0,['NCT02602028'],EFO_0005755,rheumatic disease
1365,CD86,CD86 molecule,ABATACEPT,Protein,CHEMBL1201823,4.0,['NCT03882008'],EFO_0005755,rheumatic disease
1366,ADRB1,adrenoceptor beta 1,EPINEPHRINE,Small molecule,CHEMBL679,4.0,['NCT03119038'],EFO_0005755,rheumatic disease
1367,NR3C1,nuclear receptor subfamily 3 group C member 1,PREDNISOLONE,Small molecule,CHEMBL131,4.0,[],EFO_0005755,rheumatic disease
1368,ATP4A,ATPase H+/K+ transporting subunit alpha,ESOMEPRAZOLE MAGNESIUM,Small molecule,CHEMBL2146133,4.0,[],EFO_0005755,rheumatic disease
1369,NR3C1,nuclear receptor subfamily 3 group C member 1,DEXAMETHASONE,Small molecule,CHEMBL384467,4.0,[],EFO_0005755,rheumatic disease
1370,ALOX5,arachidonate 5-lipoxygenase,SULFASALAZINE,Small molecule,CHEMBL421,4.0,['NCT02638896'],EFO_0005755,rheumatic disease
1371,PTGS2,prostaglandin-endoperoxide synthase 2,KETOROLAC,Small molecule,CHEMBL469,4.0,['NCT02765815'],EFO_0005755,rheumatic disease
1372,SCN4A,sodium voltage-gated channel alpha subunit 4,BUPIVACAINE,Small molecule,CHEMBL1098,4.0,"['NCT02765815', 'NCT02365727']",EFO_0005755,rheumatic disease
1373,MC2R,melanocortin 2 receptor,CORTICOTROPIN,Protein,CHEMBL1201610,4.0,['NCT02920710'],EFO_0005755,rheumatic disease
1374,NR3C1,nuclear receptor subfamily 3 group C member 1,METHYLPREDNISOLONE,Small molecule,CHEMBL650,4.0,[],EFO_0005755,rheumatic disease
1375,PTGS2,prostaglandin-endoperoxide synthase 2,NAPROXEN,Small molecule,CHEMBL154,4.0,"['NCT02500641', 'NCT01994226']",EFO_0005755,rheumatic disease
1376,OPRK1,opioid receptor kappa 1,NALTREXONE,Small molecule,CHEMBL19019,4.0,['NCT00908089'],EFO_0005755,rheumatic disease
1377,SCN5A,sodium voltage-gated channel alpha subunit 5,LIDOCAINE,Small molecule,CHEMBL79,4.0,['NCT00904605'],EFO_0005755,rheumatic disease
1378,NR3C1,nuclear receptor subfamily 3 group C member 1,METHYLPREDNISOLONE SODIUM SUCCINATE,Small molecule,CHEMBL1201081,4.0,[],EFO_0005755,rheumatic disease
1379,GABRA1,gamma-aminobutyric acid type A receptor subunit alpha1,REMIMAZOLAM,Small molecule,CHEMBL4297526,4.0,['NCT05760534'],EFO_0005755,rheumatic disease
1380,JAK3,Janus kinase 3,TOFACITINIB,Small molecule,CHEMBL221959,4.0,"['NCT04485325', 'NCT04928066', 'NCT02157012', 'NCT03976245', 'NCT05606107', 'NCT04927000']",EFO_0005755,rheumatic disease
1381,NR3C1,nuclear receptor subfamily 3 group C member 1,TRIAMCINOLONE ACETONIDE,Small molecule,CHEMBL1504,4.0,['NCT03636373'],EFO_0005755,rheumatic disease
1382,GUCY1A2,guanylate cyclase 1 soluble subunit alpha 2,RIOCIGUAT,Small molecule,CHEMBL2107834,4.0,['NCT02625558'],EFO_0005755,rheumatic disease
1383,TUBB4A,tubulin beta 4A class IVa,COLCHICINE,Small molecule,CHEMBL107,4.0,"['NCT02060552', 'NCT02500641', 'NCT01994226', 'NCT01451645']",EFO_0005755,rheumatic disease
1384,SCN1A,sodium voltage-gated channel alpha subunit 1,ROPIVACAINE,Small molecule,CHEMBL1077896,4.0,['NCT02570503'],EFO_0005755,rheumatic disease
1385,SCN5A,sodium voltage-gated channel alpha subunit 5,ROPIVACAINE,Small molecule,CHEMBL1077896,4.0,['NCT02570503'],EFO_0005755,rheumatic disease
1386,HMGCR,3-hydroxy-3-methylglutaryl-CoA reductase,ATORVASTATIN,Small molecule,CHEMBL1487,4.0,['NCT00120887'],EFO_0005755,rheumatic disease
1387,FLT4,fms related receptor tyrosine kinase 4,NINTEDANIB ESYLATE,Small molecule,CHEMBL3039504,4.0,[],EFO_0005755,rheumatic disease
1388,PTH1R,parathyroid hormone 1 receptor,TERIPARATIDE,Protein,CHEMBL525610,4.0,['NCT01400516'],EFO_0005755,rheumatic disease
1389,SCN3A,sodium voltage-gated channel alpha subunit 3,LIDOCAINE,Small molecule,CHEMBL79,4.0,['NCT00904605'],EFO_0005755,rheumatic disease
1390,JAK1,Janus kinase 1,FILGOTINIB,Small molecule,CHEMBL3301607,4.0,['NCT04985435'],EFO_0005755,rheumatic disease
1391,NR3C1,nuclear receptor subfamily 3 group C member 1,TRIAMCINOLONE HEXACETONIDE,Small molecule,CHEMBL1200878,4.0,['NCT04614311'],EFO_0005755,rheumatic disease
1392,NR3C1,nuclear receptor subfamily 3 group C member 1,BETAMETHASONE PHOSPHORIC ACID,Small molecule,CHEMBL1201207,4.0,['NCT05139875'],EFO_0005755,rheumatic disease
1393,TLR9,toll like receptor 9,HYDROXYCHLOROQUINE SULFATE,Small molecule,CHEMBL1690,4.0,[],EFO_0005755,rheumatic disease
1394,NDUFA10,NADH:ubiquinone oxidoreductase subunit A10,METFORMIN,Small molecule,CHEMBL1431,4.0,['NCT02741960'],EFO_0005755,rheumatic disease
1395,ADRA2B,adrenoceptor alpha 2B,EPINEPHRINE,Small molecule,CHEMBL679,4.0,"['NCT02464176', 'NCT03513276']",EFO_0005755,rheumatic disease
1396,GABRA5,gamma-aminobutyric acid type A receptor subunit alpha5,PROPOFOL,Small molecule,CHEMBL526,4.0,"['NCT02292082', 'NCT02784626', 'NCT03540030']",EFO_0005755,rheumatic disease
1397,SCN4A,sodium voltage-gated channel alpha subunit 4,LIDOCAINE,Small molecule,CHEMBL79,4.0,['NCT00904605'],EFO_0005755,rheumatic disease
1398,PTGS2,prostaglandin-endoperoxide synthase 2,DEXIBUPROFEN,Small molecule,CHEMBL175,4.0,[],EFO_0005755,rheumatic disease
1399,FAAH,fatty acid amide hydrolase,ACETAMINOPHEN,Small molecule,CHEMBL112,4.0,"['NCT01382940', 'NCT00246168']",EFO_0005755,rheumatic disease
1400,MT-ND6,mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 6,METFORMIN,Small molecule,CHEMBL1431,4.0,['NCT02741960'],EFO_0005755,rheumatic disease
1401,PTGS2,prostaglandin-endoperoxide synthase 2,INDOPROFEN,Small molecule,CHEMBL15870,4.0,[],EFO_0005755,rheumatic disease
1402,GABRB3,gamma-aminobutyric acid type A receptor subunit beta3,SEVOFLURANE,Small molecule,CHEMBL1200694,4.0,['NCT03540030'],EFO_0005755,rheumatic disease
1403,SCN10A,sodium voltage-gated channel alpha subunit 10,ROPIVACAINE,Small molecule,CHEMBL1077896,4.0,"['NCT03801265', 'NCT03513276']",EFO_0005755,rheumatic disease
1404,ADRA1D,adrenoceptor alpha 1D,EPINEPHRINE,Small molecule,CHEMBL679,4.0,"['NCT02365727', 'NCT02765815']",EFO_0005755,rheumatic disease
1405,PTGS1,prostaglandin-endoperoxide synthase 1,MECLOFENAMATE SODIUM,Small molecule,CHEMBL1562610,4.0,[],EFO_0005755,rheumatic disease
1406,ADRB1,adrenoceptor beta 1,EPINEPHRINE,Small molecule,CHEMBL679,4.0,['NCT02570503'],EFO_0005755,rheumatic disease
1407,TNF,tumor necrosis factor,ETANERCEPT,Protein,CHEMBL1201572,4.0,"['NCT01934933', 'NCT02364479', 'NCT02915354', 'NCT00247962', 'NCT00458185', 'NCT02509026', 'NCT00410046', 'NCT00420238', 'NCT00444340', 'NCT00873730', 'NCT01298531']",EFO_0005755,rheumatic disease
1408,FGB,fibrinogen beta chain,"FIBRINOGEN, HUMAN",Unknown,CHEMBL2109072,4.0,['NCT01235715'],EFO_0005755,rheumatic disease
1409,SCN9A,sodium voltage-gated channel alpha subunit 9,ROPIVACAINE,Small molecule,CHEMBL1077896,4.0,"['NCT02576249', 'NCT01537146', 'NCT00620828', 'NCT02365181', 'NCT02658149']",EFO_0005755,rheumatic disease
1410,GABRG1,gamma-aminobutyric acid type A receptor subunit gamma1,SEVOFLURANE,Small molecule,CHEMBL1200694,4.0,['NCT03540030'],EFO_0005755,rheumatic disease
1411,TUBB2B,tubulin beta 2B class IIb,COLCHICINE,Small molecule,CHEMBL107,4.0,['NCT03913442'],EFO_0005755,rheumatic disease
1412,TRPV1,transient receptor potential cation channel subfamily V member 1,ACETAMINOPHEN,Small molecule,CHEMBL112,4.0,"['NCT03781544', 'NCT05556356']",EFO_0005755,rheumatic disease
1413,KCNN4,potassium calcium-activated channel subfamily N member 4,CHLORZOXAZONE,Small molecule,CHEMBL1371,4.0,['NCT02405104'],EFO_0005755,rheumatic disease
1414,SCN3A,sodium voltage-gated channel alpha subunit 3,ROPIVACAINE,Small molecule,CHEMBL1077896,4.0,"['NCT00901628', 'NCT00562627', 'NCT02863120']",EFO_0005755,rheumatic disease
1415,SCN11A,sodium voltage-gated channel alpha subunit 11,ROPIVACAINE,Small molecule,CHEMBL1077896,4.0,['NCT02570503'],EFO_0005755,rheumatic disease
1416,PTGS2,prostaglandin-endoperoxide synthase 2,ACECLOFENAC,Small molecule,CHEMBL93645,4.0,['NCT04144101'],EFO_0005755,rheumatic disease
1417,TNFSF11,TNF superfamily member 11,DENOSUMAB,Antibody,CHEMBL1237023,4.0,['NCT01770106'],EFO_0005755,rheumatic disease
1418,PTGS1,prostaglandin-endoperoxide synthase 1,ACETAMINOPHEN,Small molecule,CHEMBL112,4.0,"['NCT03781544', 'NCT05556356']",EFO_0005755,rheumatic disease
1419,TNFSF13B,TNF superfamily member 13b,BELIMUMAB,Antibody,CHEMBL1789843,4.0,"['NCT03543839', 'NCT04515719', 'NCT04908865', 'NCT04447053']",EFO_0005755,rheumatic disease
1420,GABRA1,gamma-aminobutyric acid type A receptor subunit alpha1,MIDAZOLAM,Small molecule,CHEMBL655,4.0,['NCT02292082'],EFO_0005755,rheumatic disease
1421,GABRA2,gamma-aminobutyric acid type A receptor subunit alpha2,REMIMAZOLAM,Small molecule,CHEMBL4297526,4.0,['NCT05760534'],EFO_0005755,rheumatic disease
1422,SCN11A,sodium voltage-gated channel alpha subunit 11,LIDOCAINE,Small molecule,CHEMBL79,4.0,['NCT00904605'],EFO_0005755,rheumatic disease
1423,PTGS1,prostaglandin-endoperoxide synthase 1,DICLOFENAC SODIUM,Small molecule,CHEMBL1034,4.0,[],EFO_0005755,rheumatic disease
1424,SCN10A,sodium voltage-gated channel alpha subunit 10,MEPIVACAINE,Small molecule,CHEMBL1087,4.0,['NCT04257682'],EFO_0005755,rheumatic disease
1425,DHODH,dihydroorotate dehydrogenase (quinone),LEFLUNOMIDE,Small molecule,CHEMBL960,4.0,['NCT03797872'],EFO_0005755,rheumatic disease
1426,DHODH,dihydroorotate dehydrogenase (quinone),LEFLUNOMIDE,Small molecule,CHEMBL960,4.0,"['NCT02451748', 'NCT00451971', 'NCT01172639', 'NCT00563849', 'NCT03449758', 'NCT00422227', 'NCT02644499', 'NCT00280644']",EFO_0005755,rheumatic disease
1427,GABRA3,gamma-aminobutyric acid type A receptor subunit alpha3,SEVOFLURANE,Small molecule,CHEMBL1200694,4.0,['NCT03540030'],EFO_0005755,rheumatic disease
1428,SCN9A,sodium voltage-gated channel alpha subunit 9,ROPIVACAINE,Small molecule,CHEMBL1077896,4.0,['NCT04257682'],EFO_0005755,rheumatic disease
1429,SCN8A,sodium voltage-gated channel alpha subunit 8,LIDOCAINE,Small molecule,CHEMBL79,4.0,['NCT02102620'],EFO_0005755,rheumatic disease
1430,PTGS2,prostaglandin-endoperoxide synthase 2,MECLOFENAMIC ACID,Small molecule,CHEMBL509,4.0,[],EFO_0005755,rheumatic disease
1431,PTGS1,prostaglandin-endoperoxide synthase 1,DICLOFENAC,Small molecule,CHEMBL139,4.0,['NCT03781544'],EFO_0005755,rheumatic disease
1432,JAK3,Janus kinase 3,TOFACITINIB CITRATE,Small molecule,CHEMBL2103743,4.0,[],EFO_0005755,rheumatic disease
1433,PTGS1,prostaglandin-endoperoxide synthase 1,FLURBIPROFEN,Small molecule,CHEMBL563,4.0,[],EFO_0005755,rheumatic disease
1434,SCN4A,sodium voltage-gated channel alpha subunit 4,ROPIVACAINE,Small molecule,CHEMBL1077896,4.0,"['NCT03513276', 'NCT03801265']",EFO_0005755,rheumatic disease
1435,EPOR,erythropoietin receptor,EPOETIN BETA,Protein,CHEMBL2109092,4.0,['NCT00998088'],EFO_0005755,rheumatic disease
1436,PTGS2,prostaglandin-endoperoxide synthase 2,DICLOFENAC,Small molecule,CHEMBL139,4.0,['NCT01067430'],EFO_0005755,rheumatic disease
1437,ALOX5,arachidonate 5-lipoxygenase,SULFASALAZINE,Small molecule,CHEMBL421,4.0,['NCT04077957'],EFO_0005755,rheumatic disease
1438,TNF,tumor necrosis factor,ADALIMUMAB,Antibody,CHEMBL1201580,4.0,"['NCT02897115', 'NCT00726804']",EFO_0005755,rheumatic disease
1439,GABRA2,gamma-aminobutyric acid type A receptor subunit alpha2,PROPOFOL,Small molecule,CHEMBL526,4.0,"['NCT02784626', 'NCT02292082', 'NCT03540030']",EFO_0005755,rheumatic disease
1440,ADRA1A,adrenoceptor alpha 1A,EPINEPHRINE,Small molecule,CHEMBL679,4.0,"['NCT03513276', 'NCT02464176']",EFO_0005755,rheumatic disease
1441,ADRA1A,adrenoceptor alpha 1A,EPINEPHRINE,Small molecule,CHEMBL679,4.0,['NCT03119038'],EFO_0005755,rheumatic disease
1442,SCN3A,sodium voltage-gated channel alpha subunit 3,ROPIVACAINE,Small molecule,CHEMBL1077896,4.0,['NCT04257682'],EFO_0005755,rheumatic disease
1443,SLC6A3,solute carrier family 6 member 3,METHYLPHENIDATE,Small molecule,CHEMBL796,4.0,['NCT00361387'],EFO_0005755,rheumatic disease
1444,JAK3,Janus kinase 3,TOFACITINIB CITRATE,Small molecule,CHEMBL2103743,4.0,[],EFO_0005755,rheumatic disease
1445,PTGS1,prostaglandin-endoperoxide synthase 1,DEXIBUPROFEN,Small molecule,CHEMBL175,4.0,[],EFO_0005755,rheumatic disease
1446,TNF,tumor necrosis factor,ETANERCEPT,Protein,CHEMBL1201572,4.0,"['NCT00099554', 'NCT00259610', 'NCT00195494', 'NCT00094341', 'NCT00132418', 'NCT00252668', 'NCT02092467', 'NCT00422227', 'NCT00848354', 'NCT02374021', 'NCT00858780', 'NCT01331837', 'NCT00768053', 'NCT00837434', 'NCT00565409', 'NCT00346294', 'NCT00654368', 'NCT00546533', 'NCT00115219', 'NCT00913458', 'NCT02433184', 'NCT00244556', 'NCT01578850', 'NCT01000441', 'NCT01313208', 'NCT01303874', 'NCT01021735', 'NCT01295151']",EFO_0005755,rheumatic disease
1447,SCN11A,sodium voltage-gated channel alpha subunit 11,ROPIVACAINE,Small molecule,CHEMBL1077896,4.0,['NCT02299271'],EFO_0005755,rheumatic disease
1448,KCNK10,potassium two pore domain channel subfamily K member 10,DESFLURANE,Small molecule,CHEMBL1200733,4.0,['NCT03540030'],EFO_0005755,rheumatic disease
1449,PTGS2,prostaglandin-endoperoxide synthase 2,DICLOFENAC POTASSIUM,Small molecule,CHEMBL1200804,4.0,[],EFO_0005755,rheumatic disease
1450,TLR7,toll like receptor 7,HYDROXYCHLOROQUINE,Small molecule,CHEMBL1535,4.0,"['NCT05626348', 'NCT02714634']",EFO_0005755,rheumatic disease
1451,PTGS2,prostaglandin-endoperoxide synthase 2,NAPROXEN,Small molecule,CHEMBL154,4.0,['NCT05430230'],EFO_0005755,rheumatic disease
1452,TUBB2B,tubulin beta 2B class IIb,COLCHICINE,Small molecule,CHEMBL107,4.0,['NCT02602028'],EFO_0005755,rheumatic disease
1453,SCN8A,sodium voltage-gated channel alpha subunit 8,ROPIVACAINE,Small molecule,CHEMBL1077896,4.0,['NCT02365727'],EFO_0005755,rheumatic disease
1454,SLC22A12,solute carrier family 22 member 12,LESINURAD,Small molecule,CHEMBL2105720,4.0,[],EFO_0005755,rheumatic disease
1455,TUBB8,tubulin beta 8 class VIII,COLCHICINE,Small molecule,CHEMBL107,4.0,['NCT02602028'],EFO_0005755,rheumatic disease
1456,GPD2,glycerol-3-phosphate dehydrogenase 2,METFORMIN,Small molecule,CHEMBL1431,4.0,['NCT02741960'],EFO_0005755,rheumatic disease
1457,SLC6A4,solute carrier family 6 member 4,DULOXETINE HYDROCHLORIDE,Small molecule,CHEMBL1200328,4.0,['NCT03792828'],EFO_0005755,rheumatic disease
1458,NR3C2,nuclear receptor subfamily 3 group C member 2,SPIRONOLACTONE,Small molecule,CHEMBL1393,4.0,['NCT02046668'],EFO_0005755,rheumatic disease
1459,OPRM1,opioid receptor mu 1,MORPHINE,Small molecule,CHEMBL70,4.0,"['NCT02292082', 'NCT02658149']",EFO_0005755,rheumatic disease
1460,TNF,tumor necrosis factor,GOLIMUMAB,Antibody,CHEMBL1201833,4.0,[],EFO_0005755,rheumatic disease
1461,NR3C1,nuclear receptor subfamily 3 group C member 1,PREDNISONE,Small molecule,CHEMBL635,4.0,[],EFO_0005755,rheumatic disease
1462,DHFR,dihydrofolate reductase,METHOTREXATE,Small molecule,CHEMBL34259,4.0,['NCT03505008'],EFO_0005755,rheumatic disease
1463,EDNRA,endothelin receptor type A,BOSENTAN,Small molecule,CHEMBL957,4.0,"['NCT02480335', 'NCT01395732']",EFO_0005755,rheumatic disease
1464,RBX1,ring-box 1,LENALIDOMIDE,Small molecule,CHEMBL848,4.0,['NCT01408199'],EFO_0005755,rheumatic disease
1465,SCN7A,sodium voltage-gated channel alpha subunit 7,PRILOCAINE,Small molecule,CHEMBL1194,4.0,['NCT02384915'],EFO_0005755,rheumatic disease
1466,TNF,tumor necrosis factor,ETANERCEPT,Protein,CHEMBL1201572,4.0,"['NCT00783536', 'NCT01009879']",EFO_0005755,rheumatic disease
1467,FLT1,fms related receptor tyrosine kinase 1,NINTEDANIB ESYLATE,Small molecule,CHEMBL3039504,4.0,[],EFO_0005755,rheumatic disease
1468,ADRA1B,adrenoceptor alpha 1B,EPINEPHRINE,Small molecule,CHEMBL679,4.0,"['NCT02765815', 'NCT02365727']",EFO_0005755,rheumatic disease
1469,PTGS2,prostaglandin-endoperoxide synthase 2,DIFLUNISAL,Small molecule,CHEMBL898,4.0,[],EFO_0005755,rheumatic disease
1470,NDUFB9,NADH:ubiquinone oxidoreductase subunit B9,METFORMIN,Small molecule,CHEMBL1431,4.0,['NCT02741960'],EFO_0005755,rheumatic disease
1471,SCN1A,sodium voltage-gated channel alpha subunit 1,LIDOCAINE,Small molecule,CHEMBL79,4.0,['NCT02176304'],EFO_0005755,rheumatic disease
1472,PTGS2,prostaglandin-endoperoxide synthase 2,INDOMETHACIN,Small molecule,CHEMBL6,4.0,[],EFO_0005755,rheumatic disease
1473,PTGS1,prostaglandin-endoperoxide synthase 1,PIRPROFEN,Small molecule,CHEMBL188952,4.0,[],EFO_0005755,rheumatic disease
1474,GABRD,gamma-aminobutyric acid type A receptor subunit delta,SEVOFLURANE,Small molecule,CHEMBL1200694,4.0,['NCT03540030'],EFO_0005755,rheumatic disease
1475,NR3C1,nuclear receptor subfamily 3 group C member 1,METHYLPREDNISOLONE HEMISUCCINATE,Small molecule,CHEMBL1201265,4.0,[],EFO_0005755,rheumatic disease
1476,PTGS2,prostaglandin-endoperoxide synthase 2,NAPROXEN,Small molecule,CHEMBL154,4.0,[],EFO_0005755,rheumatic disease
1477,PDE4B,phosphodiesterase 4B,APREMILAST,Small molecule,CHEMBL514800,4.0,['NCT03747939'],EFO_0005755,rheumatic disease
1478,SCN5A,sodium voltage-gated channel alpha subunit 5,ROPIVACAINE,Small molecule,CHEMBL1077896,4.0,"['NCT02863120', 'NCT00562627', 'NCT00901628']",EFO_0005755,rheumatic disease
1479,SCN4A,sodium voltage-gated channel alpha subunit 4,BUPIVACAINE,Small molecule,CHEMBL1098,4.0,"['NCT02777749', 'NCT02697955', 'NCT03653416', 'NCT02011464', 'NCT02292082', 'NCT00542139']",EFO_0005755,rheumatic disease
1480,GUCY1B2,guanylate cyclase 1 soluble subunit beta 2 (pseudogene),RIOCIGUAT,Small molecule,CHEMBL2107834,4.0,['NCT02625558'],EFO_0005755,rheumatic disease
1481,CD86,CD86 molecule,ABATACEPT,Protein,CHEMBL1201823,4.0,['NCT01717846'],EFO_0005755,rheumatic disease
1482,NR3C1,nuclear receptor subfamily 3 group C member 1,HYDROCORTISONE PROBUTATE,Small molecule,CHEMBL1200953,4.0,[],EFO_0005755,rheumatic disease
1483,NDUFS2,NADH:ubiquinone oxidoreductase core subunit S2,METFORMIN,Small molecule,CHEMBL1431,4.0,['NCT02741960'],EFO_0005755,rheumatic disease
1484,PTGS1,prostaglandin-endoperoxide synthase 1,NAPROXEN,Small molecule,CHEMBL154,4.0,[],EFO_0005755,rheumatic disease
1485,SCN5A,sodium voltage-gated channel alpha subunit 5,ROPIVACAINE,Small molecule,CHEMBL1077896,4.0,['NCT04257682'],EFO_0005755,rheumatic disease
1486,TNF,tumor necrosis factor,ETANERCEPT,Protein,CHEMBL1201572,4.0,['NCT05080218'],EFO_0005755,rheumatic disease
1487,PTGS2,prostaglandin-endoperoxide synthase 2,SULFASALAZINE,Small molecule,CHEMBL421,4.0,['NCT00908089'],EFO_0005755,rheumatic disease
1488,SCN9A,sodium voltage-gated channel alpha subunit 9,LIDOCAINE,Small molecule,CHEMBL79,4.0,[],EFO_0005755,rheumatic disease
1489,OPRM1,opioid receptor mu 1,TRAMADOL,Small molecule,CHEMBL1237044,4.0,['NCT03781544'],EFO_0005755,rheumatic disease
1490,SLC6A4,solute carrier family 6 member 4,DULOXETINE,Small molecule,CHEMBL1175,4.0,['NCT03792828'],EFO_0005755,rheumatic disease
1491,TUBB3,tubulin beta 3 class III,COLCHICINE,Small molecule,CHEMBL107,4.0,['NCT03913442'],EFO_0005755,rheumatic disease
1492,JAK1,Janus kinase 1,BARICITINIB,Small molecule,CHEMBL2105759,4.0,['NCT05300932'],EFO_0005755,rheumatic disease
1493,IMPDH1,inosine monophosphate dehydrogenase 1,MYCOPHENOLATE SODIUM,Small molecule,CHEMBL2106643,4.0,['NCT01112215'],EFO_0005755,rheumatic disease
1494,CHRNB1,cholinergic receptor nicotinic beta 1 subunit,VECURONIUM,Small molecule,CHEMBL1201219,4.0,['NCT03540030'],EFO_0005755,rheumatic disease
1495,SLC6A2,solute carrier family 6 member 2,DULOXETINE HYDROCHLORIDE,Small molecule,CHEMBL1200328,4.0,['NCT03792828'],EFO_0005755,rheumatic disease
1496,TNF,tumor necrosis factor,GOLIMUMAB,Antibody,CHEMBL1201833,4.0,['NCT01295151'],EFO_0005755,rheumatic disease
1497,SCN1A,sodium voltage-gated channel alpha subunit 1,ROPIVACAINE HYDROCHLORIDE,Small molecule,CHEMBL1889140,4.0,['NCT00620828'],EFO_0005755,rheumatic disease
1498,IL1B,interleukin 1 beta,CANAKINUMAB,Antibody,CHEMBL1201834,4.0,[],EFO_0005755,rheumatic disease
1499,SCN2A,sodium voltage-gated channel alpha subunit 2,MEPIVACAINE,Small molecule,CHEMBL1087,4.0,['NCT02384915'],EFO_0005755,rheumatic disease
1500,JAK2,Janus kinase 2,TOFACITINIB,Small molecule,CHEMBL221959,4.0,['NCT05080218'],EFO_0005755,rheumatic disease
1501,ADRA1B,adrenoceptor alpha 1B,EPINEPHRINE,Small molecule,CHEMBL679,4.0,"['NCT00901628', 'NCT00562627', 'NCT02462148']",EFO_0005755,rheumatic disease
1502,PDE4A,phosphodiesterase 4A,APREMILAST,Small molecule,CHEMBL514800,4.0,[],EFO_0005755,rheumatic disease
1503,NDUFS6,NADH:ubiquinone oxidoreductase subunit S6,METFORMIN,Small molecule,CHEMBL1431,4.0,['NCT02741960'],EFO_0005755,rheumatic disease
1504,SCN8A,sodium voltage-gated channel alpha subunit 8,ROPIVACAINE HYDROCHLORIDE,Small molecule,CHEMBL1889140,4.0,['NCT00620828'],EFO_0005755,rheumatic disease
1505,PTGS2,prostaglandin-endoperoxide synthase 2,SULFASALAZINE,Small molecule,CHEMBL421,4.0,['NCT03797872'],EFO_0005755,rheumatic disease
1506,CRBN,cereblon,THALIDOMIDE,Small molecule,CHEMBL468,4.0,['NCT03122431'],EFO_0005755,rheumatic disease
1507,NDUFB6,NADH:ubiquinone oxidoreductase subunit B6,METFORMIN,Small molecule,CHEMBL1431,4.0,['NCT02741960'],EFO_0005755,rheumatic disease
1508,PDGFRB,platelet derived growth factor receptor beta,NINTEDANIB,Small molecule,CHEMBL502835,4.0,[],EFO_0005755,rheumatic disease
1509,PTGS1,prostaglandin-endoperoxide synthase 1,ASPIRIN,Small molecule,CHEMBL25,4.0,[],EFO_0005755,rheumatic disease
1510,JAK2,Janus kinase 2,TOFACITINIB,Small molecule,CHEMBL221959,4.0,[],EFO_0005755,rheumatic disease
1511,PTGS1,prostaglandin-endoperoxide synthase 1,NAPROXEN SODIUM,Small molecule,CHEMBL1200806,4.0,[],EFO_0005755,rheumatic disease
1512,SCN8A,sodium voltage-gated channel alpha subunit 8,MEPIVACAINE,Small molecule,CHEMBL1087,4.0,['NCT02384915'],EFO_0005755,rheumatic disease
1513,PTGS2,prostaglandin-endoperoxide synthase 2,KETOPROFEN,Small molecule,CHEMBL571,4.0,[],EFO_0005755,rheumatic disease
1514,SCN1A,sodium voltage-gated channel alpha subunit 1,ROPIVACAINE,Small molecule,CHEMBL1077896,4.0,"['NCT01537146', 'NCT00620828', 'NCT02576249', 'NCT02658149', 'NCT02365181']",EFO_0005755,rheumatic disease
1515,NR3C1,nuclear receptor subfamily 3 group C member 1,PREDNISOLONE,Small molecule,CHEMBL131,4.0,[],EFO_0005755,rheumatic disease
1516,SCN2A,sodium voltage-gated channel alpha subunit 2,LIDOCAINE,Small molecule,CHEMBL79,4.0,['NCT01045694'],EFO_0005755,rheumatic disease
1517,TNF,tumor necrosis factor,ADALIMUMAB,Antibody,CHEMBL1201580,4.0,[],EFO_0005755,rheumatic disease
1518,GABRA3,gamma-aminobutyric acid type A receptor subunit alpha3,PROPOFOL,Small molecule,CHEMBL526,4.0,"['NCT02292082', 'NCT02784626', 'NCT03540030']",EFO_0005755,rheumatic disease
1519,IL1B,interleukin 1 beta,CANAKINUMAB,Antibody,CHEMBL1201834,4.0,[],EFO_0005755,rheumatic disease
1520,PLG,plasminogen,TRANEXAMIC ACID,Small molecule,CHEMBL877,4.0,"['NCT01873768', 'NCT02278263', 'NCT01940523']",EFO_0005755,rheumatic disease
1521,TLR7,toll like receptor 7,HYDROXYCHLOROQUINE,Small molecule,CHEMBL1535,4.0,['NCT05666336'],EFO_0005755,rheumatic disease
1522,PTGS1,prostaglandin-endoperoxide synthase 1,SULFASALAZINE,Small molecule,CHEMBL421,4.0,['NCT00908089'],EFO_0005755,rheumatic disease
1523,PTGS1,prostaglandin-endoperoxide synthase 1,MECLOFENAMIC ACID,Small molecule,CHEMBL509,4.0,[],EFO_0005755,rheumatic disease
1524,NDUFAF3,NADH:ubiquinone oxidoreductase complex assembly factor 3,METFORMIN,Small molecule,CHEMBL1431,4.0,['NCT02741960'],EFO_0005755,rheumatic disease
1525,SCN11A,sodium voltage-gated channel alpha subunit 11,MEPIVACAINE,Small molecule,CHEMBL1087,4.0,['NCT02384915'],EFO_0005755,rheumatic disease
1526,NR3C1,nuclear receptor subfamily 3 group C member 1,TRIAMCINOLONE,Small molecule,CHEMBL1451,4.0,['NCT03586687'],EFO_0005755,rheumatic disease
1527,PTGS2,prostaglandin-endoperoxide synthase 2,INDOMETHACIN,Small molecule,CHEMBL6,4.0,[],EFO_0005755,rheumatic disease
1528,PTGS2,prostaglandin-endoperoxide synthase 2,KETOROLAC,Small molecule,CHEMBL469,4.0,['NCT02612272'],EFO_0005755,rheumatic disease
1529,SCN8A,sodium voltage-gated channel alpha subunit 8,ROPIVACAINE,Small molecule,CHEMBL1077896,4.0,['NCT04155983'],EFO_0005755,rheumatic disease
1530,CHRNG,cholinergic receptor nicotinic gamma subunit,VECURONIUM,Small molecule,CHEMBL1201219,4.0,['NCT03540030'],EFO_0005755,rheumatic disease
1531,TUBB2B,tubulin beta 2B class IIb,COLCHICINE,Small molecule,CHEMBL107,4.0,[],EFO_0005755,rheumatic disease
1532,PTGS2,prostaglandin-endoperoxide synthase 2,NAPROXEN,Small molecule,CHEMBL154,4.0,[],EFO_0005755,rheumatic disease
1533,PTGS1,prostaglandin-endoperoxide synthase 1,TOLMETIN SODIUM,Small molecule,CHEMBL1200613,4.0,[],EFO_0005755,rheumatic disease
1534,ATP4A,ATPase H+/K+ transporting subunit alpha,ESOMEPRAZOLE,Small molecule,CHEMBL1201320,4.0,[],EFO_0005755,rheumatic disease
1535,ADRA2C,adrenoceptor alpha 2C,CLONIDINE,Small molecule,CHEMBL134,4.0,['NCT03119038'],EFO_0005755,rheumatic disease
1536,PTGS2,prostaglandin-endoperoxide synthase 2,SULFASALAZINE,Small molecule,CHEMBL421,4.0,[],EFO_0005755,rheumatic disease
1537,SCN2A,sodium voltage-gated channel alpha subunit 2,ROPIVACAINE,Small molecule,CHEMBL1077896,4.0,['NCT02570503'],EFO_0005755,rheumatic disease
1538,TNFSF11,TNF superfamily member 11,DENOSUMAB,Antibody,CHEMBL1237023,4.0,['NCT05559268'],EFO_0005755,rheumatic disease
1539,NR3C1,nuclear receptor subfamily 3 group C member 1,METHYLPREDNISOLONE ACETATE,Small molecule,CHEMBL1364144,4.0,['NCT02451748'],EFO_0005755,rheumatic disease
1540,TLR7,toll like receptor 7,HYDROXYCHLOROQUINE,Small molecule,CHEMBL1535,4.0,[],EFO_0005755,rheumatic disease
1541,OPRM1,opioid receptor mu 1,TAPENTADOL HYDROCHLORIDE,Small molecule,CHEMBL1201777,4.0,['NCT01631513'],EFO_0005755,rheumatic disease
1542,TNF,tumor necrosis factor,ETANERCEPT,Protein,CHEMBL1201572,4.0,"['NCT00432406', 'NCT00245960', 'NCT00127842']",EFO_0005755,rheumatic disease
1543,TNF,tumor necrosis factor,ADALIMUMAB,Antibody,CHEMBL1201580,4.0,[],EFO_0005755,rheumatic disease
1544,PDGFRA,platelet derived growth factor receptor alpha,NINTEDANIB ESYLATE,Small molecule,CHEMBL3039504,4.0,[],EFO_0005755,rheumatic disease
1545,PTGS1,prostaglandin-endoperoxide synthase 1,DICLOFENAC,Small molecule,CHEMBL139,4.0,[],EFO_0005755,rheumatic disease
1546,SCN10A,sodium voltage-gated channel alpha subunit 10,LIDOCAINE,Small molecule,CHEMBL79,4.0,[],EFO_0005755,rheumatic disease
1547,KDR,kinase insert domain receptor,NINTEDANIB ESYLATE,Small molecule,CHEMBL3039504,4.0,[],EFO_0005755,rheumatic disease
1548,SLC6A2,solute carrier family 6 member 2,DULOXETINE,Small molecule,CHEMBL1175,4.0,['NCT03792828'],EFO_0005755,rheumatic disease
1549,JAK3,Janus kinase 3,TOFACITINIB CITRATE,Small molecule,CHEMBL2103743,4.0,['NCT02157012'],EFO_0005755,rheumatic disease
1550,SCN3A,sodium voltage-gated channel alpha subunit 3,ROPIVACAINE HYDROCHLORIDE,Small molecule,CHEMBL1889140,4.0,['NCT00620828'],EFO_0005755,rheumatic disease
1551,SCN10A,sodium voltage-gated channel alpha subunit 10,ROPIVACAINE,Small molecule,CHEMBL1077896,4.0,['NCT02299271'],EFO_0005755,rheumatic disease
